<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=us-ascii">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>Aerius, INN-desloratadine</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;}
@font-face
	{font-family:"Tms Rmn";
	panose-1:2 2 6 3 4 5 5 2 3 4;}
@font-face
	{font-family:Helv;
	panose-1:2 11 6 4 2 2 2 3 2 4;}
@font-face
	{font-family:"New York";
	panose-1:2 4 5 3 6 5 6 2 3 4;}
@font-face
	{font-family:System;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:Batang;
	panose-1:2 3 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:PMingLiU;
	panose-1:2 1 6 1 0 1 1 1 1 1;}
@font-face
	{font-family:"MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;}
@font-face
	{font-family:Dotum;
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:SimHei;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:MingLiU;
	panose-1:2 1 6 9 0 1 1 1 1 1;}
@font-face
	{font-family:Mincho;
	panose-1:2 2 6 9 4 3 5 8 3 5;}
@font-face
	{font-family:Gulim;
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:Century;
	panose-1:2 4 6 4 5 5 5 2 3 4;}
@font-face
	{font-family:"Angsana New";
	panose-1:2 2 6 3 5 4 5 2 3 4;}
@font-face
	{font-family:"Cordia New";
	panose-1:2 11 3 4 2 2 2 2 2 4;}
@font-face
	{font-family:Mangal;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Latha;
	panose-1:2 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Sylfaen;
	panose-1:1 10 5 2 5 3 6 3 3 3;}
@font-face
	{font-family:Vrinda;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Raavi;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Shruti;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Sendnya;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Gautami;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tunga;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Estrangelo Edessa";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Yu Gothic";
	panose-1:2 11 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:DengXian;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Palatino Linotype";
	panose-1:2 4 5 2 5 5 5 3 3 4;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:"Segoe UI Emoji";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI Symbol";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:BISansCond;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Arial Black";
	panose-1:2 11 10 4 2 1 2 2 2 4;}
@font-face
	{font-family:"Bahnschrift Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiLight";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Bahnschrift;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiBold";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift Light SemiCondensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiLight SemiConde";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiCondensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiBold SemiConden";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift Light Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiLight Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiBold Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Candara;
	panose-1:2 14 5 2 3 3 3 2 2 4;}
@font-face
	{font-family:"Candara Light";
	panose-1:2 14 5 2 3 3 3 2 2 4;}
@font-face
	{font-family:"Comic Sans MS";
	panose-1:3 15 7 2 3 3 2 2 2 4;}
@font-face
	{font-family:Consolas;
	panose-1:2 11 6 9 2 2 4 3 2 4;}
@font-face
	{font-family:Constantia;
	panose-1:2 3 6 2 5 3 6 3 3 3;}
@font-face
	{font-family:Corbel;
	panose-1:2 11 5 3 2 2 4 2 2 4;}
@font-face
	{font-family:"Corbel Light";
	panose-1:2 11 3 3 2 2 4 2 2 4;}
@font-face
	{font-family:Ebrima;
	panose-1:2 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Franklin Gothic Medium";
	panose-1:2 11 6 3 2 1 2 2 2 4;}
@font-face
	{font-family:Gabriola;
	panose-1:4 4 6 5 5 16 2 2 13 2;}
@font-face
	{font-family:Gadugi;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Georgia;
	panose-1:2 4 5 2 5 4 5 2 3 3;}
@font-face
	{font-family:Impact;
	panose-1:2 11 8 6 3 9 2 5 2 4;}
@font-face
	{font-family:"Ink Free";
	panose-1:3 8 4 2 0 5 0 0 0 0;}
@font-face
	{font-family:"Javanese Text";
	panose-1:2 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Leelawadee UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Leelawadee UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Lucida Console";
	panose-1:2 11 6 9 4 5 4 2 2 4;}
@font-face
	{font-family:"Lucida Sans Unicode";
	panose-1:2 11 6 2 3 5 4 2 2 4;}
@font-face
	{font-family:"Malgun Gothic";
	panose-1:2 11 5 3 2 0 0 2 0 4;}
@font-face
	{font-family:"\@Malgun Gothic";}
@font-face
	{font-family:"Malgun Gothic Semilight";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"\@Malgun Gothic Semilight";}
@font-face
	{font-family:"Microsoft Himalaya";
	panose-1:1 1 1 0 1 1 1 1 1 1;}
@font-face
	{font-family:"Microsoft JhengHei";
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@Microsoft JhengHei";}
@font-face
	{font-family:"Microsoft JhengHei UI";
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@Microsoft JhengHei UI";}
@font-face
	{font-family:"Microsoft JhengHei Light";
	panose-1:2 11 3 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@Microsoft JhengHei Light";}
@font-face
	{font-family:"Microsoft JhengHei UI Light";
	panose-1:2 11 3 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@Microsoft JhengHei UI Light";}
@font-face
	{font-family:"Microsoft New Tai Lue";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Microsoft PhagsPa";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Microsoft Sans Serif";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:"Microsoft Tai Le";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Microsoft YaHei";
	panose-1:2 11 5 3 2 2 4 2 2 4;}
@font-face
	{font-family:"\@Microsoft YaHei";}
@font-face
	{font-family:"Microsoft YaHei UI";
	panose-1:2 11 5 3 2 2 4 2 2 4;}
@font-face
	{font-family:"\@Microsoft YaHei UI";}
@font-face
	{font-family:"Microsoft YaHei Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"\@Microsoft YaHei Light";}
@font-face
	{font-family:"Microsoft YaHei UI Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"\@Microsoft YaHei UI Light";}
@font-face
	{font-family:"Microsoft Yi Baiti";
	panose-1:3 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:MingLiU-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@MingLiU-ExtB";}
@font-face
	{font-family:PMingLiU-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@PMingLiU-ExtB";}
@font-face
	{font-family:MingLiU_HKSCS-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@MingLiU_HKSCS-ExtB";}
@font-face
	{font-family:"Mongolian Baiti";
	panose-1:3 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;}
@font-face
	{font-family:"MS UI Gothic";
	panose-1:2 11 6 0 7 2 5 8 2 4;}
@font-face
	{font-family:"\@MS UI Gothic";}
@font-face
	{font-family:"MS PGothic";
	panose-1:2 11 6 0 7 2 5 8 2 4;}
@font-face
	{font-family:"\@MS PGothic";}
@font-face
	{font-family:"MV Boli";
	panose-1:2 0 5 0 3 2 0 9 0 0;}
@font-face
	{font-family:"Myanmar Text";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Nirmala UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Nirmala UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe MDL2 Assets";
	panose-1:5 10 1 2 1 1 1 1 1 1;}
@font-face
	{font-family:"Segoe Print";
	panose-1:2 0 6 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Segoe Script";
	panose-1:3 11 5 4 2 0 0 0 0 3;}
@font-face
	{font-family:"Segoe UI Black";
	panose-1:2 11 10 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Historic";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Semibold";
	panose-1:2 11 7 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:NSimSun;
	panose-1:2 1 6 9 3 1 1 1 1 1;}
@font-face
	{font-family:"\@NSimSun";}
@font-face
	{font-family:SimSun-ExtB;
	panose-1:2 1 6 9 6 1 1 1 1 1;}
@font-face
	{font-family:"\@SimSun-ExtB";}
@font-face
	{font-family:"Sitka Small";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Text";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Subheading";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Heading";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Display";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Banner";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Trebuchet MS";
	panose-1:2 11 6 3 2 2 2 2 2 4;}
@font-face
	{font-family:Webdings;
	panose-1:5 3 1 2 1 5 9 6 7 3;}
@font-face
	{font-family:"\@Yu Gothic";
	panose-1:2 11 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Yu Gothic UI";
	panose-1:2 11 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic UI";}
@font-face
	{font-family:"Yu Gothic UI Semibold";
	panose-1:2 11 7 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic UI Semibold";}
@font-face
	{font-family:"Yu Gothic Light";
	panose-1:2 11 3 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic Light";}
@font-face
	{font-family:"Yu Gothic UI Light";
	panose-1:2 11 3 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic UI Light";}
@font-face
	{font-family:"Yu Gothic Medium";
	panose-1:2 11 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic Medium";}
@font-face
	{font-family:"Yu Gothic UI Semilight";
	panose-1:2 11 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic UI Semilight";}
@font-face
	{font-family:"HoloLens MDL2 Assets";
	panose-1:5 10 1 2 1 1 1 1 1 1;}
@font-face
	{font-family:"Agency FB";
	panose-1:2 11 5 3 2 2 2 2 2 4;}
@font-face
	{font-family:Algerian;
	panose-1:4 2 7 5 4 10 2 6 7 2;}
@font-face
	{font-family:"Book Antiqua";
	panose-1:2 4 6 2 5 3 5 3 3 4;}
@font-face
	{font-family:"Arial Narrow";
	panose-1:2 11 6 6 2 2 2 3 2 4;}
@font-face
	{font-family:"Arial Rounded MT Bold";
	panose-1:2 15 7 4 3 5 4 3 2 4;}
@font-face
	{font-family:"Baskerville Old Face";
	panose-1:2 2 6 2 8 5 5 2 3 3;}
@font-face
	{font-family:"Bauhaus 93";
	panose-1:4 3 9 5 2 11 2 2 12 2;}
@font-face
	{font-family:"Bell MT";
	panose-1:2 2 5 3 6 3 5 2 3 3;}
@font-face
	{font-family:"Bernard MT Condensed";
	panose-1:2 5 8 6 6 9 5 2 4 4;}
@font-face
	{font-family:"Bodoni MT";
	panose-1:2 7 6 3 8 6 6 2 2 3;}
@font-face
	{font-family:"Bodoni MT Black";
	panose-1:2 7 10 3 8 6 6 2 2 3;}
@font-face
	{font-family:"Bodoni MT Condensed";
	panose-1:2 7 6 6 8 6 6 2 2 3;}
@font-face
	{font-family:"Bodoni MT Poster Compressed";
	panose-1:2 7 7 6 8 6 1 5 2 4;}
@font-face
	{font-family:"Bookman Old Style";
	panose-1:2 5 6 4 5 5 5 2 2 4;}
@font-face
	{font-family:"Bradley Hand ITC";
	panose-1:3 7 4 2 5 3 2 3 2 3;}
@font-face
	{font-family:"Britannic Bold";
	panose-1:2 11 9 3 6 7 3 2 2 4;}
@font-face
	{font-family:"Berlin Sans FB";
	panose-1:2 14 6 2 2 5 2 2 3 6;}
@font-face
	{font-family:"Berlin Sans FB Demi";
	panose-1:2 14 8 2 2 5 2 2 3 6;}
@font-face
	{font-family:Broadway;
	panose-1:4 4 9 5 8 11 2 2 5 2;}
@font-face
	{font-family:"Brush Script MT";
	panose-1:3 6 8 2 4 4 6 7 3 4;}
@font-face
	{font-family:"Bookshelf Symbol 7";
	panose-1:5 1 1 1 1 1 1 1 1 1;}
@font-face
	{font-family:"Californian FB";
	panose-1:2 7 4 3 6 8 11 3 2 4;}
@font-face
	{font-family:"Calisto MT";
	panose-1:2 4 6 3 5 5 5 3 3 4;}
@font-face
	{font-family:Castellar;
	panose-1:2 10 4 2 6 4 6 1 3 1;}
@font-face
	{font-family:"Century Schoolbook";
	panose-1:2 4 6 4 5 5 5 2 3 4;}
@font-face
	{font-family:Centaur;
	panose-1:2 3 5 4 5 2 5 2 3 4;}
@font-face
	{font-family:Chiller;
	panose-1:4 2 4 4 3 16 7 2 6 2;}
@font-face
	{font-family:"Colonna MT";
	panose-1:4 2 8 5 6 2 2 3 2 3;}
@font-face
	{font-family:"Cooper Black";
	panose-1:2 8 9 4 4 3 11 2 4 4;}
@font-face
	{font-family:"Copperplate Gothic Bold";
	panose-1:2 14 7 5 2 2 6 2 4 4;}
@font-face
	{font-family:"Copperplate Gothic Light";
	panose-1:2 14 5 7 2 2 6 2 4 4;}
@font-face
	{font-family:"Curlz MT";
	panose-1:4 4 4 4 5 7 2 2 2 2;}
@font-face
	{font-family:Dubai;
	panose-1:2 11 5 3 3 4 3 3 2 4;}
@font-face
	{font-family:"Dubai Light";
	panose-1:2 11 3 3 3 4 3 3 2 4;}
@font-face
	{font-family:"Dubai Medium";
	panose-1:2 11 6 3 3 4 3 3 2 4;}
@font-face
	{font-family:Elephant;
	panose-1:2 2 9 4 9 5 5 2 3 3;}
@font-face
	{font-family:"Engravers MT";
	panose-1:2 9 7 7 8 5 5 2 3 4;}
@font-face
	{font-family:"Eras Bold ITC";
	panose-1:2 11 9 7 3 5 4 2 2 4;}
@font-face
	{font-family:"Eras Demi ITC";
	panose-1:2 11 8 5 3 5 4 2 8 4;}
@font-face
	{font-family:"Eras Light ITC";
	panose-1:2 11 4 2 3 5 4 2 8 4;}
@font-face
	{font-family:"Eras Medium ITC";
	panose-1:2 11 6 2 3 5 4 2 8 4;}
@font-face
	{font-family:"Felix Titling";
	panose-1:4 6 5 5 6 2 2 2 10 4;}
@font-face
	{font-family:Forte;
	panose-1:3 6 9 2 4 5 2 7 2 3;}
@font-face
	{font-family:"Franklin Gothic Book";
	panose-1:2 11 5 3 2 1 2 2 2 4;}
@font-face
	{font-family:"Franklin Gothic Demi";
	panose-1:2 11 7 3 2 1 2 2 2 4;}
@font-face
	{font-family:"Franklin Gothic Demi Cond";
	panose-1:2 11 7 6 3 4 2 2 2 4;}
@font-face
	{font-family:"Franklin Gothic Heavy";
	panose-1:2 11 9 3 2 1 2 2 2 4;}
@font-face
	{font-family:"Franklin Gothic Medium Cond";
	panose-1:2 11 6 6 3 4 2 2 2 4;}
@font-face
	{font-family:"Freestyle Script";
	panose-1:3 8 4 2 3 2 5 11 4 4;}
@font-face
	{font-family:"French Script MT";
	panose-1:3 2 4 2 4 6 7 4 6 5;}
@font-face
	{font-family:"Footlight MT Light";
	panose-1:2 4 6 2 6 3 10 2 3 4;}
@font-face
	{font-family:Garamond;
	panose-1:2 2 4 4 3 3 1 1 8 3;}
@font-face
	{font-family:Gigi;
	panose-1:4 4 5 4 6 16 7 2 13 2;}
@font-face
	{font-family:"Gill Sans MT";
	panose-1:2 11 5 2 2 1 4 2 2 3;}
@font-face
	{font-family:"Gill Sans MT Condensed";
	panose-1:2 11 5 6 2 1 4 2 2 3;}
@font-face
	{font-family:"Gill Sans Ultra Bold Condensed";
	panose-1:2 11 10 6 2 1 4 2 2 3;}
@font-face
	{font-family:"Gill Sans Ultra Bold";
	panose-1:2 11 10 2 2 1 4 2 2 3;}
@font-face
	{font-family:"Gloucester MT Extra Condensed";
	panose-1:2 3 8 8 2 6 1 1 1 1;}
@font-face
	{font-family:"Gill Sans MT Ext Condensed Bold";
	panose-1:2 11 9 2 2 1 4 2 2 3;}
@font-face
	{font-family:"Century Gothic";
	panose-1:2 11 5 2 2 2 2 2 2 4;}
@font-face
	{font-family:"Goudy Old Style";
	panose-1:2 2 5 2 5 3 5 2 3 3;}
@font-face
	{font-family:"Goudy Stout";
	panose-1:2 2 9 4 7 3 11 2 4 1;}
@font-face
	{font-family:"Harlow Solid Italic";
	panose-1:4 3 6 4 2 15 2 2 13 2;}
@font-face
	{font-family:Harrington;
	panose-1:4 4 5 5 5 10 2 2 7 2;}
@font-face
	{font-family:Haettenschweiler;
	panose-1:2 11 7 6 4 9 2 6 2 4;}
@font-face
	{font-family:"High Tower Text";
	panose-1:2 4 5 2 5 5 6 3 3 3;}
@font-face
	{font-family:"Imprint MT Shadow";
	panose-1:4 2 6 5 6 3 3 3 2 2;}
@font-face
	{font-family:"Informal Roman";
	panose-1:3 6 4 2 3 4 6 11 2 4;}
@font-face
	{font-family:"Blackadder ITC";
	panose-1:4 2 5 5 5 16 7 2 13 2;}
@font-face
	{font-family:"Edwardian Script ITC";
	panose-1:3 3 3 2 4 7 7 13 8 4;}
@font-face
	{font-family:"Kristen ITC";
	panose-1:3 5 5 2 4 2 2 3 2 2;}
@font-face
	{font-family:Jokerman;
	panose-1:4 9 6 5 6 13 6 2 7 2;}
@font-face
	{font-family:"Juice ITC";
	panose-1:4 4 4 3 4 10 2 2 2 2;}
@font-face
	{font-family:"Kunstler Script";
	panose-1:3 3 4 2 2 6 7 13 13 6;}
@font-face
	{font-family:"Wide Latin";
	panose-1:2 10 10 7 5 5 5 2 4 4;}
@font-face
	{font-family:"Lucida Bright";
	panose-1:2 4 6 2 5 5 5 2 3 4;}
@font-face
	{font-family:"Lucida Calligraphy";
	panose-1:3 1 1 1 1 1 1 1 1 1;}
@font-face
	{font-family:"Lucida Fax";
	panose-1:2 6 6 2 5 5 5 2 2 4;}
@font-face
	{font-family:"Lucida Handwriting";
	panose-1:3 1 1 1 1 1 1 1 1 1;}
@font-face
	{font-family:"Lucida Sans";
	panose-1:2 11 6 2 3 5 4 2 2 4;}
@font-face
	{font-family:"Lucida Sans Typewriter";
	panose-1:2 11 5 9 3 5 4 3 2 4;}
@font-face
	{font-family:Magneto;
	panose-1:4 3 8 5 5 8 2 2 13 2;}
@font-face
	{font-family:"Maiandra GD";
	panose-1:2 14 5 2 3 3 8 2 2 4;}
@font-face
	{font-family:"Matura MT Script Capitals";
	panose-1:3 2 8 2 6 6 2 7 2 2;}
@font-face
	{font-family:Mistral;
	panose-1:3 9 7 2 3 4 7 2 4 3;}
@font-face
	{font-family:"Modern No\. 20";
	panose-1:2 7 7 4 7 5 5 2 3 3;}
@font-face
	{font-family:"Monotype Corsiva";
	panose-1:3 1 1 1 1 2 1 1 1 1;}
@font-face
	{font-family:"Niagara Engraved";
	panose-1:4 2 5 2 7 7 3 3 2 2;}
@font-face
	{font-family:"Niagara Solid";
	panose-1:4 2 5 2 7 7 2 2 2 2;}
@font-face
	{font-family:"OCR A Extended";
	panose-1:2 1 5 9 2 1 2 1 3 3;}
@font-face
	{font-family:"Old English Text MT";
	panose-1:3 4 9 2 4 5 8 3 8 6;}
@font-face
	{font-family:Onyx;
	panose-1:4 5 6 2 8 7 2 2 2 3;}
@font-face
	{font-family:"MS Outlook";
	panose-1:5 1 1 0 1 0 0 0 0 0;}
@font-face
	{font-family:"Palace Script MT";
	panose-1:3 3 3 2 2 6 7 12 11 5;}
@font-face
	{font-family:Papyrus;
	panose-1:3 7 5 2 6 5 2 3 2 5;}
@font-face
	{font-family:Parchment;
	panose-1:3 4 6 2 4 7 8 4 8 4;}
@font-face
	{font-family:Perpetua;
	panose-1:2 2 5 2 6 4 1 2 3 3;}
@font-face
	{font-family:"Perpetua Titling MT";
	panose-1:2 2 5 2 6 5 5 2 8 4;}
@font-face
	{font-family:Playbill;
	panose-1:4 5 6 3 10 6 2 2 2 2;}
@font-face
	{font-family:"Poor Richard";
	panose-1:2 8 5 2 5 5 5 2 7 2;}
@font-face
	{font-family:Pristina;
	panose-1:3 6 4 2 4 4 6 8 2 4;}
@font-face
	{font-family:"Rage Italic";
	panose-1:3 7 5 2 4 5 7 7 3 4;}
@font-face
	{font-family:Ravie;
	panose-1:4 4 8 5 5 8 9 2 6 2;}
@font-face
	{font-family:"MS Reference Sans Serif";
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"MS Reference Specialty";
	panose-1:5 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Rockwell Condensed";
	panose-1:2 6 6 3 5 4 5 2 1 4;}
@font-face
	{font-family:Rockwell;
	panose-1:2 6 6 3 2 2 5 2 4 3;}
@font-face
	{font-family:"Rockwell Extra Bold";
	panose-1:2 6 9 3 4 5 5 2 4 3;}
@font-face
	{font-family:"Script MT Bold";
	panose-1:3 4 6 2 4 6 7 8 9 4;}
@font-face
	{font-family:"Showcard Gothic";
	panose-1:4 2 9 4 2 1 2 2 6 4;}
@font-face
	{font-family:"Snap ITC";
	panose-1:4 4 10 7 6 10 2 2 2 2;}
@font-face
	{font-family:Stencil;
	panose-1:4 4 9 5 13 8 2 2 4 4;}
@font-face
	{font-family:"Tw Cen MT";
	panose-1:2 11 6 2 2 1 4 2 6 3;}
@font-face
	{font-family:"Tw Cen MT Condensed";
	panose-1:2 11 6 6 2 1 4 2 2 3;}
@font-face
	{font-family:"Tw Cen MT Condensed Extra Bold";
	panose-1:2 11 8 3 2 2 2 2 2 4;}
@font-face
	{font-family:"Tempus Sans ITC";
	panose-1:4 2 4 4 3 13 7 2 2 2;}
@font-face
	{font-family:"Viner Hand ITC";
	panose-1:3 7 5 2 3 5 2 2 2 3;}
@font-face
	{font-family:Vivaldi;
	panose-1:3 2 6 2 5 5 6 9 8 4;}
@font-face
	{font-family:"Vladimir Script";
	panose-1:3 5 4 2 4 4 7 7 3 5;}
@font-face
	{font-family:"Wingdings 2";
	panose-1:5 2 1 2 1 5 7 7 7 7;}
@font-face
	{font-family:"Wingdings 3";
	panose-1:5 4 1 2 1 8 7 7 7 7;}
@font-face
	{font-family:AngsanaUPC;}
@font-face
	{font-family:CordiaUPC;}
@font-face
	{font-family:Abadi;}
@font-face
	{font-family:"Abadi Extra Light";}
@font-face
	{font-family:Aharoni;}
@font-face
	{font-family:Aldhabi;}
@font-face
	{font-family:Aparajita;}
@font-face
	{font-family:"Arabic Typesetting";}
@font-face
	{font-family:"Arial Nova";}
@font-face
	{font-family:"Arial Nova Cond";}
@font-face
	{font-family:"Arial Nova Cond Light";}
@font-face
	{font-family:"Arial Nova Light";}
@font-face
	{font-family:"Avenir Next LT Pro";}
@font-face
	{font-family:"Avenir Next LT Pro Light";}
@font-face
	{font-family:BatangChe;}
@font-face
	{font-family:Bembo;}
@font-face
	{font-family:Biome;}
@font-face
	{font-family:"Biome Light";}
@font-face
	{font-family:"Browallia New";}
@font-face
	{font-family:BrowalliaUPC;}
@font-face
	{font-family:Cavolini;}
@font-face
	{font-family:Dante;}
@font-face
	{font-family:DaunPenh;}
@font-face
	{font-family:David;}
@font-face
	{font-family:Daytona;}
@font-face
	{font-family:"Daytona Condensed";}
@font-face
	{font-family:"Daytona Condensed Light";}
@font-face
	{font-family:"Daytona Light";}
@font-face
	{font-family:"DengXian Light";}
@font-face
	{font-family:DilleniaUPC;}
@font-face
	{font-family:DokChampa;}
@font-face
	{font-family:DotumChe;}
@font-face
	{font-family:"Elephant Pro";}
@font-face
	{font-family:EucrosiaUPC;}
@font-face
	{font-family:Euphemia;}
@font-face
	{font-family:FangSong;}
@font-face
	{font-family:FrankRuehl;}
@font-face
	{font-family:FreesiaUPC;}
@font-face
	{font-family:"Georgia Pro";}
@font-face
	{font-family:"Georgia Pro Black";}
@font-face
	{font-family:"Georgia Pro Cond";}
@font-face
	{font-family:"Georgia Pro Cond Black";}
@font-face
	{font-family:"Georgia Pro Cond Light";}
@font-face
	{font-family:"Georgia Pro Cond Semibold";}
@font-face
	{font-family:"Georgia Pro Light";}
@font-face
	{font-family:"Georgia Pro Semibold";}
@font-face
	{font-family:"Gill Sans Nova";}
@font-face
	{font-family:"Gill Sans Nova Cond";}
@font-face
	{font-family:"Gill Sans Nova Cond Lt";}
@font-face
	{font-family:"Gill Sans Nova Cond Ultra Bold";}
@font-face
	{font-family:"Gill Sans Nova Cond XBd";}
@font-face
	{font-family:"Gill Sans Nova Light";}
@font-face
	{font-family:"Gill Sans Nova Ultra Bold";}
@font-face
	{font-family:Gisha;}
@font-face
	{font-family:Grotesque;}
@font-face
	{font-family:"Grotesque Light";}
@font-face
	{font-family:GulimChe;}
@font-face
	{font-family:Gungsuh;}
@font-face
	{font-family:GungsuhChe;}
@font-face
	{font-family:"Hadassah Friedlaender";}
@font-face
	{font-family:HGGothicE;}
@font-face
	{font-family:HGMaruGothicMPRO;}
@font-face
	{font-family:HGMinchoE;}
@font-face
	{font-family:HGPGothicE;}
@font-face
	{font-family:HGPMinchoE;}
@font-face
	{font-family:HGPSoeiKakugothicUB;}
@font-face
	{font-family:HGSGothicE;}
@font-face
	{font-family:HGSMinchoE;}
@font-face
	{font-family:HGSoeiKakugothicUB;}
@font-face
	{font-family:HGSSoeiKakugothicUB;}
@font-face
	{font-family:IrisUPC;}
@font-face
	{font-family:"Iskoola Pota";}
@font-face
	{font-family:JasmineUPC;}
@font-face
	{font-family:KaiTi;}
@font-face
	{font-family:Kalinga;}
@font-face
	{font-family:Kartika;}
@font-face
	{font-family:"Khmer UI";}
@font-face
	{font-family:Kigelia;}
@font-face
	{font-family:"Kigelia Arabic";}
@font-face
	{font-family:"Kigelia Arabic Light";}
@font-face
	{font-family:"Kigelia Light";}
@font-face
	{font-family:KodchiangUPC;}
@font-face
	{font-family:Kokila;}
@font-face
	{font-family:"Lao UI";}
@font-face
	{font-family:Leelawadee;}
@font-face
	{font-family:"Levenim MT";}
@font-face
	{font-family:LilyUPC;}
@font-face
	{font-family:"Mangal Pro";}
@font-face
	{font-family:Meiryo;}
@font-face
	{font-family:"Meiryo UI";}
@font-face
	{font-family:"Microsoft GothicNeo";}
@font-face
	{font-family:"Microsoft GothicNeo Light";}
@font-face
	{font-family:"Microsoft Uighur";}
@font-face
	{font-family:MingLiU_HKSCS;}
@font-face
	{font-family:Miriam;}
@font-face
	{font-family:"Miriam Fixed";}
@font-face
	{font-family:"Modern Love";}
@font-face
	{font-family:"Modern Love Caps";}
@font-face
	{font-family:"Modern Love Grunge";}
@font-face
	{font-family:MoolBoran;}
@font-face
	{font-family:"MS PMincho";}
@font-face
	{font-family:"MT Extra";}
@font-face
	{font-family:Narkisim;}
@font-face
	{font-family:"Neue Haas Grotesk Text Pro";}
@font-face
	{font-family:"News Gothic MT";}
@font-face
	{font-family:Nyala;}
@font-face
	{font-family:OCRB;}
@font-face
	{font-family:"Plantagenet Cherokee";}
@font-face
	{font-family:Posterama;}
@font-face
	{font-family:"Quire Sans";}
@font-face
	{font-family:"Quire Sans Light";}
@font-face
	{font-family:"Quire Sans Pro Light";}
@font-face
	{font-family:"Rockwell Light";}
@font-face
	{font-family:"Rockwell Nova";}
@font-face
	{font-family:"Rockwell Nova Cond";}
@font-face
	{font-family:"Rockwell Nova Cond Light";}
@font-face
	{font-family:"Rockwell Nova Extra Bold";}
@font-face
	{font-family:"Rockwell Nova Light";}
@font-face
	{font-family:Rod;}
@font-face
	{font-family:"Sabon Next LT";}
@font-face
	{font-family:"Sagona Book";}
@font-face
	{font-family:"Sagona ExtraLight";}
@font-face
	{font-family:"Sakkal Majalla";}
@font-face
	{font-family:"Sanskrit Text";}
@font-face
	{font-family:Selawik;}
@font-face
	{font-family:"Selawik Light";}
@font-face
	{font-family:"Selawik Semibold";}
@font-face
	{font-family:"Shonar Bangla";}
@font-face
	{font-family:"Simplified Arabic";}
@font-face
	{font-family:"Simplified Arabic Fixed";}
@font-face
	{font-family:"Sitka Banner Semibold";}
@font-face
	{font-family:"Sitka Display Semibold";}
@font-face
	{font-family:"Sitka Heading Semibold";}
@font-face
	{font-family:"Sitka Small Semibold";}
@font-face
	{font-family:"Sitka Subheading Semibold";}
@font-face
	{font-family:"Sitka Text Semibold";}
@font-face
	{font-family:"Source Sans Pro";}
@font-face
	{font-family:"Source Sans Pro Black";}
@font-face
	{font-family:"Source Sans Pro ExtraLight";}
@font-face
	{font-family:"Source Sans Pro Light";}
@font-face
	{font-family:"Source Sans Pro SemiBold";}
@font-face
	{font-family:"Speak Pro";}
@font-face
	{font-family:"Speak Pro Light";}
@font-face
	{font-family:STCaiyun;}
@font-face
	{font-family:STFangsong;}
@font-face
	{font-family:STHupo;}
@font-face
	{font-family:STKaiti;}
@font-face
	{font-family:STXihei;}
@font-face
	{font-family:STXingkai;}
@font-face
	{font-family:STXinwei;}
@font-face
	{font-family:STZhongsong;}
@font-face
	{font-family:"TH SarabunPSK";}
@font-face
	{font-family:"The Hand";}
@font-face
	{font-family:"The Hand Black";}
@font-face
	{font-family:"The Hand Extrablack";}
@font-face
	{font-family:"The Hand Light";}
@font-face
	{font-family:"The Serif Hand";}
@font-face
	{font-family:"The Serif Hand Black";}
@font-face
	{font-family:"The Serif Hand Extrablack";}
@font-face
	{font-family:"The Serif Hand Light";}
@font-face
	{font-family:"Tisa Offc Serif Pro";}
@font-face
	{font-family:"Tisa Offc Serif Pro Thin";}
@font-face
	{font-family:"Trade Gothic Next";}
@font-face
	{font-family:"Trade Gothic Next Cond";}
@font-face
	{font-family:"Trade Gothic Next Cond Hv";}
@font-face
	{font-family:"Trade Gothic Next Heavy";}
@font-face
	{font-family:"Trade Gothic Next Light";}
@font-face
	{font-family:"Traditional Arabic";}
@font-face
	{font-family:"UD Digi Kyokasho N-B";}
@font-face
	{font-family:"UD Digi Kyokasho N-R";}
@font-face
	{font-family:"UD Digi Kyokasho NK-B";}
@font-face
	{font-family:"UD Digi Kyokasho NK-R";}
@font-face
	{font-family:"UD Digi Kyokasho NP-B";}
@font-face
	{font-family:"UD Digi Kyokasho NP-R";}
@font-face
	{font-family:Univers;}
@font-face
	{font-family:"Univers Condensed";}
@font-face
	{font-family:"Univers Condensed Light";}
@font-face
	{font-family:"Univers Light";}
@font-face
	{font-family:"Urdu Typesetting";}
@font-face
	{font-family:Utsaah;}
@font-face
	{font-family:Vani;}
@font-face
	{font-family:"Verdana Pro";}
@font-face
	{font-family:"Verdana Pro Black";}
@font-face
	{font-family:"Verdana Pro Cond";}
@font-face
	{font-family:"Verdana Pro Cond Black";}
@font-face
	{font-family:"Verdana Pro Cond Light";}
@font-face
	{font-family:"Verdana Pro Cond SemiBold";}
@font-face
	{font-family:"Verdana Pro Light";}
@font-face
	{font-family:"Verdana Pro SemiBold";}
@font-face
	{font-family:Vijaya;}
@font-face
	{font-family:"Walbaum Display";}
@font-face
	{font-family:"Walbaum Display Heavy";}
@font-face
	{font-family:"Walbaum Display Light";}
@font-face
	{font-family:"Walbaum Display SemiBold";}
@font-face
	{font-family:"Walbaum Heading";}
@font-face
	{font-family:"Walbaum Text";}
@font-face
	{font-family:"Yu Mincho";}
@font-face
	{font-family:"Yu Mincho Demibold";}
@font-face
	{font-family:"Yu Mincho Light";}
@font-face
	{font-family:"TimesNewRoman\,Italic";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:TimesNewRoman;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Arial\,Italic";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:TimesNewRomanPSMT;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Times New Roman Bold";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:PraxisCom-Regular;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Arial Bold";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:EUAlbertina;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 5 4 5 2 3 4;}
@font-face
	{font-family:"\@TimesNewRoman\,Italic";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Arial\,Italic";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:"\@Batang";
	panose-1:2 3 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:"\@BatangChe";}
@font-face
	{font-family:"\@Gungsuh";}
@font-face
	{font-family:"\@GungsuhChe";}
@font-face
	{font-family:"\@DengXian Light";}
@font-face
	{font-family:"\@Gulim";
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:"\@GulimChe";}
@font-face
	{font-family:"\@Dotum";
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:"\@DotumChe";}
@font-face
	{font-family:"\@Meiryo";}
@font-face
	{font-family:"\@Meiryo UI";}
@font-face
	{font-family:"\@MingLiU";
	panose-1:2 1 6 9 0 1 1 1 1 1;}
@font-face
	{font-family:"\@PMingLiU";
	panose-1:2 1 6 1 0 1 1 1 1 1;}
@font-face
	{font-family:"\@MingLiU_HKSCS";}
@font-face
	{font-family:"\@MS PMincho";}
@font-face
	{font-family:"\@STXingkai";}
@font-face
	{font-family:"\@STZhongsong";}
@font-face
	{font-family:"\@Yu Mincho";}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
h1
	{margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:17.85pt;
	text-indent:-17.85pt;
	line-height:13.0pt;
	font-size:13.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
h2
	{margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Helvetica",sans-serif;
	font-weight:bold;
	font-style:italic;}
h3
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:4.0pt;
	margin-left:0in;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
h4
	{margin:0in;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
h5
	{margin:0in;
	text-align:justify;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
h6
	{margin:0in;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:normal;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-link:"Heading 7 Char";
	margin:0in;
	text-align:justify;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{margin:0in;
	text-align:center;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{margin-top:0in;
	margin-right:70.8pt;
	margin-bottom:0in;
	margin-left:85.05pt;
	text-indent:-28.35pt;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoIndex1, li.MsoIndex1, div.MsoIndex1
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex2, li.MsoIndex2, div.MsoIndex2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:22.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex3, li.MsoIndex3, div.MsoIndex3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:33.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex4, li.MsoIndex4, div.MsoIndex4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:44.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex5, li.MsoIndex5, div.MsoIndex5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:55.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex6, li.MsoIndex6, div.MsoIndex6
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:66.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex7, li.MsoIndex7, div.MsoIndex7
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:77.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex8, li.MsoIndex8, div.MsoIndex8
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:88.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex9, li.MsoIndex9, div.MsoIndex9
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:99.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc1, li.MsoToc1, div.MsoToc1
	{margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc2, li.MsoToc2, div.MsoToc2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc3, li.MsoToc3, div.MsoToc3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:22.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc4, li.MsoToc4, div.MsoToc4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:33.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc5, li.MsoToc5, div.MsoToc5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:44.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc6, li.MsoToc6, div.MsoToc6
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:55.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc7, li.MsoToc7, div.MsoToc7
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:66.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc8, li.MsoToc8, div.MsoToc8
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:77.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc9, li.MsoToc9, div.MsoToc9
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:88.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoNormalIndent, li.MsoNormalIndent, div.MsoNormalIndent
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-link:"Footnote Text Char";
	margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-link:"Comment Text Char";
	margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	font-size:8.0pt;
	font-family:"Arial",sans-serif;}
p.MsoIndexHeading, li.MsoIndexHeading, div.MsoIndexHeading
	{margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Cambria",serif;
	font-weight:bold;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{margin:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoTof, li.MsoTof, div.MsoTof
	{margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoEnvelopeAddress, li.MsoEnvelopeAddress, div.MsoEnvelopeAddress
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	line-height:13.0pt;
	font-size:12.0pt;
	font-family:"Cambria",serif;}
p.MsoEnvelopeReturn, li.MsoEnvelopeReturn, div.MsoEnvelopeReturn
	{margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Cambria",serif;}
span.MsoEndnoteReference
	{vertical-align:super;}
p.MsoEndnoteText, li.MsoEndnoteText, div.MsoEndnoteText
	{mso-style-link:"Endnote Text Char";
	margin:0in;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToa, li.MsoToa, div.MsoToa
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoMacroText, li.MsoMacroText, div.MsoMacroText
	{mso-style-link:"Macro Text Char";
	margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Courier New";}
p.MsoToaHeading, li.MsoToaHeading, div.MsoToaHeading
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	line-height:13.0pt;
	font-size:12.0pt;
	font-family:"Cambria",serif;
	font-weight:bold;}
p.MsoList, li.MsoList, div.MsoList
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListCxSpFirst, li.MsoListCxSpFirst, div.MsoListCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListCxSpMiddle, li.MsoListCxSpMiddle, div.MsoListCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListCxSpLast, li.MsoListCxSpLast, div.MsoListCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet, li.MsoListBullet, div.MsoListBullet
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBulletCxSpFirst, li.MsoListBulletCxSpFirst, div.MsoListBulletCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBulletCxSpMiddle, li.MsoListBulletCxSpMiddle, div.MsoListBulletCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBulletCxSpLast, li.MsoListBulletCxSpLast, div.MsoListBulletCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber, li.MsoListNumber, div.MsoListNumber
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumberCxSpFirst, li.MsoListNumberCxSpFirst, div.MsoListNumberCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumberCxSpMiddle, li.MsoListNumberCxSpMiddle, div.MsoListNumberCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumberCxSpLast, li.MsoListNumberCxSpLast, div.MsoListNumberCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList2, li.MsoList2, div.MsoList2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList2CxSpFirst, li.MsoList2CxSpFirst, div.MsoList2CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList2CxSpMiddle, li.MsoList2CxSpMiddle, div.MsoList2CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList2CxSpLast, li.MsoList2CxSpLast, div.MsoList2CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList3, li.MsoList3, div.MsoList3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList3CxSpFirst, li.MsoList3CxSpFirst, div.MsoList3CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList3CxSpMiddle, li.MsoList3CxSpMiddle, div.MsoList3CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList3CxSpLast, li.MsoList3CxSpLast, div.MsoList3CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList4, li.MsoList4, div.MsoList4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList4CxSpFirst, li.MsoList4CxSpFirst, div.MsoList4CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList4CxSpMiddle, li.MsoList4CxSpMiddle, div.MsoList4CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList4CxSpLast, li.MsoList4CxSpLast, div.MsoList4CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList5, li.MsoList5, div.MsoList5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList5CxSpFirst, li.MsoList5CxSpFirst, div.MsoList5CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList5CxSpMiddle, li.MsoList5CxSpMiddle, div.MsoList5CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList5CxSpLast, li.MsoList5CxSpLast, div.MsoList5CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet2, li.MsoListBullet2, div.MsoListBullet2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet2CxSpFirst, li.MsoListBullet2CxSpFirst, div.MsoListBullet2CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet2CxSpMiddle, li.MsoListBullet2CxSpMiddle, div.MsoListBullet2CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet2CxSpLast, li.MsoListBullet2CxSpLast, div.MsoListBullet2CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet3, li.MsoListBullet3, div.MsoListBullet3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet3CxSpFirst, li.MsoListBullet3CxSpFirst, div.MsoListBullet3CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet3CxSpMiddle, li.MsoListBullet3CxSpMiddle, div.MsoListBullet3CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet3CxSpLast, li.MsoListBullet3CxSpLast, div.MsoListBullet3CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet4, li.MsoListBullet4, div.MsoListBullet4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet4CxSpFirst, li.MsoListBullet4CxSpFirst, div.MsoListBullet4CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet4CxSpMiddle, li.MsoListBullet4CxSpMiddle, div.MsoListBullet4CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet4CxSpLast, li.MsoListBullet4CxSpLast, div.MsoListBullet4CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet5, li.MsoListBullet5, div.MsoListBullet5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet5CxSpFirst, li.MsoListBullet5CxSpFirst, div.MsoListBullet5CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet5CxSpMiddle, li.MsoListBullet5CxSpMiddle, div.MsoListBullet5CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet5CxSpLast, li.MsoListBullet5CxSpLast, div.MsoListBullet5CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber2, li.MsoListNumber2, div.MsoListNumber2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber2CxSpFirst, li.MsoListNumber2CxSpFirst, div.MsoListNumber2CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber2CxSpMiddle, li.MsoListNumber2CxSpMiddle, div.MsoListNumber2CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber2CxSpLast, li.MsoListNumber2CxSpLast, div.MsoListNumber2CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber3, li.MsoListNumber3, div.MsoListNumber3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber3CxSpFirst, li.MsoListNumber3CxSpFirst, div.MsoListNumber3CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber3CxSpMiddle, li.MsoListNumber3CxSpMiddle, div.MsoListNumber3CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber3CxSpLast, li.MsoListNumber3CxSpLast, div.MsoListNumber3CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber4, li.MsoListNumber4, div.MsoListNumber4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber4CxSpFirst, li.MsoListNumber4CxSpFirst, div.MsoListNumber4CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber4CxSpMiddle, li.MsoListNumber4CxSpMiddle, div.MsoListNumber4CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber4CxSpLast, li.MsoListNumber4CxSpLast, div.MsoListNumber4CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber5, li.MsoListNumber5, div.MsoListNumber5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber5CxSpFirst, li.MsoListNumber5CxSpFirst, div.MsoListNumber5CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber5CxSpMiddle, li.MsoListNumber5CxSpMiddle, div.MsoListNumber5CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber5CxSpLast, li.MsoListNumber5CxSpLast, div.MsoListNumber5CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{mso-style-link:"Title Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	text-align:center;
	line-height:13.0pt;
	font-size:16.0pt;
	font-family:"Cambria",serif;
	font-weight:bold;}
p.MsoClosing, li.MsoClosing, div.MsoClosing
	{mso-style-link:"Closing Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:3.0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoSignature, li.MsoSignature, div.MsoSignature
	{mso-style-link:"Signature Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:3.0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-link:"Body Text Char";
	margin:0in;
	text-align:justify;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{mso-style-link:"Body Text Indent Char";
	margin:0in;
	text-align:justify;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoListContinue, li.MsoListContinue, div.MsoListContinue
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinueCxSpFirst, li.MsoListContinueCxSpFirst, div.MsoListContinueCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinueCxSpMiddle, li.MsoListContinueCxSpMiddle, div.MsoListContinueCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinueCxSpLast, li.MsoListContinueCxSpLast, div.MsoListContinueCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue2, li.MsoListContinue2, div.MsoListContinue2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.5in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue2CxSpFirst, li.MsoListContinue2CxSpFirst, div.MsoListContinue2CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue2CxSpMiddle, li.MsoListContinue2CxSpMiddle, div.MsoListContinue2CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue2CxSpLast, li.MsoListContinue2CxSpLast, div.MsoListContinue2CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.5in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue3, li.MsoListContinue3, div.MsoListContinue3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue3CxSpFirst, li.MsoListContinue3CxSpFirst, div.MsoListContinue3CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue3CxSpMiddle, li.MsoListContinue3CxSpMiddle, div.MsoListContinue3CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue3CxSpLast, li.MsoListContinue3CxSpLast, div.MsoListContinue3CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue4, li.MsoListContinue4, div.MsoListContinue4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue4CxSpFirst, li.MsoListContinue4CxSpFirst, div.MsoListContinue4CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue4CxSpMiddle, li.MsoListContinue4CxSpMiddle, div.MsoListContinue4CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue4CxSpLast, li.MsoListContinue4CxSpLast, div.MsoListContinue4CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue5, li.MsoListContinue5, div.MsoListContinue5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue5CxSpFirst, li.MsoListContinue5CxSpFirst, div.MsoListContinue5CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue5CxSpMiddle, li.MsoListContinue5CxSpMiddle, div.MsoListContinue5CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue5CxSpLast, li.MsoListContinue5CxSpLast, div.MsoListContinue5CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoMessageHeader, li.MsoMessageHeader, div.MsoMessageHeader
	{mso-style-link:"Message Header Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:13.0pt;
	background:#CCCCCC;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Cambria",serif;}
p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle
	{mso-style-link:"Subtitle Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	text-align:center;
	line-height:13.0pt;
	font-size:12.0pt;
	font-family:"Cambria",serif;}
p.MsoSalutation, li.MsoSalutation, div.MsoSalutation
	{mso-style-link:"Salutation Char";
	margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoDate, li.MsoDate, div.MsoDate
	{mso-style-link:"Date Char";
	margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyTextFirstIndent, li.MsoBodyTextFirstIndent, div.MsoBodyTextFirstIndent
	{mso-style-link:"Body Text First Indent Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-indent:10.5pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyTextFirstIndent2, li.MsoBodyTextFirstIndent2, div.MsoBodyTextFirstIndent2
	{mso-style-link:"Body Text First Indent 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	text-indent:10.5pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoNoteHeading, li.MsoNoteHeading, div.MsoNoteHeading
	{mso-style-link:"Note Heading Char";
	margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	color:black;}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin-top:0in;
	margin-right:-.1pt;
	margin-bottom:0in;
	margin-left:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:-.15pt;}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-indent:-28.35pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-indent:-28.35pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBlockText, li.MsoBlockText, div.MsoBlockText
	{margin-top:0in;
	margin-right:-.25in;
	margin-bottom:0in;
	margin-left:.5in;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:#954F72;
	text-decoration:underline;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-link:"Document Map Char";
	margin:0in;
	line-height:13.0pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{margin:0in;
	font-size:10.0pt;
	font-family:"Courier New";}
p.MsoAutoSig, li.MsoAutoSig, div.MsoAutoSig
	{mso-style-link:"E-mail Signature Char";
	margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p
	{margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;}
address
	{mso-style-link:"HTML Address Char";
	margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-style:italic;}
pre
	{mso-style-link:"HTML Preformatted Char";
	margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Courier New";}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{margin:0in;
	line-height:13.0pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
	{margin:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{margin:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoQuote, li.MsoQuote, div.MsoQuote
	{mso-style-link:"Quote Char";
	margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	color:black;
	font-style:italic;}
p.MsoIntenseQuote, li.MsoIntenseQuote, div.MsoIntenseQuote
	{mso-style-link:"Intense Quote Char";
	margin-top:10.0pt;
	margin-right:.65in;
	margin-bottom:14.0pt;
	margin-left:.65in;
	line-height:13.0pt;
	border:none;
	padding:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	color:#4F81BD;
	font-weight:bold;
	font-style:italic;}
p.MsoBibliography, li.MsoBibliography, div.MsoBibliography
	{margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoTocHeading, li.MsoTocHeading, div.MsoTocHeading
	{margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Cambria",serif;
	font-weight:bold;}
p.Uberschrift2, li.Uberschrift2, div.Uberschrift2
	{mso-style-name:"Uberschrift 2";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:Courier;
	font-weight:bold;}
p.western, li.western, div.western
	{mso-style-name:western;
	margin-top:5.0pt;
	margin-right:0in;
	margin-bottom:5.0pt;
	margin-left:0in;
	text-align:justify;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.Considrant, li.Considrant, div.Considrant
	{mso-style-name:Consid\00E9rant;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:35.45pt;
	text-align:justify;
	text-indent:-35.45pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.CharChar
	{mso-style-name:"Char Char";
	letter-spacing:-.15pt;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	font-size:11.0pt;
	font-family:Courier;
	letter-spacing:-.15pt;
	font-weight:bold;}
p.QRDBullet, li.QRDBullet, div.QRDBullet
	{mso-style-name:"QRD Bullet";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-indent:-28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	color:black;}
p.Default, li.Default, div.Default
	{mso-style-name:Default;
	margin:0in;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:black;}
p.TitleA, li.TitleA, div.TitleA
	{mso-style-name:"Title A";
	margin:0in;
	text-align:center;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.TitleB, li.TitleB, div.TitleB
	{mso-style-name:"Title B";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-indent:-28.35pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-link:"Comment Text";}
span.EndnoteTextChar
	{mso-style-name:"Endnote Text Char";
	mso-style-link:"Endnote Text";}
span.BodyTextChar
	{mso-style-name:"Body Text Char";
	mso-style-link:"Body Text";}
span.Heading7Char
	{mso-style-name:"Heading 7 Char";
	mso-style-link:"Heading 7";
	font-style:italic;}
span.BodyTextFirstIndentChar
	{mso-style-name:"Body Text First Indent Char";
	mso-style-link:"Body Text First Indent";}
span.BodyTextIndentChar
	{mso-style-name:"Body Text Indent Char";
	mso-style-link:"Body Text Indent";
	font-weight:bold;}
span.BodyTextFirstIndent2Char
	{mso-style-name:"Body Text First Indent 2 Char";
	mso-style-link:"Body Text First Indent 2";
	font-weight:normal;}
span.ClosingChar
	{mso-style-name:"Closing Char";
	mso-style-link:Closing;}
span.DateChar
	{mso-style-name:"Date Char";
	mso-style-link:Date;}
span.DocumentMapChar
	{mso-style-name:"Document Map Char";
	mso-style-link:"Document Map";
	font-family:"Tahoma",sans-serif;}
span.E-mailSignatureChar
	{mso-style-name:"E-mail Signature Char";
	mso-style-link:"E-mail Signature";}
span.FootnoteTextChar
	{mso-style-name:"Footnote Text Char";
	mso-style-link:"Footnote Text";}
span.HTMLAddressChar
	{mso-style-name:"HTML Address Char";
	mso-style-link:"HTML Address";
	font-style:italic;}
span.HTMLPreformattedChar
	{mso-style-name:"HTML Preformatted Char";
	mso-style-link:"HTML Preformatted";
	font-family:"Courier New";}
span.IntenseQuoteChar
	{mso-style-name:"Intense Quote Char";
	mso-style-link:"Intense Quote";
	color:#4F81BD;
	font-weight:bold;
	font-style:italic;}
span.MacroTextChar
	{mso-style-name:"Macro Text Char";
	mso-style-link:"Macro Text";
	font-family:"Courier New";}
span.MessageHeaderChar
	{mso-style-name:"Message Header Char";
	mso-style-link:"Message Header";
	font-family:"Cambria",serif;
	background:#CCCCCC;}
span.NoteHeadingChar
	{mso-style-name:"Note Heading Char";
	mso-style-link:"Note Heading";}
span.QuoteChar
	{mso-style-name:"Quote Char";
	mso-style-link:Quote;
	color:black;
	font-style:italic;}
span.SalutationChar
	{mso-style-name:"Salutation Char";
	mso-style-link:Salutation;}
span.SignatureChar
	{mso-style-name:"Signature Char";
	mso-style-link:Signature;}
span.SubtitleChar
	{mso-style-name:"Subtitle Char";
	mso-style-link:Subtitle;
	font-family:"Cambria",serif;}
span.TitleChar
	{mso-style-name:"Title Char";
	mso-style-link:Title;
	font-family:"Cambria",serif;
	font-weight:bold;}
p.No-numheading3Agency, li.No-numheading3Agency, div.No-numheading3Agency
	{mso-style-name:"No-num heading 3 \(Agency\)";
	mso-style-link:"No-num heading 3 \(Agency\) Char";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
span.No-numheading3AgencyChar
	{mso-style-name:"No-num heading 3 \(Agency\) Char";
	mso-style-link:"No-num heading 3 \(Agency\)";
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.DraftingNotesAgency, li.DraftingNotesAgency, div.DraftingNotesAgency
	{mso-style-name:"Drafting Notes \(Agency\)";
	mso-style-link:"Drafting Notes \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	font-size:11.0pt;
	font-family:"Courier New";
	color:#339966;
	font-style:italic;}
span.DraftingNotesAgencyChar
	{mso-style-name:"Drafting Notes \(Agency\) Char";
	mso-style-link:"Drafting Notes \(Agency\)";
	font-family:"Courier New";
	color:#339966;
	font-style:italic;}
p.BodytextAgency, li.BodytextAgency, div.BodytextAgency
	{mso-style-name:"Body text \(Agency\)";
	mso-style-link:"Body text \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
span.BodytextAgencyChar
	{mso-style-name:"Body text \(Agency\) Char";
	mso-style-link:"Body text \(Agency\)";
	font-family:"Verdana",sans-serif;}
span.msoIns
	{mso-style-name:"";
	text-decoration:underline;
	color:teal;}
span.msoDel
	{mso-style-name:"";
	text-decoration:line-through;
	color:red;}
 /* Page Definitions */
 @page WordSection1
	{size:595.35pt 842.0pt;
	margin:56.7pt 70.9pt 56.7pt 70.9pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>

</head>

<body lang=EN-US link=blue vlink="#954F72" style='word-wrap:break-word'>

<div class=WordSection1>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>ANNEX I</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=TitleA><span lang=EN-GB>SUMMARY OF PRODUCT CHARACTERISTICS</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius 5&nbsp;mg
film-coated tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; QUALITATIVE
AND QUANTITATIVE COMPOSITION</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Each tablet contains
5&nbsp;mg desloratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Excipient(s) with known effect:</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This medicine
contains lactose. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>For the full
list of excipients, see section&nbsp;6.1.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Film-coated
tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CLINICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.1&nbsp;&nbsp;&nbsp;&nbsp; Therapeutic
indications</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius is
indicated in adults and adolescents aged 12&nbsp;years and older for the relief
of symptoms associated with:</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>allergic rhinitis (see section&nbsp;5.1)</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>urticaria (see section&nbsp;5.1)</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.2&nbsp;&nbsp;&nbsp;&nbsp; Posology
and method of administration</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Posology</span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><i><span
lang=EN-GB>Adults and adolescents (12&nbsp;years of age and over) </span></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The recommended
dose of Aerius is one tablet once a day.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Intermittent
allergic rhinitis (presence of symptoms for less than 4&nbsp;days per week or
for less than 4&nbsp;weeks) should be managed in accordance with the evaluation
of patient&#8217;s disease history and the treatment could be discontinued
after symptoms are resolved and reinitiated upon their reappearance. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In persistent
allergic rhinitis (presence of symptoms for 4&nbsp;days or more per week and
for more than 4&nbsp;weeks), continued treatment may be proposed to the
patients during the allergen exposure periods.</span></p>

<p class=MsoNormal style='line-height:normal'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><i><span
lang=EN-GB>Paediatric population</span></i></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>There is limited clinical trial efficacy experience with the use of
desloratadine in adolescents 12&nbsp;through 17&nbsp;years of age (see
sections&nbsp;4.8 and 5.1).</span></p>

<p class=MsoNormal style='line-height:normal'><a name="OLE_LINK2"><span
lang=EN-GB>&nbsp;</span></a></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The safety and
efficacy of </span><span lang=EN-GB>Aerius 5&nbsp;mg film-coated tablets</span><span
lang=EN-GB> in children below the age of 12</span><span lang=EN-GB>&nbsp;</span><span
lang=EN-GB>years have not been established.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Method of administration</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Oral use.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The dose can be
taken with or without food.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.3&nbsp;&nbsp;&nbsp;&nbsp; Contraindications</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hypersensitivity
to the active substance, to any of the excipients listed in section&nbsp;6.1,
or to loratadine. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.4&nbsp;&nbsp;&nbsp;&nbsp; Special
warnings and precautions for use</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In the case of
severe renal insufficiency, Aerius should be used with caution (see section&nbsp;5.2).</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine
should be administered with caution in patients with medical or familial
history of seizures, and mainly young children </span><a name="_Hlk29909058"><span
lang=EN-GB>(see section 4.8)</span></a><span lang=EN-GB>, being more
susceptible to develop new seizures under desloratadine treatment. Healthcare
providers may consider discontinuing desloratadine in patients who experience a
seizure while on treatment.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText2><span lang=EN-GB style='color:windowtext'>Patients with
rare hereditary problems of galactose intolerance, the Lapp lactase deficiency
or glucose-galactose malabsorption should not take this medicine.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.5&nbsp;&nbsp;&nbsp;&nbsp; Interaction
with other medicinal products and other forms of interaction</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>No clinically
relevant interactions were observed in clinical trials with desloratadine
tablets in which erythromycin or ketoconazole were co-administered (see
section&nbsp;5.1).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Interaction
studies have only been performed in adults.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In a clinical
pharmacology trial, Aerius tablets taken concomitantly with alcohol did not
potentiate the performance impairing effects of alcohol (see section&nbsp;5.1).
</span><span lang=EN-GB>However, cases of alcohol intolerance and intoxication
have been reported during post&#8209;marketing use. Therefore, caution is
recommended if alcohol is taken concomitantly.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.6&nbsp;&nbsp;&nbsp;&nbsp; Fertility,
pregnancy and lactation</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Pregnancy</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>A large amount
of data on pregnant women (more than 1,000&nbsp;pregnancy outcomes) indicate no
malformative nor foeto/ neonatal toxicity of desloratadine.</span><span
lang=EN-GB> Animal studies do not indicate direct or indirect harmful effects
with respect to reproductive toxicity (see section&nbsp;5.3). </span><span
lang=EN-GB>As a precautionary measure, it is preferable to avoid the use of
Aerius during pregnancy.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Breast-feeding</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Desloratadine has been identified in
breastfed newborns/infants of treated women. The effect of desloratadine on
newborns/infants is unknown. A decision must be made whether to discontinue
breast-feeding or to discontinue/abstain from Aerius therapy taking into
account the benefit of breast feeding for the child and the benefit of therapy
for the woman.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Fertility</span></u></p>

<p class=MsoCommentText style='line-height:normal'><span lang=EN-GB
style='font-size:11.0pt'>There are no data available </span><span lang=EN-GB
style='font-size:11.0pt'>on male and female fertility.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.7&nbsp;&nbsp;&nbsp;&nbsp; Effects
on ability to drive and use machines</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt'>Aerius has no or negligible influence
on the ability to drive and use machines based on clinical trials. </span><span
lang=EN-GB>Patients should be informed that most people do not experience <span
style='layout-grid-mode:line'>drowsiness</span></span><span lang=EN-GB
style='layout-grid-mode:line'>. Nevertheless, as there is individual variation
in response </span><span lang=EN-GB>to all medicinal products, it is
recommended that patients are advised not to engage in activities requiring
mental alertness, such as driving a car or using machines, until they have
established their own response to the medicinal product.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.8&nbsp;&nbsp;&nbsp;&nbsp; Undesirable
effects</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Summary of the safety
profile</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In clinical
trials in a range of indications including allergic rhinitis and chronic
idiopathic urticaria, at the recommended dose of 5&nbsp;mg daily, undesirable
effects with Aerius were reported in 3&nbsp;% of patients in excess of those
treated with placebo. The most frequent of adverse reactions reported in excess
of placebo were fatigue (1.2&nbsp;%), dry mouth (0.8&nbsp;%) and headache
(0.6&nbsp;%). </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In a clinical
trial with 578&nbsp;adolescent patients, 12&nbsp;through 17&nbsp;years of age,
the most common adverse event was headache; this occurred in 5.9&nbsp;% of
patients treated</span><span lang=EN-GB> with desloratadine and 6.9&nbsp;% of
patients receiving placebo.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Tabulated list of adverse
reactions</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The frequency of
the clinical trial adverse reactions reported in excess of placebo and other
undesirable effects reported during the post-marketing period are listed in the
following table. </span><span lang=EN-GB>Frequencies are defined as </span><span
lang=EN-GB>very common (&#8805;&nbsp;1/10), </span><span lang=EN-GB>common
(&#8805;&nbsp;1/100 to &lt;&nbsp;1/10), uncommon (&#8805;&nbsp;1/1,000 to
&lt;&nbsp;1/100), rare (&#8805;&nbsp;1/10,000 to &lt;&nbsp;1/1,000), very rare
(&lt;&nbsp;1/10,000) and not known (cannot be estimated from the available
data).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse;border:none'>
 <thead>
  <tr style='page-break-inside:avoid'>
   <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
   padding:0in 5.4pt 0in 5.4pt'>
   <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>System
   Organ Class</span></b></p>
   </td>
   <td width="27%" valign=top style='width:27.92%;border:solid windowtext 1.0pt;
   border-left:none;padding:0in 5.4pt 0in 5.4pt'>
   <p class=MsoBodyText align=center style='text-align:center;line-height:normal;
   page-break-after:avoid'><b><span lang=EN-GB style='letter-spacing:-.15pt;
   layout-grid-mode:line'>Frequency</span></b></p>
   </td>
   <td width="38%" valign=top style='width:38.76%;border:solid windowtext 1.0pt;
   border-left:none;padding:0in 5.4pt 0in 5.4pt'>
   <p class=MsoBodyText align=left style='text-align:left;line-height:normal;
   page-break-after:avoid'><b><span lang=EN-GB style='letter-spacing:-.15pt;
   layout-grid-mode:line'>Adverse reactions seen with Aerius</span></b></p>
   </td>
  </tr>
 </thead>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='page-break-after:avoid'><b><span lang=EN-GB>Metabolism
  and nutrition disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB>Increased appetite</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Psychiatric
  disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB style='letter-spacing:-.15pt;
  layout-grid-mode:line'>Very rare</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB style='letter-spacing:-.15pt;
  layout-grid-mode:line'>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB style='letter-spacing:-.15pt;
  layout-grid-mode:line'>Hallucinations</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB style='letter-spacing:-.15pt;
  layout-grid-mode:line'>Abnormal behaviour, aggression</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>Nervous system disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Common</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Headache</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Dizziness,
  somnolence, insomnia, psychomotor hyperactivity, seizures</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>Cardiac disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Tachycardia,
  palpitations</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>QT
  prolongation</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>Gastrointestinal disorders</span></b></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Common</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Dry mouth</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Abdominal
  pain, nausea, vomiting, dyspepsia, diarrhoea</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>Hepatobiliary disorders</span></b></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='layout-grid-mode:line'>Elevations of liver enzymes,
  increased bilirubin, hepatitis</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='layout-grid-mode:line'>Jaundice</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>Skin and subcutaneous tissue disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='layout-grid-mode:line'>Photosensitivity</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>Musculoskeletal and connective tissue disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB>Myalgia</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>General disorders and administration site conditions</span></b></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Common</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Fatigue</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Hypersensitivity
  reactions (such as anaphylaxis, angioedema, dyspnoea, pruritus, rash, and
  urticaria)</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Asthenia</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>Investigations</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Weight
  increased</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>Other undesirable effects reported during the post&#8209;marketing period
in paediatric patients with an unknown frequency included QT prolongation,
arrhythmia, bradycardia, abnormal behaviour, and aggression.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u><span
lang=EN-GB>A retrospective observational safety study indicated an increased
incidence of new-onset seizure in patients 0 to 19 years of age when receiving
desloratadine compared with periods not receiving desloratadine. Among children
0-4 years old, the adjusted absolute increase was 37.5 (95% Confidence Interval
(CI) 10.5-64.5) per 100,000 person years (PY) with a background rate of new
onset seizure of 80.3 per 100,000 PY. Among patients 5-19 years of age, the
adjusted absolute increase was 11.3 (95% CI 2.3-20.2) per 100,000 PY with a
background rate of 36.4 per 100,000 PY. (See section 4.4.)</span></u></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Reporting of suspected adverse
reactions</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspected
adverse reactions via <span style='color:black;background:#BFBFBF'>the national
reporting system listed in </span></span><span lang=EN-GB><a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span
style='background:#BFBFBF'>Appendix V</span></a></span><span lang=EN-GB>.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.9&nbsp;&nbsp;&nbsp;&nbsp; Overdose</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The adverse
event profile associated with overdosage, as seen during post&#8209;marketing
use, is similar to that seen with therapeutic doses, but the magnitude of the
effects can be higher.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Treatment</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>In the event of overdose, consider
standard measures to remove unabsorbed active substance. Symptomatic and supportive
treatment is recommended.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine is
not eliminated by haemodialysis; it is not known if it is eliminated by
peritoneal dialysis.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Symptoms</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Based on a
multiple dose clinical trial, in which up to 45&nbsp;mg of desloratadine was
administered (nine&nbsp;times the clinical dose), no clinically relevant
effects were observed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The adverse
event profile associated with overdosage, as seen during post&#8209;marketing
use, is similar to that seen with therapeutic doses, but the magnitude of the effects
can be higher.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='font-family:"Arial",sans-serif'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACOLOGICAL
PROPERTIES</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.1&nbsp;&nbsp;&nbsp;&nbsp; Pharmacodynamic
properties</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Pharmacotherapeutic
group: antihistamines &#8211; H<sub>1</sub> antagonist, ATC code: R06A X27</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Mechanism of action</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Desloratadine is a non-sedating,
long-acting histamine antagonist with selective peripheral H<sub>1</sub>-receptor
antagonist activity. After oral administration, desloratadine selectively
blocks peripheral histamine H<sub>1</sub>-receptors because the substance is
excluded from entry to the central nervous system.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Desloratadine has demonstrated
antiallergic properties from <i>in vitro </i>studies.<i> </i>These include
inhibiting the release of proinflammatory cytokines such as IL-4, IL-6, IL-8,
and IL-13 from human mast cells/basophils, as well as inhibition of the
expression of the adhesion molecule P-selectin on endothelial cells. The
clinical relevance of these observations remains to be confirmed.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><u><span
lang=EN-GB style='font-weight:normal'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Clinical efficacy and safety</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>In a multiple dose clinical trial, in
which up to 20&nbsp;mg of desloratadine was administered daily for
14&nbsp;days, no statistically or clinically relevant cardiovascular effect was
observed. In a clinical pharmacology trial, in which desloratadine was
administered at a dose of 45&nbsp;mg daily (nine times the clinical dose) for
ten days, no prolongation of QTc interval was seen.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>No clinically relevant changes in
desloratadine plasma concentrations were observed in multiple-dose ketoconazole
and erythromycin interaction trials.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Desloratadine does not readily penetrate
the central nervous system. In controlled clinical trials, at the recommended
dose of 5&nbsp;mg daily, there was no excess incidence of somnolence as
compared to placebo. Aerius given at a single daily dose of 7.5&nbsp;mg did not
affect psychomotor performance in clinical trials. In a single dose study
performed in adults, desloratadine 5&nbsp;mg did not affect standard measures
of flight performance including exacerbation of subjective sleepiness or tasks
related to flying.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>In clinical pharmacology trials,
co-administration with alcohol did not increase the alcohol-induced impairment
in performance or increase in sleepiness. No significant differences were found
in the psychomotor test results between desloratadine and placebo groups,
whether administered alone or with alcohol. </span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>In patients with allergic rhinitis,
Aerius was effective in relieving symptoms such as sneezing, nasal discharge
and itching, as well as ocular itching, tearing and redness, and itching of
palate. <span style='layout-grid-mode:line'>Aerius effectively controlled
symptoms for 24&nbsp;hours.</span></span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='layout-grid-mode:line;font-weight:normal'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>The efficacy of Aerius tablets has not
been clearly demonstrated in trials with adolescent patients 12&nbsp;th</span><span
lang=EN-GB style='font-weight:normal'>rough 17&nbsp;years of age<span
style='layout-grid-mode:line'>.</span></span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>In addition to the established
classifications of seasonal and perennial, allergic rhinitis can alternatively
be classified as intermittent allergic rhinitis and persistent allergic
rhinitis according to the duration of symptoms. Intermittent allergic rhinitis
is defined as the presence of symptoms for less than 4 days per week or for
less than 4 weeks. Persistent allergic rhinitis is defined as the presence of
symptoms for 4 days or more per week and for more than 4 weeks.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Aerius was effective in alleviating the
burden of seasonal allergic rhinitis as shown by the total score of the
rhino-conjunctivitis quality of life questionnaire. The greatest amelioration
was seen in the domains of practical problems and daily activities limited by
symptoms. </span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Chronic idiopathic urticaria was studied
as a clinical model for urticarial conditions, since&nbsp;the underlying pathophysiology
is similar, regardless of etiology,&nbsp;and&nbsp;because chronic patients can
be more easily recruited prospectively. Since histamine release is a causal
factor in all urticarial diseases, desloratadine is expected to be effective in
providing symptomatic relief for other urticarial conditions, in addition to
chronic idiopathic urticaria, as advised in clinical guidelines.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>In two placebo-controlled six week trials
in patients with chronic idiopathic urticaria, Aerius was effective in
relieving pruritus and decreasing the size and number of hives by the end of
the first dosing interval. In each trial, the effects were sustained over the
24&nbsp;hour dosing interval. As with other antihistamine trials in chronic
idiopathic urticaria, the minority of patients who were identified as
non-responsive to antihistamines was excluded. An improvement in pruritus of
more than 50&nbsp;% was observed in 55&nbsp;% of patients treated with
desloratadine compared with 19&nbsp;% of patients treated with placebo.
Treatment with Aerius also significantly reduced interference with sleep and
daytime function, as measured by a four-point scale used to assess these
variables.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.2&nbsp;&nbsp;&nbsp;&nbsp; Pharmacokinetic
properties</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Absorption</span></u></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Desloratadine plasma concentrations can be detected within
30&nbsp;minutes of administration. Desloratadine is well absorbed with maximum
concentration achieved after approximately 3&nbsp;hours; the terminal phase
half-life is approximately 27&nbsp;hours. The degree of accumulation of
desloratadine was consistent with its half-life (approximately 27&nbsp;hours)
and a once daily dosing frequency. The bioavailability of desloratadine was
dose proportional over the range of 5&nbsp;mg to 20&nbsp;mg. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In a
pharmacokinetic trial in which patient demographics were comparable to those of
the general seasonal allergic rhinitis population, 4&nbsp;% of the subjects
achieved a higher concentration of desloratadine. This percentage may vary
according to ethnic background. Maximum desloratadine concentration was about
3-fold higher at approximately 7&nbsp;hours with a terminal phase half-life of
approximately 89&nbsp;hours. The safety profile of these subjects was not
different from that of the general population.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Distribution</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Desloratadine is moderately bound
(83&nbsp;% - 87&nbsp;%) to plasma proteins. There is no evidence of clinically
relevant medicine accumulation following once daily dosing of desloratadine
(5&nbsp;mg to 20&nbsp;mg) for 14&nbsp;days. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Biotransformation</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The enzyme
responsible for the metabolism of desloratadine has not been identified yet,
and therefore, some interactions with other medicinal products cannot be fully
excluded. Desloratadine does not inhibit CYP3A4 <i>in vivo,</i> and <i>in vitro</i>
studies have shown that the medicinal product does not inhibit CYP2D6 and is
neither a substrate nor an inhibitor of P-glycoprotein.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Elimination</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In a single dose
trial using a 7.5&nbsp;mg dose of desloratadine, there was no effect of food
(high-fat, high caloric breakfast) on the disposition of desloratadine.<span
style='layout-grid-mode:line'> In another study, grapefruit juice had no effect
on the disposition of desloratadine.</span></span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Renally impaired patients</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The
pharmacokinetics of desloratadine in patients with chronic renal insufficiency
(CRI) was compared with that of healthy subjects in one single&#8209;dose study
and one multiple dose study. In the single&#8209;dose study, the exposure to
desloratadine was approximately 2 and 2.5&#8209;fold greater in subjects with
mild to moderate and severe CRI, respectively, than in healthy subjects. In the
multiple&#8209;dose study, steady state was reached after Day&nbsp;11, and
compared to healthy subjects the exposure to desloratadine was ~1.5&#8209;fold
greater in subjects with mild to moderate CRI and ~2.5&#8209;fold greater in
subjects with severe CRI. In both studies, changes in exposure (AUC and C<sub>max</sub>)
of desloratadine and 3&#8209;hydroxydesloratadine were not clinically relevant.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.3&nbsp;&nbsp;&nbsp;&nbsp; Preclinical
safety data</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine is
the primary active metabolite of loratadine. Non-clinical studies conducted
with desloratadine and loratadine demonstrated that there are no qualitative or
quantitative differences in the toxicity profile of desloratadine and
loratadine at comparable levels of exposure to desloratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Non-clinical
data reveal no special hazard for humans based on conventional studies of
safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic
potential, toxicity to reproduction and development. The lack of carcinogenic
potential was demonstrated in studies conducted with desloratadine and
loratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.1&nbsp;&nbsp;&nbsp;&nbsp; List
of excipients</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Tablet core: calcium hydrogen phosphate
dihydrate, microcrystalline cellulose, maize starch, talc. </span></p>

<p class=MsoBlockText style='margin:0in;margin-bottom:.0001pt'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>Tablet
coating: film coat (containing lactose monohydrate, hypromellose, titanium
dioxide, macrogol&nbsp;400, indigotin (E132)), clear coat (containing
hypromellose, macrogol&nbsp;400), carnauba wax, white wax.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.2&nbsp;&nbsp;&nbsp;&nbsp; Incompatibilities</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Not applicable.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.3&nbsp;&nbsp;&nbsp;&nbsp; Shelf
life</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>2&nbsp;years</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.4&nbsp;&nbsp;&nbsp;&nbsp; Special
precautions for storage</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not store
above 30&deg;C. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Store in the
original package.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.5&nbsp;&nbsp;&nbsp;&nbsp; Nature
and contents of container</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius is
supplied in blisters comprised of laminate blister film with foil lidding.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The materials of
the blister consist of a polychlorotrifluoroethylene (PCTFE)/Polyvinyl Chloride
(PVC) film (product contact surface) with an aluminium foil lidding coated with
a vinyl heat seal coat (product contact surface) which is heat sealed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Packs of 1, 2,
3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 90, 100&nbsp;tablets.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Not all pack
sizes may be marketed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.6&nbsp;&nbsp;&nbsp;&nbsp; Special
precautions for disposal</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>No special
requirements.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION HOLDER</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Merck Sharp
&amp; Dohme B.V.</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>Waarderweg 39</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>2031 BN Haarlem</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>The Netherlands</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBERS</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><a name="OLE_LINK9"></a><a
name="OLE_LINK10"><span lang=EN-GB>EU/1/00/160/001-013</span></a></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EU/1/00/160/036</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DATE
OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt'>Date of first authorisation: </span><span
lang=EN-GB>15 January 2001</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt;letter-spacing:
-.15pt'>Date of latest renewal: 15 January 2006</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>10.&nbsp;&nbsp;&nbsp;&nbsp; DATE
OF REVISION OF THE TEXT</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Detailed
information on this medicinal product is available on the website of the
European Medicines Agency http://www.ema.europa.eu.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius
2.5&nbsp;mg orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; QUALITATIVE
AND QUANTITATIVE COMPOSITION</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Each
orodispersible tablet contains 2.5&nbsp;mg desloratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Excipient(s) with known effect:</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This medicine
contains mannitol and aspartame (E951). </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>For the full
list of excipients, see section&nbsp;6.1.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Orodispersible tablet</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Light-red,
flat-faced, round, speckled tablets, one side branded with &#8220;K&#8221; </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CLINICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.1&nbsp;&nbsp;&nbsp;&nbsp; Therapeutic
indications</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius is
indicated in adults, adolescents aged 12&nbsp;years and older and children aged
6&nbsp;&#8211;&nbsp;11&nbsp;years old for the relief of symptoms associated
with:</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>allergic rhinitis (see section&nbsp;5.1)</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>urticaria (see section&nbsp;5.1)</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.2&nbsp;&nbsp;&nbsp;&nbsp; Posology
and method of administration</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Posology</span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><i><span
lang=EN-GB>Adults and adolescents (12</span></i><span lang=EN-GB>&nbsp;<i>years
of age and over)</i></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The recommended
dose of Aerius is two 2.5&nbsp;mg orodispersible tablets placed in the mouth
once a day.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><i><span
lang=EN-GB>Paediatric population</span></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Children
6&nbsp;to 11&nbsp;years of age: the recommended dose of Aerius is one
2.5&nbsp;mg orodispersible tablet placed in mouth once a day.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The safety and
efficacy of Aerius 2.5&nbsp;mg orodispersible tablets in children below the age
of 6&nbsp;years have not been established.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>There is limited
clinical trial efficacy experience with the use of desloratadine in children 6
through 11&nbsp;years of age (see section&nbsp;5.2).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>There is limited clinical trial efficacy experience with the use of
desloratadine in adolescents 12&nbsp;through 17&nbsp;years of age (see
sections&nbsp;4.8 and 5.1).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Intermittent
allergic rhinitis (presence of symptoms for less than 4 days per week or for
less than 4&nbsp;weeks) should be managed in accordance with the evaluation of
patient&#8217;s disease history and the treatment could be discontinued after
symptoms are resolved and reinitiated upon their reappearance. In persistent
allergic rhinitis (presence of symptoms for 4 days or more per week and for
more than 4&nbsp;weeks), continued treatment may be proposed to the patients
during the allergen exposure periods.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Method
of administration</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>Oral use.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The dose can be
taken with or without food.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>Immediately before use, the blister must be
carefully peeled open and the dose of </span><span lang=EN-GB>orodispersible
tablet <span style='layout-grid-mode:line'>removed without crushing it. The
dose of </span>orodispersible tablet <span style='layout-grid-mode:line'>is
placed in the mouth where it will disperse immediately. Water or other liquid
is not needed to swallow the dose. The dose must be taken as soon as the
blister has been opened.</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.3&nbsp;&nbsp;&nbsp;&nbsp; Contraindications</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hypersensitivity
to the active substance, to any of the excipients listed in section&nbsp;6.1,
or to loratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.4&nbsp;&nbsp;&nbsp;&nbsp; Special
warnings and precautions for use</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In the case of
severe renal insufficiency, Aerius should be used with caution (see section&nbsp;5.2).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine
should be administered with caution in patients with medical or familial
history of seizures, and mainly young children </span><span lang=EN-GB>(see
section 4.8)</span><span lang=EN-GB>, being more susceptible to develop new
seizures under desloratadine treatment. Healthcare providers may consider
discontinuing desloratadine in patients who experience a seizure while on
treatment.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This product
contains 1.4&nbsp;mg of phenylalanine per 2.5&nbsp;mg dose of Aerius
orodispersible tablet. Phenylalanine may be harmful for people with
phenylketonuria.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.5&nbsp;&nbsp;&nbsp;&nbsp; Interaction
with other medicinal products and other forms of interaction</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>No clinically
relevant interactions were observed in clinical trials with desloratadine tablets
in which erythromycin or ketoconazole were co-administered (see
section&nbsp;5.1). </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Interaction
studies have only been performed in adults.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In a clinical
pharmacology trial, Aerius tablets taken concomitantly with alcohol did not
potentiate the performance impairing effects of alcohol (see section&nbsp;5.1).
</span><span lang=EN-GB>However, cases of alcohol intolerance and intoxication
have been reported during post&#8209;marketing use. Therefore, caution is
recommended if alcohol is taken concomitantly.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.6&nbsp;&nbsp;&nbsp;&nbsp; Fertility,
pregnancy and lactation</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Pregnancy</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>A large amount
of data on pregnant women (more than 1,000&nbsp;pregnancy outcomes) indicate no
malformative nor foeto/ neonatal toxicity of desloratadine.</span><span
lang=EN-GB> Animal studies do not indicate direct or indirect harmful effects
with respect to reproductive toxicity (see section&nbsp;5.3). </span><span
lang=EN-GB>As a precautionary measure, it is preferable to avoid the use of
Aerius during pregnancy.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Breast-feeding</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Desloratadine has been identified in
breastfed newborns/infants of treated women. The effect of desloratadine on
newborns/infants is unknown. A decision must be made whether to discontinue
breast-feeding or to discontinue/abstain from Aerius therapy taking into
account the benefit of breast feeding for the child and the benefit of therapy
for the woman.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Fertility</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>There are no
data available on male and female fertility.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.7&nbsp;&nbsp;&nbsp;&nbsp; Effects
on ability to drive and use machines</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt'>Aerius has no or negligible influence
on the ability to drive and use machines based on clinical trials. </span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='layout-grid-mode:line'>P</span><span lang=EN-GB>atients
should be informed that most people do not experience <span style='layout-grid-mode:
line'>drowsiness. Nevertheless, </span></span><span lang=EN-GB
style='layout-grid-mode:line'>as there is individual variation in response </span><span
lang=EN-GB>to all medicinal products, it is recommended that patients are
advised not to engage in activities requiring mental alertness, such as driving
a car or using machines, until they have established their own response to the
medicinal product.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.8&nbsp;&nbsp;&nbsp;&nbsp; Undesirable
effects</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Summary
of the safety profile</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In clinical
trials, desloratadine in the syrup formulation was administered to a paediatric
population. The overall incidence of adverse reactions was similar between the
desloratadine syrup and the placebo groups and did not differ significantly
than the safety profile seen in adult patients. </span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In clinical
trials in a range of indications including allergic rhinitis and chronic
idiopathic urticaria, at the recommended dose of 5&nbsp;mg daily, undesirable
effects with Aerius tablets were reported in 3&nbsp;% of patients in excess of
those treated with placebo. The most frequent of adverse events reported in
excess of placebo were fatigue (1.2&nbsp;%), dry mouth (0.8&nbsp;%) and
headache (0.6&nbsp;%).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In a clinical
trial with 578&nbsp;adolescent patients, 12&nbsp;through 17&nbsp;years of age,
the most common adverse event was headache; this occurred in 5.9&nbsp;% of
patients treated</span><span lang=EN-GB> with desloratadine and 6.9&nbsp;% of
patients receiving placebo.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Tabulated
list of adverse reactions</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The frequency of
the clinical trial adverse reactions reported in excess of placebo and other
undesirable effects reported during the post-marketing period are listed in the
following table. </span><span lang=EN-GB>Frequencies are defined as </span><span
lang=EN-GB>very common (&#8805;&nbsp;1/10), </span><span lang=EN-GB>common
(&#8805;&nbsp;1/100 to &lt;&nbsp;1/10), uncommon (&#8805;&nbsp;1/1,000 to
&lt;&nbsp;1/100), rare (&#8805;&nbsp;1/10,000 to &lt;&nbsp;1/1,000), very rare
(&lt;&nbsp;1/10,000) and not known (cannot be estimated from the available
data).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse;border:none'>
 <thead>
  <tr style='page-break-inside:avoid'>
   <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
   padding:0in 5.4pt 0in 5.4pt'>
   <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>System
   Organ Class</span></b></p>
   </td>
   <td width="27%" valign=top style='width:27.92%;border:solid windowtext 1.0pt;
   border-left:none;padding:0in 5.4pt 0in 5.4pt'>
   <p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
   lang=EN-GB>Frequency</span></b></p>
   </td>
   <td width="38%" valign=top style='width:38.76%;border:solid windowtext 1.0pt;
   border-left:none;padding:0in 5.4pt 0in 5.4pt'>
   <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Adverse
   reactions seen with Aerius</span></b></p>
   </td>
  </tr>
 </thead>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='page-break-after:avoid'><b><span lang=EN-GB>Metabolism
  and nutrition disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB>Increased appetite</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Psychiatric
  disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>Very rare</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hallucinations</span></p>
  <p class=MsoNormal style='line-height:normal'><span style='letter-spacing:
  -.15pt;layout-grid-mode:line'>Abnormal behaviour,</span><span
  style='font-size:9.0pt;font-family:"Verdana",sans-serif;color:black'> </span><span
  style='letter-spacing:-.15pt;layout-grid-mode:line'>aggression</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Nervous
  system disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>Common</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>Very rare</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Headache</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Dizziness,
  somnolence, insomnia, psychomotor hyperactivity, seizures</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Cardiac
  disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Tachycardia,
  palpitations</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='letter-spacing:-.15pt;layout-grid-mode:line'>QT prolongation</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Gastrointestinal
  disorders</span></b></p>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>Common</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>Very rare</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Dry mouth</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Abdominal
  pain, nausea, vomiting, dyspepsia, diarrhoea</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Hepatobiliary
  disorders</span></b></p>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB style='letter-spacing:-.15pt;
  layout-grid-mode:line'>Very rare</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB style='letter-spacing:-.15pt;
  layout-grid-mode:line'>&nbsp;</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB style='letter-spacing:-.15pt;
  layout-grid-mode:line'>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB style='layout-grid-mode:line'>Elevations
  of liver enzymes, increased bilirubin, hepatitis</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB style='layout-grid-mode:line'>Jaundice</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Skin and
  subcutaneous tissue disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Photosensitivity</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Musculoskeletal
  and connective tissue disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>Very rare</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Myalgia</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>General
  disorders and administration site conditions</span></b></p>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>Common</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>Very rare</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Fatigue</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hypersensitivity
  reactions (such as anaphylaxis, angioedema, dyspnoea, pruritus, rash, and
  urticaria)</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Asthenia</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-GB>Investigations</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><span lang=EN-GB>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><span lang=EN-GB>Weight increased</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>Other undesirable effects reported during the post&#8209;marketing period
in paediatric patients with an unknown frequency included QT prolongation,
arrhythmia, bradycardia, abnormal behaviour, and aggression.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>A retrospective observational safety study indicated an increased
incidence of new-onset seizure in patients 0 to 19 years of age when receiving
desloratadine compared with periods not receiving desloratadine. Among children
0-4 years old, the adjusted absolute increase was 37.5 (95% Confidence Interval
(CI) 10.5-64.5) per 100,000 person years (PY) with a background rate of new
onset seizure of 80.3 per 100,000 PY. Among patients 5-19 years of age, the
adjusted absolute increase was 11.3 (95% CI 2.3-20.2) per 100,000 PY with a
background rate of 36.4 per 100,000 PY. (See section 4.4.)</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Reporting
of suspected adverse reactions</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspected
adverse reactions via <span style='color:black;background:#BFBFBF'>the national
reporting system listed in </span></span><span lang=EN-GB><a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span
style='background:#BFBFBF'>Appendix V</span></a></span><span lang=EN-GB>.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.9&nbsp;&nbsp;&nbsp;&nbsp; Overdose</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The adverse
event profile associated with overdosage, as seen during post&#8209;marketing
use, is similar to that seen with therapeutic doses, but the magnitude of the
effects can be higher.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Treatment</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In the event of
overdose, consider standard measures to remove unabsorbed active substance.
Symptomatic and supportive treatment is recommended.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine is
not eliminated by haemodialysis; it is not known if it is eliminated by
peritoneal dialysis.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Symptoms</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Based on a
multiple dose clinical trial, in which up to 45&nbsp;mg of desloratadine was
administered (nine&nbsp;times the clinical dose), no clinically relevant
effects were observed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The adverse
event profile associated with overdosage, as seen during post&#8209;marketing
use, is similar to that seen with therapeutic doses, but the magnitude of the
effects can be higher.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACOLOGICAL
PROPERTIES</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.1 &nbsp;&nbsp;&nbsp; Pharmacodynamic
properties</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Pharmacotherapeutic
group: antihistamines &#8211; H<sub>1</sub> antagonist, ATC code: R06A X27</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Mechanism
of action</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine is
a non-sedating, long-acting histamine antagonist with selective peripheral H<sub>1</sub>-receptor
antagonist activity. After oral administration, desloratadine selectively
blocks peripheral histamine H<sub>1</sub>-receptors because the substance is
excluded from entry to the central nervous system.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine has
demonstrated antiallergic properties from <i>in vitro </i>studies.<i> </i>These
include inhibiting the release of proinflammatory cytokines such as IL-4, IL-6,
IL-8, and IL-13 from human mast cells/basophils, as well as inhibition of the
expression of the adhesion molecule P-selectin on endothelial cells. The
clinical relevance of these observations remains to be confirmed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Clinical
efficacy and safety</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In a multiple
dose trial, Aerius orodispersible tablets were well tolerated.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>At the
recommended dose, Aerius 5&nbsp;mg orodispersible tablet was found to be
bioequivalent to the Aerius 5&nbsp;mg conventional tablet formulation of
desloratadine. Therefore, the efficacy of Aerius orodispersible tablet is
expected to be the same as with the Aerius tablet formulation.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In a multiple
dose clinical trial, in which up to 20&nbsp;mg of desloratadine was
administered daily for 14&nbsp;days, no statistically or clinically relevant
cardiovascular effect was observed. In a clinical pharmacology trial, in which
desloratadine was administered at a dose of 45&nbsp;mg daily (nine times the
clinical dose) for ten days, no prolongation of QTc interval was seen.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>No clinically
relevant changes in desloratadine plasma concentrations were observed in
multiple-dose, ketoconazole and erythromycin interaction trials.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Desloratadine does not readily penetrate
the central nervous system. In clinical trials, at the recommended dose of
5&nbsp;mg daily, there was no excess incidence of somnolence as compared to
placebo. Aerius tablets given at a single daily dose of 7.5&nbsp;mg did not
affect psychomotor performance in clinical trials. In a single dose study
performed in adults, desloratadine 5&nbsp;mg did not affect standard measures
of flight performance including exacerbation of subjective sleepiness or tasks
related to flying.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In clinical
pharmacology trials, co-administration with alcohol did not increase the
alcohol-induced impairment in performance or increase in sleepiness. No
significant differences were found in the psychomotor test results between
desloratadine and placebo groups, whether administered alone or with alcohol. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In patients with
allergic rhinitis, Aerius tablets were effective in relieving symptoms such as
sneezing, nasal discharge and itching, as well as ocular itching, tearing and
redness, and itching of palate. <span style='layout-grid-mode:line'>Aerius
tablets effectively controlled symptoms for 24&nbsp;hours.</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The efficacy of
Aerius tablets has not been clearly demonstrated in trials with adolescent
patients 12&nbsp;th</span><span lang=EN-GB>rough 17&nbsp;years of age.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In addition to
the established classifications of seasonal and perennial, allergic rhinitis
can alternatively be classified as intermittent allergic rhinitis and
persistent allergic rhinitis according to the duration of symptoms.
Intermittent allergic rhinitis is defined as the presence of symptoms for less
than 4 days per week or for less than 4 weeks. Persistent allergic rhinitis is
defined as the presence of symptoms for 4 days or more per week and for more
than 4 weeks.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius was
effective in alleviating the burden of seasonal allergic rhinitis as shown by
the total score of the rhino-conjunctivitis quality of life questionnaire. The
greatest amelioration was seen in the domains of practical problems and daily
activities limited by symptoms. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Chronic idiopathic urticaria was studied
as a clinical model for urticarial conditions, since&nbsp;the underlying
pathophysiology is similar, regardless of etiology,&nbsp;and&nbsp;because
chronic patients can be more easily recruited prospectively. Since histamine
release is a causal factor in all urticarial diseases, desloratadine is
expected to be effective in providing symptomatic relief for other urticarial
conditions, in addition to chronic idiopathic urticaria, as advised in clinical
guidelines.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>In two placebo-controlled six week trials in
patients with chronic idiopathic urticaria, Aerius was effective in relieving pruritus
and decreasing the size and number of hives by the end of the first dosing
interval. In each trial, the effects were sustained over the 24&nbsp;hour
dosing interval. As with other antihistamine trials in chronic idiopathic
urticaria, the minority of patients who were identified as non-responsive to
antihistamines was excluded. An improvement in pruritus of more than 50&nbsp;%
was observed in 55&nbsp;% of patients treated with desloratadine compared with
19&nbsp;% of patients treated with placebo. Treatment with Aerius also
significantly reduced interference with sleep and daytime function, as measured
by a four-point scale used to assess these variables.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.2&nbsp;&nbsp;&nbsp;&nbsp; Pharmacokinetic
properties </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Absorption</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine
plasma concentrations can be detected within 30&nbsp;minutes of administration.
Desloratadine is well absorbed with maximum concentration achieved after
approximately 3&nbsp;hours; the terminal phase half-life is approximately
27&nbsp;hours. The degree of accumulation of desloratadine was consistent with
its half-life (approximately 27&nbsp;hours) and a once daily dosing frequency.
The bioavailability of desloratadine was dose proportional over the range of
5&nbsp;mg to 20&nbsp;mg. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>In a series of pharmacokinetic and clinical
trials, 6&nbsp;% of the subjects reached a higher concentration of desloratadine.
The prevalence of this poor metaboliser phenotype was comparable for adult
(6&nbsp;%) and paediatric subjects 2- to 11-year old (6&nbsp;%), and greater
among Blacks (18&nbsp;% adult, 16&nbsp;% paediatric) than Caucasians (2&nbsp;%
adult, 3&nbsp;% paediatric) in both populations </span><span lang=EN-GB>however
the safety profile of these subjects was not different from that of the general
population<span style='layout-grid-mode:line'>.</span></span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>In a multiple-dose pharmacokinetic study conducted with the tablet
formulation in healthy adult subjects, four subjects were found to be poor
metabolisers of desloratadine. These subjects had a C<sub>max</sub>
concentration about 3-fold higher at approximately 7&nbsp;hours with a terminal
phase half-life of approximately&nbsp;89&nbsp;hours.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Distribution</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine is
moderately bound (83&nbsp;% - 87&nbsp;%) to plasma proteins. There is no
evidence of clinically relevant medicine accumulation following once daily
dosing of desloratadine (5&nbsp;mg to 20&nbsp;mg) for 14&nbsp;days. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Biotransformation</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The enzyme responsible
for the metabolism of desloratadine has not been identified yet, and therefore,
some interactions with other medicinal products cannot be fully excluded.<span
style='layout-grid-mode:line'> </span>Desloratadine does not inhibit CYP3A4 <i>in
vivo,</i> and <i>in vitro</i> studies have shown that the medicinal product
does not inhibit CYP2D6 and is neither a substrate nor an inhibitor of
P-glycoprotein.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>In single-dose crossover studies of Aerius
5&nbsp;mg </span><span lang=EN-GB>orodispersible tablets <span
style='layout-grid-mode:line'>with Aerius 5 mg conventional tablets, the
formulations were bioequivalent. </span>Aerius 2.5&nbsp;mg tablets has not been
evaluated in paediatric patients however in conjunction with the dose finding
studies in paediatrics, the pharmacokinetics data for Aerius orodispersible
tablets supports the use of the 2.5&nbsp;mg dose in paediatric patients
6&nbsp;to&nbsp;11&nbsp;years of age.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Elimination</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>The presence of food prolongs T<sub>max</sub> for
desloratadine from 2.5&nbsp;to 4&nbsp;hours and T<sub>max</sub> for
3-OH-desloratadine from 4&nbsp;to 6&nbsp;hours. In a separate study, grapefruit
juice had no effect on the disposition of desloratadine. Water had no effect on
the bioavailability of Aerius orodispersible tablets.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Renally impaired patients</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The
pharmacokinetics of desloratadine in patients with chronic renal insufficiency
(CRI) was compared with that of healthy subjects in one single&#8209;dose study
and one multiple dose study. In the single&#8209;dose study, the exposure to
desloratadine was approximately 2 and 2.5&#8209;fold greater in subjects with
mild to moderate and severe CRI, respectively, than in healthy subjects. In the
multiple&#8209;dose study, steady state was reached after Day&nbsp;11, and
compared to healthy subjects the exposure to desloratadine was ~1.5&#8209;fold
greater in subjects with mild to moderate CRI and ~2.5&#8209;fold greater in
subjects with severe CRI. In both studies, changes in exposure (AUC and C<sub>max</sub>)
of desloratadine and 3&#8209;hydroxydesloratadine were not clinically relevant.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.3&nbsp;&nbsp;&nbsp;&nbsp; Preclinical
safety data</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine is
the primary active metabolite of loratadine. Non-clinical studies conducted
with desloratadine and loratadine demonstrated that there are no qualitative or
quantitative differences in the toxicity profile of desloratadine and
loratadine at comparable levels of exposure to desloratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Non-clinical
data reveal no special hazard for humans based on conventional studies of
safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic
potential, toxicity to reproduction and development. The collective analysis of
preclinical and clinical irritation studies for the orodispersible tablet
indicate that this formulation in unlikely to pose risk for local irritation
with clinical use. The lack of carcinogenic potential was demonstrated in
studies conducted with desloratadine and loratadine.</span></p>

<p class=MsoEndnoteText><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoEndnoteText><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.1&nbsp;&nbsp;&nbsp;&nbsp; List
of excipients</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>microcrystalline
cellulose</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>pregelatinized
starch</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>sodium starch
glycolate</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>magnesium
stearate</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>butylated
methacrylate copolymer</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>crospovidone</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>sodium hydrogen
carbonate </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>citric acid</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>colloidal
silicon dioxide</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>ferric oxide</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>mannitol</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>aspartame (E951)</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>flavour
Tutti-Frutti</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.2&nbsp;&nbsp;&nbsp;&nbsp; Incompatibilities</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Not applicable.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.3&nbsp;&nbsp;&nbsp;&nbsp; Shelf
life</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>2&nbsp;years</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.4&nbsp;&nbsp;&nbsp;&nbsp; Special
precautions for storage</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Store in the
original package.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.5&nbsp;&nbsp;&nbsp;&nbsp; Nature
and contents of container</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius
orodispersible tablets are supplied in unit dose blisters comprised of laminate
blister film with foil lidding.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>The blister materials consist of a four layer aluminum foil laminate
cold form blister film and a paper backed laminated aluminum foil lidding film.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The cold form
blister film is composed of polyvinyl chloride (PVC) film adhesively laminated
to an oriented polyamide (OPA) film, adhesively laminated to aluminum foil,
adhesively laminated to polyvinyl chloride (PVC) film.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Packs of
5,&nbsp;6,&nbsp;10,&nbsp;12,&nbsp;15,&nbsp;18,&nbsp;20,&nbsp;30,&nbsp;50,&nbsp;60,&nbsp;90
and 100&nbsp;orodispersible tablets.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Not all pack
sizes may be marketed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.6&nbsp;&nbsp;&nbsp;&nbsp; Special
precautions for disposal</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>No special requirements</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION HOLDER</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Merck Sharp
&amp; Dohme B.V.</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>Waarderweg 39</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>2031 BN Haarlem</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>The Netherlands</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBERS </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EU/1/00/160/037-048</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DATE
OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt'>Date of first authorisation: </span><span
lang=EN-GB>15 January 2001</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt'>Date of latest renewal: 15 January 2006</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>10.&nbsp;&nbsp;&nbsp;&nbsp; DATE
OF REVISION OF THE TEXT</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Detailed
information on this medicinal product is available on the website of the
European Medicines Agency http://www.ema.europa.eu.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius 5&nbsp;mg
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; QUALITATIVE
AND QUANTITATIVE COMPOSITION</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Each
orodispersible tablet contains 5&nbsp;mg desloratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Excipient(s) with known effect:</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This medicine
contains mannitol and aspartame (E951). </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>For the full
list of excipients, see section&nbsp;6.1.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Orodispersible tablet</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Light-red,
flat-faced, round, speckled tablets, one side branded with &#8220;A&#8221; </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CLINICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.1&nbsp;&nbsp;&nbsp;&nbsp; Therapeutic
indications</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius is
indicated in adults and adolescents aged 12&nbsp;years and older for the relief
of symptoms associated with:</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>allergic rhinitis (see section&nbsp;5.1)</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>urticaria (see section&nbsp;5.1)</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.2&nbsp;&nbsp;&nbsp;&nbsp; Posology
and method of administration</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Posology</span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><i><span
lang=EN-GB>Adults and adolescents (12&nbsp;years of age and over)</span></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The recommended
dose of Aerius is one 5&nbsp;mg orodispersible tablet placed in the mouth once
a day.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Intermittent
allergic rhinitis (presence of symptoms for less than 4&nbsp;days per week or
for less than 4&nbsp;weeks) should be managed in accordance with the evaluation
of patient&#8217;s disease history and the treatment could be discontinued
after symptoms are resolved and reinitiated upon their reappearance. In
persistent allergic rhinitis (presence of symptoms for 4&nbsp;days or more per
week and for more than 4&nbsp;weeks), continued treatment may be proposed to
the patients during the allergen exposure periods.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><i><span
lang=EN-GB>Paediatric population</span></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The safety and
efficacy of Aerius&nbsp;5 mg orodispersible tablets in children below the age
of 12</span><span lang=EN-GB>&nbsp;</span><span lang=EN-GB>years have not been
established.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>There is limited
clinical trial efficacy experience with the use of desloratadine in adolescents
12&nbsp;through 17&nbsp;years of age (see sections&nbsp;4.8 and 5.1).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Method
of administration</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>Oral use.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The dose can be
taken with or without food.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>Immediately before use, the blister must be
carefully peeled open and the dose of </span><span lang=EN-GB>orodispersible
tablet<span style='layout-grid-mode:line'> removed without crushing it. The
dose of </span>orodispersible tablet<span style='layout-grid-mode:line'> is
placed in the mouth where it will disperse immediately. Water or other liquid
is not needed to swallow the dose. The dose must be taken as soon as the
blister has been opened.</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.3&nbsp;&nbsp;&nbsp;&nbsp; Contraindications</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hypersensitivity
to the active substance, to any of the excipients listed in section&nbsp;6.1,
or to loratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.4&nbsp;&nbsp;&nbsp;&nbsp; Special
warnings and precautions for use</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In the case of
severe renal insufficiency, Aerius should be used with caution (see section&nbsp;5.2).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine
should be administered with caution in patients with medical or familial
history of seizures, and mainly young children </span><span lang=EN-GB>(see
section 4.8)</span><span lang=EN-GB>, being more susceptible to develop new
seizures under desloratadine treatment. Healthcare providers may consider
discontinuing desloratadine in patients who experience a seizure while on
treatment.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This product
contains 2.9&nbsp;mg of phenylalanine per 5&nbsp;mg dose of Aerius
orodispersible tablet. Phenylalanine may be harmful for people with
phenylketonuria.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.5&nbsp;&nbsp;&nbsp;&nbsp; Interaction
with other medicinal products and other forms of interaction</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>No clinically
relevant interactions were observed in clinical trials with desloratadine
tablets in which erythromycin or ketoconazole were co-administered (see
section&nbsp;5.1). </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Interaction
studies have only been performed in adults.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In a clinical
pharmacology trial, Aerius tablets taken concomitantly with alcohol did not
potentiate the performance impairing effects of alcohol (see section&nbsp;5.1).
</span><span lang=EN-GB>However, cases of alcohol intolerance and intoxication
have been reported during post&#8209;marketing use. Therefore, caution is
recommended if alcohol is taken concomitantly.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.6&nbsp;&nbsp;&nbsp;&nbsp; Fertility,
pregnancy and lactation</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Pregnancy</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>A large amount
of data on pregnant women (more than 1,000&nbsp;pregnancy outcomes) indicate no
malformative nor foeto/ neonatal toxicity of desloratadine.</span><span
lang=EN-GB> Animal studies do not indicate direct or indirect harmful effects
with respect to reproductive toxicity (see section&nbsp;5.3). </span><span
lang=EN-GB>As a precautionary measure, it is preferable to avoid the use of
Aerius during pregnancy.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Breast-feeding</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Desloratadine has been identified in
breastfed newborns/infants of treated women. The effect of desloratadine on
newborns/infants is unknown. A decision must be made whether to discontinue breast-feeding
or to discontinue/abstain from Aerius therapy taking into account the benefit
of breast feeding for the child and the benefit of therapy for the woman.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Fertility</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>There are no
data available on male and female fertility.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.7&nbsp;&nbsp;&nbsp;&nbsp; Effects
on ability to drive and use machines</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt'>Aerius has no or negligible influence on the
ability to drive and use machines based on clinical trials. P</span><span
lang=EN-GB>atients should be informed that most people do not experience <span
style='layout-grid-mode:line'>drowsiness. Nevertheless, as there is individual
variation in response </span></span><span lang=EN-GB>to all medicinal products,
it is recommended that patients are advised not to engage in activities
requiring mental alertness, such as driving a car or using machines, until they
have established their own response to the medicinal product.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.8&nbsp;&nbsp;&nbsp;&nbsp; Undesirable
effects</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Summary
of the safety profile</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In clinical
trials in a range of indications including allergic rhinitis and chronic
idiopathic urticaria, at the recommended dose of 5&nbsp;mg daily, undesirable
effects with Aerius tablets were reported in 3&nbsp;% of patients in excess of
those treated with placebo. The most frequent of adverse reactions reported in
excess of placebo were fatigue (1.2&nbsp;%), dry mouth (0.8&nbsp;%) and
headache (0.6&nbsp;%). </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In a clinical
trial with 578&nbsp;adolescent patients, 12&nbsp;through 17&nbsp;years of age,
the most common adverse event was headache; this occurred in 5.9&nbsp;% of
patients treated</span><span lang=EN-GB> with desloratadine and 6.9&nbsp;% of
patients receiving placebo.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Tabulated
list of adverse reactions</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The frequency of
the clinical trial adverse reactions reported in excess of placebo and other
undesirable effects reported during the post-marketing period are listed in the
following table. </span><span lang=EN-GB>Frequencies are defined as </span><span
lang=EN-GB>very common (&#8805;&nbsp;1/10), </span><span lang=EN-GB>common
(&#8805;&nbsp;1/100 to &lt;&nbsp;1/10), uncommon (&#8805;&nbsp;1/1,000 to
&lt;&nbsp;1/100), rare (&#8805;&nbsp;1/10,000 to &lt;&nbsp;1/1,000), very rare
(&lt;&nbsp;1/10,000) and not known (cannot be estimated from the available
data).</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse;border:none'>
 <thead>
  <tr style='page-break-inside:avoid'>
   <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
   padding:0in 5.4pt 0in 5.4pt'>
   <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
   style='letter-spacing:-.15pt'>System Organ Class</span></b></p>
   </td>
   <td width="27%" valign=top style='width:27.92%;border:solid windowtext 1.0pt;
   border-left:none;padding:0in 5.4pt 0in 5.4pt'>
   <p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
   lang=EN-GB style='letter-spacing:-.15pt'>Frequency</span></b></p>
   </td>
   <td width="38%" valign=top style='width:38.76%;border:solid windowtext 1.0pt;
   border-left:none;padding:0in 5.4pt 0in 5.4pt'>
   <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
   style='letter-spacing:-.15pt'>Adverse reactions seen with Aerius</span></b></p>
   </td>
  </tr>
 </thead>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='page-break-after:avoid'><b><span lang=EN-GB>Metabolism
  and nutrition disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB>Increased appetite</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
  style='letter-spacing:-.15pt'>Psychiatric disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt'>Very rare</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt'>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='letter-spacing:-.15pt'>Hallucinations</span></p>
  <p class=MsoNormal style='line-height:normal'><span style='letter-spacing:
  -.15pt;layout-grid-mode:line'>Abnormal behaviour,</span><span
  style='font-size:9.0pt;font-family:"Verdana",sans-serif;color:black'> </span><span
  style='letter-spacing:-.15pt;layout-grid-mode:line'>aggression</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
  style='letter-spacing:-.15pt'>Nervous system disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt'>Common</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt'>Very rare</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='letter-spacing:-.15pt'>Headache</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='letter-spacing:-.15pt'>Dizziness, somnolence, insomnia, psychomotor hyperactivity,
  seizures</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
  style='letter-spacing:-.15pt'>Cardiac disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Tachycardia,
  palpitations</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='letter-spacing:-.15pt;layout-grid-mode:line'>QT prolongation</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
  style='letter-spacing:-.15pt'>Gastrointestinal disorders</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='letter-spacing:-.15pt'>&nbsp;</span></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt'>Common</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt'>Very rare</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='letter-spacing:-.15pt'>Dry mouth</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='letter-spacing:-.15pt'>Abdominal pain, nausea, vomiting, dyspepsia,
  diarrhoea</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
  style='letter-spacing:-.15pt'>Hepatobiliary disorders</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='letter-spacing:-.15pt'>&nbsp;</span></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='layout-grid-mode:line'>Elevations of liver enzymes,
  increased bilirubin, hepatitis</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='layout-grid-mode:line'>Jaundice</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
  style='letter-spacing:-.15pt'>Skin and subcutaneous tissue disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt'>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='letter-spacing:-.15pt'>Photosensitivity</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
  style='letter-spacing:-.15pt'>Musculoskeletal and connective tissue disorders</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt'>Very rare</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='letter-spacing:-.15pt'>Myalgia</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
  style='letter-spacing:-.15pt'>General disorders and administration site
  conditions</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='letter-spacing:-.15pt'>&nbsp;</span></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt'>Common</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt'>Very rare</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt'>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='letter-spacing:-.15pt'>Fatigue</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='letter-spacing:-.15pt'>Hypersensitivity reactions (such as
  anaphylaxis, angioedema, dyspnoea, pruritus, rash, and urticaria)</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='letter-spacing:-.15pt'>Asthenia</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-GB style='letter-spacing:-.15pt'>Investigations</span></b></p>
  </td>
  <td width="27%" valign=top style='width:27.92%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><span lang=EN-GB style='letter-spacing:-.15pt'>Not known</span></p>
  </td>
  <td width="38%" valign=top style='width:38.76%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><span lang=EN-GB style='letter-spacing:-.15pt'>Weight
  increased</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>Other undesirable effects reported during the post&#8209;marketing
period in paediatric patients with an unknown frequency included QT
prolongation, arrhythmia, bradycardia, abnormal behaviour, and aggression.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>A retrospective observational safety study indicated an increased
incidence of new-onset seizure in patients 0 to 19 years of age when receiving
desloratadine compared with periods not receiving desloratadine. Among children
0-4 years old, the adjusted absolute increase was 37.5 (95% Confidence Interval
(CI) 10.5-64.5) per 100,000 person years (PY) with a background rate of new
onset seizure of 80.3 per 100,000 PY. Among patients 5-19 years of age, the
adjusted absolute increase was 11.3 (95% CI 2.3-20.2) per 100,000 PY with a
background rate of 36.4 per 100,000 PY. (See section 4.4.)</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Reporting
of suspected adverse reactions</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspected
adverse reactions via <span style='color:black;background:#BFBFBF'>the national
reporting system listed in </span></span><span lang=EN-GB><a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span
style='background:#BFBFBF'>Appendix V</span></a></span><span lang=EN-GB>.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.9&nbsp;&nbsp;&nbsp;&nbsp; Overdose</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The adverse
event profile associated with overdosage, as seen during post&#8209;marketing
use, is similar to that seen with therapeutic doses, but the magnitude of the
effects can be higher.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Treatment</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>In the event of overdose, consider
standard measures to remove unabsorbed active substance. Symptomatic and
supportive treatment is recommended.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine is
not eliminated by haemodialysis; it is not known if it is eliminated by
peritoneal dialysis.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Symptoms</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Based on a
multiple dose clinical trial, in which up to 45&nbsp;mg of desloratadine was
administered (nine&nbsp;times the clinical dose), no clinically relevant
effects were observed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The adverse
event profile associated with overdosage, as seen during post&#8209;marketing
use, is similar to that seen with therapeutic doses, but the magnitude of the
effects can be higher.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACOLOGICAL
PROPERTIES</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.1&nbsp;&nbsp;&nbsp;&nbsp; Pharmacodynamic
properties</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Pharmacotherapeutic
group: antihistamines &#8211; H<sub>1</sub> antagonist, ATC code: R06A X27</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Mechanism
of action</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine is
a non-sedating, long-acting histamine antagonist with selective peripheral H<sub>1</sub>-receptor
antagonist activity. After oral administration, desloratadine selectively
blocks peripheral histamine H<sub>1</sub>-receptors because the substance is
excluded from entry to the central nervous system.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine has
demonstrated antiallergic properties from <i>in vitro </i>studies.<i> </i>These
include inhibiting the release of proinflammatory cytokines such as IL-4, IL-6,
IL-8, and IL-13 from human mast cells/basophils, as well as inhibition of the
expression of the adhesion molecule P-selectin on endothelial cells. The
clinical relevance of these observations remains to be confirmed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Clinical
efficacy and safety</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In a multiple
dose trial, Aerius orodispersible tablets were well tolerated.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>At the
recommended dose, Aerius 5&nbsp;mg orodispersible tablet was found to be
bioequivalent to the Aerius 5&nbsp;mg conventional tablet formulation of
desloratadine. Therefore, the efficacy of Aerius orodispersible tablet is
expected to be the same as with the Aerius tablet formulation.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In a
multiple-dose clinical trial, in which up to 20&nbsp;mg of desloratadine was
administered daily for 14&nbsp;days, no statistically or clinically relevant
cardiovascular effect was observed. In a clinical pharmacology trial, in which
desloratadine was administered at a dose of 45&nbsp;mg daily (nine times the
clinical dose) for ten days, no prolongation of QTc interval was seen.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>No clinically
relevant changes in desloratadine plasma concentrations were observed in
multiple-dose, ketoconazole and erythromycin interaction trials.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Desloratadine does not readily penetrate
the central nervous system. In clinical trials, at the recommended dose of
5&nbsp;mg daily, there was no excess incidence of somnolence as compared to
placebo. Aerius tablets given at a single daily dose of 7.5&nbsp;mg did not affect
psychomotor performance in clinical trials. In a single dose study performed in
adults, desloratadine 5&nbsp;mg did not affect standard measures of flight
performance including exacerbation of subjective sleepiness or tasks related to
flying.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In clinical
pharmacology trials, co-administration with alcohol did not increase the
alcohol-induced impairment in performance or increase in sleepiness. No
significant differences were found in the psychomotor test results between
desloratadine and placebo groups, whether administered alone or with alcohol. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In patients with
allergic rhinitis, Aerius tablets were effective in relieving symptoms such as
sneezing, nasal discharge and itching, as well as ocular itching, tearing and
redness, and itching of palate. <span style='layout-grid-mode:line'>Aerius
tablets effectively controlled symptoms for 24&nbsp;hours.</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The efficacy of
Aerius tablets has not been clearly demonstrated in trials with adolescent
patients 12&nbsp;th</span><span lang=EN-GB>rough 17&nbsp;years of age<span
style='layout-grid-mode:line'>.</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In addition to
the established classifications of seasonal and perennial, allergic rhinitis can
alternatively be classified as intermittent allergic rhinitis and persistent
allergic rhinitis according to the duration of <span style='layout-grid-mode:
line'>symptoms. Intermittent</span> allergic rhinitis is defined as the
presence of symptoms for less than 4 days per week or for less than 4 weeks.
Persistent allergic rhinitis is defined as the presence of symptoms for 4 days
or more per week and for more than 4 weeks.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius was
effective in alleviating the burden of seasonal allergic rhinitis as shown by
the total score of the rhino-conjunctivitis quality of life questionnaire. The
greatest amelioration was seen in the domains of practical problems and daily
activities limited by symptoms. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Chronic idiopathic urticaria was studied
as a clinical model for urticarial conditions, since&nbsp;the underlying
pathophysiology is similar, regardless of etiology,&nbsp;and&nbsp;because
chronic patients can be more easily recruited prospectively. Since histamine
release is a causal factor in all urticarial diseases, desloratadine is
expected to be effective in providing symptomatic relief for other urticarial
conditions, in addition to chronic idiopathic urticaria, as advised in clinical
guidelines.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>In two placebo-controlled six week trials in
patients with chronic idiopathic urticaria, Aerius was effective in relieving
pruritus and decreasing the size and number of hives by the end of the first
dosing interval. In each trial, the effects were sustained over the
24&nbsp;hour dosing interval. As with other antihistamine trials in chronic
idiopathic urticaria, the minority of patients who were identified as
non-responsive to antihistamines was excluded. An improvement in pruritus of
more than 50&nbsp;% was observed in 55&nbsp;% of patients treated with
desloratadine compared with 19&nbsp;% of patients treated with placebo. Treatment
with Aerius also significantly reduced interference with sleep and daytime
function, as measured by a four-point scale used to assess these variables.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.2&nbsp;&nbsp;&nbsp;&nbsp; Pharmacokinetic
properties </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Absorption</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine
plasma concentrations can be detected within 30&nbsp;minutes of administration.
Desloratadine is well absorbed with maximum concentration achieved after
approximately 3&nbsp;hours; the terminal phase half-life is approximately
27&nbsp;hours. The degree of accumulation of desloratadine was consistent with
its half-life (approximately 27&nbsp;hours) and a once daily dosing frequency.
The bioavailability of desloratadine was dose proportional over the range of
5&nbsp;mg to 20&nbsp;mg. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>In a series of pharmacokinetic and clinical trials,&nbsp;6&nbsp;% of
the subjects reached a higher concentration of desloratadine. The prevalence of
this poor metaboliser phenotype was greater among Black adults than Caucasian
adults (18&nbsp;%&nbsp;vs.&nbsp;2&nbsp;%) however the safety profile of these
subjects was not different from that of the general population. </span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>In a multiple-dose pharmacokinetic study conducted with the tablet
formulation in healthy adult subjects, four subjects were found to be poor
metabolisers of desloratadine. These subjects had a C<sub>max</sub>
concentration about 3-fold higher at approximately 7&nbsp;hours with a terminal
phase half-life of approximately 89&nbsp;hours.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Distribution</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine is
moderately bound (83&nbsp;% - 87&nbsp;%) to plasma proteins. There is no
evidence of clinically relevant medicine accumulation following once daily
dosing of desloratadine (5&nbsp;mg to 20&nbsp;mg) for 14&nbsp;days. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Biotransformation</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>The enzyme responsible for the metabolism
of desloratadine has not been identified yet, and therefore, some interactions
with other medicinal products cannot be fully excluded.<span style='layout-grid-mode:
line'> </span>Desloratadine does not inhibit CYP3A4 <i>in vivo,</i> and <i>in
vitro</i> studies have shown that the medicinal product does not inhibit CYP2D6
and is neither a substrate nor an inhibitor of P-glycoprotein.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>In single-dose crossover studies of Aerius
5&nbsp;mg </span><span lang=EN-GB>orodispersible tablets <span
style='layout-grid-mode:line'>with Aerius </span>5&nbsp;mg conventional<span
style='layout-grid-mode:line'> tablets, the formulations were bioequivalent. </span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Elimination</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>The presence of food prolongs T<sub>max</sub> for
desloratadine from 2.5&nbsp;to 4&nbsp;hours and T<sub>max</sub> for
3-OH-desloratadine from 4&nbsp;to 6&nbsp;hours. In a separate study, grapefruit
juice had no effect on the disposition of desloratadine. Water had no effect on
the bioavailability of Aerius orodispersible tablets.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Renally impaired patients</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The
pharmacokinetics of desloratadine in patients with chronic renal insufficiency
(CRI) was compared with that of healthy subjects in one single&#8209;dose study
and one multiple dose study. In the single&#8209;dose study, the exposure to
desloratadine was approximately 2 and 2.5&#8209;fold greater in subjects with
mild to moderate and severe CRI, respectively, than in healthy subjects. In the
multiple&#8209;dose study, steady state was reached after Day&nbsp;11, and
compared to healthy subjects the exposure to desloratadine was ~1.5&#8209;fold
greater in subjects with mild to moderate CRI and ~2.5&#8209;fold greater in
subjects with severe CRI. In both studies, changes in exposure (AUC and C<sub>max</sub>)
of desloratadine and 3&#8209;hydroxydesloratadine were not clinically relevant.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.3&nbsp;&nbsp;&nbsp;&nbsp; Preclinical
safety data</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine is
the primary active metabolite of loratadine. Non-clinical studies conducted
with desloratadine and loratadine demonstrated that there are no qualitative or
quantitative differences in the toxicity profile of desloratadine and
loratadine at comparable levels of exposure to desloratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Non-clinical
data reveal no special hazard for humans based on conventional studies of
safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic
potential, toxicity to reproduction and development. The collective analysis of
preclinical and clinical irritation studies for the orodispersible tablet
indicate that this formulation is unlikely to pose risk for local irritation
with clinical use. The lack of carcinogenic potential was demonstrated in
studies conducted with desloratadine and loratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.1&nbsp;&nbsp;&nbsp;&nbsp; List
of excipients</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>microcrystalline
cellulose</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>pregelatinized
starch</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>sodium starch
glycolate</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>magnesium
stearate</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>butylated
methacrylate copolymer</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>crospovidone</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>sodium hydrogen
carbonate </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>citric acid</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>colloidal
silicon dioxide</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>ferric oxide</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>mannitol</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>aspartame (E951)</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>flavour
Tutti-Frutti</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.2&nbsp;&nbsp;&nbsp;&nbsp; Incompatibilities</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Not applicable.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.3&nbsp;&nbsp;&nbsp;&nbsp; Shelf
life</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>2&nbsp;years</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.4&nbsp;&nbsp;&nbsp;&nbsp; Special
precautions for storage</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Store in the
original package.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.5&nbsp;&nbsp;&nbsp;&nbsp; Nature
and contents of container</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius
orodispersible tablets are supplied in unit dose blisters comprised of laminate
blister film with foil lidding.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>The blister materials consist of a four layer aluminum foil laminate
cold form blister film and a paper backed laminated aluminum foil lidding film.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The cold form
blister film is composed of polyvinyl chloride (PVC) film adhesively laminated
to an oriented polyamide (OPA) film, adhesively laminated to aluminum foil,
adhesively laminated to polyvinyl chloride (PVC) film.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Packs of
5,&nbsp;6,&nbsp;10,&nbsp;12,&nbsp;15,&nbsp;18,&nbsp;20,&nbsp;30,&nbsp;50,&nbsp;60,&nbsp;90
and 100&nbsp;orodispersible tablets.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Not all pack
sizes may be marketed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.6&nbsp;&nbsp;&nbsp;&nbsp; Special
precautions for disposal</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>No special
requirements</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION HOLDER</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Merck Sharp
&amp; Dohme B.V.</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>Waarderweg 39</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>2031 BN Haarlem</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>The Netherlands</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBERS </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EU/1/00/160/049-060</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DATE
OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt'>Date of first authorisation: </span><span
lang=EN-GB>15 January 2001</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt'>Date of latest renewal: 15 January 2006</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>10.&nbsp;&nbsp;&nbsp;&nbsp; DATE
OF REVISION OF THE TEXT</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Detailed
information on this medicinal product is available on the website of the
European Medicines Agency http://www.ema.europa.eu.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius
0.5&nbsp;mg/ml oral solution</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; QUALITATIVE
AND QUANTITATIVE COMPOSITION</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Each ml of oral
solution contains 0.5&nbsp;mg desloratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Excipient(s)
with known effect:</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This medicinal
product contains 150 mg/ml of sorbitol</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>For the full
list of excipients, see section&nbsp;6.1.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Oral solution</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CLINICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.1&nbsp;&nbsp;&nbsp;&nbsp; Therapeutic
indications</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius is
indicated in adults, adolescents and children over the age of 1&nbsp;year for
the relief of symptoms associated with:</span></p>

<p class=MsoNormal style='margin-left:28.5pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>allergic rhinitis (see section&nbsp;5.1)</span></p>

<p class=MsoNormal style='margin-left:28.5pt;text-indent:-28.5pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>urticaria (see section&nbsp;5.1)</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.2&nbsp;&nbsp;&nbsp;&nbsp; Posology
and method of administration</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Posology</span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><i><span
lang=EN-GB>Adults and adolescents (12</span></i><span lang=EN-GB>&nbsp;<i>years
of age and over)</i></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The recommended
dose of Aerius is 10&nbsp;ml (5&nbsp;mg) oral solution once a day.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><i><span
lang=EN-GB>Paediatric population</span></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The prescriber
should be aware that most cases of rhinitis below 2 years of age are of
infectious origin (see section 4.4) and there are no data supporting the
treatment of infectious rhinitis with Aerius.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Children
1&nbsp;through&nbsp;5&nbsp;years of age: 2.5&nbsp;ml (1.25&nbsp;mg) Aerius oral
solution once a day.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Children
6&nbsp;through&nbsp;11&nbsp;years of age: 5&nbsp;ml (2.5&nbsp;mg) Aerius oral
solution once a day.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The safety and
efficacy of Aerius 0.5&nbsp;mg/ml oral solution in children below the age of 1&nbsp;year
have not been established.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>There is limited clinical trial efficacy experience with the use of
desloratadine in children 1 through 11&nbsp;years of age and adolescents
12&nbsp;through 17&nbsp;years of age (see sections&nbsp;4.8 and 5.1).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Intermittent
allergic rhinitis (presence of symptoms for less than 4 days per week or for
less than 4&nbsp;weeks) should be managed in accordance with the evaluation of
patient&#8217;s disease history and the treatment could be discontinued after
symptoms are resolved and reinitiated upon their reappearance. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In persistent
allergic rhinitis (presence of symptoms for 4 days or more per week and for
more than 4&nbsp;weeks), continued treatment may be proposed to the patients
during the allergen exposure periods. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Method
of administration</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Oral use.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The dose can be
taken with or without food.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.3&nbsp;&nbsp;&nbsp;&nbsp; Contraindications</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hypersensitivity
to the active substance, to any of the excipients listed in section&nbsp;6.1,
or to loratadine. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.4&nbsp;&nbsp;&nbsp;&nbsp; Special
warnings and precautions for use</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Desloratadine
should be administered with caution in patients with medical or familial
history of seizures, and mainly young children (see section 4.8), being more
susceptible to develop new seizures under desloratadine treatment. Healthcare
providers may consider discontinuing desloratadine in patients who experience a
seizure while on treatment.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoEndnoteText style='page-break-after:avoid'><u><span lang=EN-GB
style='font-size:11.0pt'>Paediatric population</span></u></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>In children
below 2&nbsp;years of age, the diagnosis of allergic rhinitis is particularly
difficult to distinguish from other forms of rhinitis. The absence of upper
respiratory tract infection or structural abnormalities, as well as patient
history, physical examinations, and appropriate laboratory and skin tests
should be considered.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>Approximately 6&nbsp;% of adults and children 2-
to 11-year old are phenotypic poor metabolisers of desloratadine and exhibit a
higher exposure (see section 5.2). The safety of desloratadine in children 2-
to 11-years of age who are poor metabolisers is the same as in children who are
normal metabolisers. The effects of desloratadine in poor metabolisers
&lt;&nbsp;2 years of age have not been studied.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In the case of
severe renal insufficiency, Aerius should be used with caution (see section&nbsp;5.2).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This medicinal
product contains sorbitol; thus, patients with rare hereditary problems of
fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase
insufficiency should not take this medicine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.5&nbsp;&nbsp;&nbsp;&nbsp; Interaction
with other medicinal products and other forms of interaction</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>No clinically
relevant interactions were observed in clinical trials with desloratadine
tablets in which </span><span lang=EN-GB>erythromycin or ketoconazole were co-administered
(see section&nbsp;5.1).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Interaction
studies have only been performed in adults.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In a clinical
pharmacology trial, Aerius tablets taken concomitantly with alcohol did not
potentiate the performance impairing effects of alcohol (see section&nbsp;5.1).
</span><span lang=EN-GB>However, cases of alcohol intolerance and intoxication
have been reported during post&#8209;marketing use. Therefore, caution is
recommended if alcohol is taken concomitantly.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.6&nbsp;&nbsp;&nbsp;&nbsp; Fertility,
pregnancy and lactation</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Pregnancy</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>A large amount
of data on pregnant women (more than 1,000&nbsp;pregnancy outcomes) indicate no
malformative nor foeto/ neonatal toxicity of desloratadine.</span><span
lang=EN-GB> Animal studies do not indicate direct or indirect harmful effects
with respect to reproductive toxicity (see section&nbsp;5.3). </span><span
lang=EN-GB>As a precautionary measure, it is preferable to avoid the use of
Aerius during pregnancy.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Breast-feeding</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine
has been identified in breastfed newborns/infants of treated women. The effect
of desloratadine on newborns/infants is unknown. A decision must be made
whether to discontinue breast-feeding or to discontinue/abstain from Aerius
therapy taking into account the benefit of breast feeding for the child and the
benefit of therapy for the woman.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Fertility</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>There are no
data available </span><span lang=EN-GB>on male and female fertility.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.7&nbsp;&nbsp;&nbsp;&nbsp; Effects
on ability to drive and use machines</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt'>Aerius has no or negligible influence
on the ability to drive and use machines based on clinical trials. </span><span
lang=EN-GB>Patients should be informed that most people do not experience
drowsiness.<span style='layout-grid-mode:line'> Nevertheless, as there is
individual variation in response </span></span><span lang=EN-GB>to all
medicinal products, it is recommended that patients are advised not to engage
in activities requiring mental alertness, such as driving a car or using
machines, until they have established their own response to the medicinal
product.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.8&nbsp;&nbsp;&nbsp;&nbsp; Undesirable
effects</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Summary
of the safety profile</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In clinical
trials in a paediatric population, the desloratadine syrup formulation was
administered to a total of 246&nbsp;children aged 6&nbsp;months through
11&nbsp;years. The overall incidence of adverse events in children
2&nbsp;through 11&nbsp;years of age was similar for the desloratadine and the
placebo groups. In infants and toddlers aged 6&nbsp;to 23&nbsp;months, the most
frequent adverse reactions reported in excess of placebo were diarrhoea
(3.7&nbsp;%), fever (2.3&nbsp;%) and insomnia (2.3&nbsp;%). In an additional
study, no adverse events were seen in subjects between 6 and 11&nbsp;years of
age following a single 2.5&nbsp;mg dose of desloratadine oral solution.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In a clinical
trial with 578&nbsp;adolescent patients, 12&nbsp;through 17&nbsp;years of age,
the most common adverse event was headache; this occurred in 5.9&nbsp;% of
patients treated</span><span lang=EN-GB> with desloratadine and 6.9&nbsp;% of
patients receiving placebo.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Adults and adolescents</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>At the recommended
dose, in clinical trials involving adults and adolescents in a range of
indications including allergic rhinitis and chronic idiopathic urticaria,
undesirable effects with Aerius were reported in 3&nbsp;% of patients in excess
of those treated with placebo. The most frequent of adverse events reported in
excess of placebo were fatigue (1.2&nbsp;%), dry mouth (0.8&nbsp;%) and
headache (0.6&nbsp;%).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Tabulated
list of adverse reactions</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The frequency of
the clinical trial adverse reactions reported in excess of placebo and other
undesirable effects reported during the post-marketing period are listed in the
following table. </span><span lang=EN-GB>Frequencies are defined as </span><span
lang=EN-GB>very common (&#8805;&nbsp;1/10), </span><span lang=EN-GB>common
(&#8805;&nbsp;1/100 to &lt;&nbsp;1/10), uncommon (&#8805;&nbsp;1/1,000 to
&lt;&nbsp;1/100), rare (&#8805;&nbsp;1/10,000 to &lt;&nbsp;1/1,000), very rare
(&lt;&nbsp;1/10,000) and not known (cannot be estimated from the available
data).</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse;border:none'>
 <thead>
  <tr style='page-break-inside:avoid;height:6.5pt'>
   <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
   padding:0in 5.4pt 0in 5.4pt;height:6.5pt'>
   <p class=MsoBodyText align=left style='text-align:left;line-height:normal;
   page-break-after:avoid'><b><span lang=EN-GB>System Organ Class</span></b></p>
   </td>
   <td width="25%" valign=top style='width:25.02%;border:solid windowtext 1.0pt;
   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:6.5pt'>
   <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><b><span
   lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Frequency</span></b></p>
   </td>
   <td width="41%" valign=top style='width:41.66%;border:solid windowtext 1.0pt;
   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:6.5pt'>
   <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
   lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Adverse
   reactions seen with Aerius</span></b></p>
   </td>
  </tr>
 </thead>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='page-break-after:avoid'><b><span lang=EN-GB>Metabolism
  and nutrition disorders</span></b></p>
  </td>
  <td width="25%" valign=top style='width:25.02%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB>Not known</span></p>
  </td>
  <td width="41%" valign=top style='width:41.66%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal;
  page-break-after:avoid'><span lang=EN-GB>Increased appetite</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>Psychiatric disorders</span></b></p>
  </td>
  <td width="25%" valign=top style='width:25.02%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known</span></p>
  </td>
  <td width="41%" valign=top style='width:41.66%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Hallucinations</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  style='letter-spacing:-.15pt;layout-grid-mode:line'>Abnormal behaviour,</span><span
  style='font-size:9.0pt;font-family:"Verdana",sans-serif;color:black'> </span><span
  style='letter-spacing:-.15pt;layout-grid-mode:line'>aggression</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>Nervous system disorders</span></b></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>&nbsp;</span></b></p>
  </td>
  <td width="25%" valign=top style='width:25.02%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Common</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Common
  (children less than 2&nbsp;years)</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare</span></p>
  </td>
  <td width="41%" valign=top style='width:41.66%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Headache</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Insomnia</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Dizziness,
  somnolence, insomnia, psychomotor hyperactivity, seizures</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>Cardiac disorders</span></b></p>
  </td>
  <td width="25%" valign=top style='width:25.02%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known</span></p>
  </td>
  <td width="41%" valign=top style='width:41.66%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Tachycardia,
  palpitations</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>QT
  prolongation</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>Gastrointestinal disorders</span></b></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="25%" valign=top style='width:25.02%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Common</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Common
  (children less than 2&nbsp;years)</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare</span></p>
  </td>
  <td width="41%" valign=top style='width:41.66%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Dry mouth</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Diarrhoea</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Abdominal
  pain, nausea, vomiting, dyspepsia, diarrhoea </span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>Hepatobiliary disorders</span></b></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="25%" valign=top style='width:25.02%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known</span></p>
  </td>
  <td width="41%" valign=top style='width:41.66%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='layout-grid-mode:line'>Elevations of liver enzymes,
  increased bilirubin,<span style='letter-spacing:-.15pt'> hepatitis</span></span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Jaundice</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>Skin and subcutaneous tissue disorders</span></b></p>
  </td>
  <td width="25%" valign=top style='width:25.02%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known</span></p>
  </td>
  <td width="41%" valign=top style='width:41.66%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='layout-grid-mode:line'>Photosensitivity</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>Musculoskeletal and connective tissue disorders</span></b></p>
  </td>
  <td width="25%" valign=top style='width:25.02%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare</span></p>
  </td>
  <td width="41%" valign=top style='width:41.66%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB>Myalgia</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>General disorders and administration site conditions</span></b></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="25%" valign=top style='width:25.02%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Common</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Common
  (children less than 2&nbsp;years)</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known</span></p>
  </td>
  <td width="41%" valign=top style='width:41.66%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Fatigue</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Fever</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Hypersensitivity
  reactions (such as anaphylaxis, angioedema, dyspnoea, pruritus, rash, and
  urticaria)</span></p>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Asthenia</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="33%" valign=top style='width:33.32%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><b><span
  lang=EN-GB>Investigations</span></b></p>
  </td>
  <td width="25%" valign=top style='width:25.02%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known</span></p>
  </td>
  <td width="41%" valign=top style='width:41.66%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
  lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Weight
  increased</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>Other undesirable effects reported during the post&#8209;marketing
period in paediatric patients with an unknown frequency included QT
prolongation, arrhythmia, bradycardia, abnormal behaviour, and aggression.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>A retrospective observational safety study indicated an increased
incidence of new-onset seizure in patients 0 to 19 years of age when receiving
desloratadine compared with periods not receiving desloratadine. Among children
0-4 years old, the adjusted absolute increase was 37.5 (95% Confidence Interval
(CI) 10.5-64.5) per 100,000 person years (PY) with a background rate of new
onset seizure of 80.3 per 100,000 PY. Among patients 5-19 years of age, the
adjusted absolute increase was 11.3 (95% CI 2.3-20.2) per 100,000 PY with a
background rate of 36.4 per 100,000 PY. (See section 4.4.)</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Reporting
of suspected adverse reactions</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Reporting
suspected adverse reactions after authorisation of the medicinal product is
important. It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals are asked to report any suspected
adverse reactions via <span style='color:black;background:#BFBFBF'>the national
reporting system listed in </span></span><span lang=EN-GB><a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span
style='background:#BFBFBF'>Appendix V</span></a></span><span lang=EN-GB>.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>4.9&nbsp;&nbsp;&nbsp;&nbsp; Overdose</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The adverse
event profile associated with overdosage, as seen during post&#8209;marketing
use, is similar to that seen with therapeutic doses, but the magnitude of the
effects can be higher.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><u><span lang=EN-GB>Treatment</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>In the event of overdose, consider
standard measures to remove unabsorbed active substance. Symptomatic and
supportive treatment is recommended.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine is
not eliminated by haemodialysis; it is not known if it is eliminated by
peritoneal dialysis.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Symptoms</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Based on a
multiple dose clinical trial in adults and adolescents, in which up to
45&nbsp;mg of desloratadine was administered (nine&nbsp;times the clinical
dose), no clinically relevant effects were observed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The adverse
event profile associated with overdosage, as seen during post&#8209;marketing
use, is similar to that seen with therapeutic doses, but the magnitude of the
effects can be higher.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACOLOGICAL
PROPERTIES</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.1&nbsp;&nbsp;&nbsp;&nbsp; Pharmacodynamic
properties</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Pharmacotherapeutic
group: antihistamines &#8211; H<sub>1</sub> antagonist, ATC code: R06A X27</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Mechanism
of action</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine is
a non-sedating, long-acting histamine antagonist with selective peripheral H<sub>1</sub>-receptor
antagonist activity. After oral administration, desloratadine selectively
blocks peripheral histamine H<sub>1</sub>-receptors because the substance is
excluded from entry to the central nervous system.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine has
demonstrated antiallergic properties from <i>in</i> <i>vitro</i> studies. These
include inhibiting the release of proinflammatory cytokines such as IL-4, IL-6,
IL-8, and IL-13 from human mast cells/basophils, as well as inhibition of the
expression of the adhesion molecule P-selectin on endothelial cells. The
clinical relevance of these observations remains to be confirmed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Clinical
efficacy and safety</span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Paediatric
population</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Efficacy of
Aerius oral solution has not been investigated in separate paediatric trials.
However, the safety of desloratadine syrup formulation, which contains the same
concentration of desloratadine as Aerius oral solution, was demonstrated in
three paediatric trials. Children, 1-11&nbsp;years of age, who were candidates
for antihistamine therapy received a daily desloratadine dose
of&nbsp;1.25&nbsp;mg (1&nbsp;through 5&nbsp;years of age) or 2.5&nbsp;mg
(6&nbsp;through 11&nbsp;years of age). Treatment was well tolerated as
documented by clinical laboratory tests, vital signs, and ECG interval data,
including QTc. When given at the recommended doses, the plasma concentrations
of desloratadine (see&nbsp;section 5.2) were comparable in the paediatric and
adult populations. Thus, since the course of allergic rhinitis/chronic
idiopathic urticaria and the profile of desloratadine are similar in adults and
paediatric patients, desloratadine efficacy data in adults can be extrapolated
to the paediatric population.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>Efficacy of Aerius syrup has not been investigated in paediatric
trials in children less than 12&nbsp;years of age.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Adults and adolescents</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In a multiple
dose clinical trial, in adults and adolescents, in which up to 20&nbsp;mg of
desloratadine was administered daily for 14&nbsp;days, no statistically or
clinically relevant cardiovascular effect was observed. In a clinical
pharmacology trial, in adults and adolescents, in which desloratadine was
administered to adults at a dose of 45&nbsp;mg daily (nine times the clinical
dose) for ten days, no prolongation of QTc interval was seen.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Desloratadine does not readily penetrate
the central nervous system. In controlled clinical trials, at the recommended
dose of 5&nbsp;mg daily for adults and adolescents, there was no excess
incidence of somnolence as compared to placebo. Aerius tablets given at a
single daily dose of 7.5&nbsp;mg to adults and adolescents did not affect
psychomotor performance in clinical trials. In a single dose study performed in
adults, desloratadine 5&nbsp;mg did not affect standard measures of flight
performance including exacerbation of subjective sleepiness or tasks related to
flying.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In clinical
pharmacology trials in adults, co-administration with alcohol did not increase
the alcohol-induced impairment in performance or increase in sleepiness. No
significant differences were found in the psychomotor test results between desloratadine
and placebo groups, whether administered alone or with alcohol. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>No clinically relevant changes in desloratadine
plasma concentrations were observed in multiple-dose ketoconazole and
erythromycin interaction trials.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In adult and adolescent
patients with allergic rhinitis, Aerius tablets were effective in relieving
symptoms such as sneezing, nasal discharge and itching, as well as ocular
itching, tearing and redness, and itching of palate. Aerius<span
style='layout-grid-mode:line'> effectively controlled symptoms for
24&nbsp;hours. </span></span><span lang=EN-GB>The efficacy of Aerius tablets
has not been clearly demonstrated in trials with adolescent patients 12&nbsp;th</span><span
lang=EN-GB>rough 17&nbsp;years of age<span style='layout-grid-mode:line'>.</span></span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>In addition to the established
classifications of seasonal and perennial, allergic rhinitis can alternatively
be classified as intermittent allergic rhinitis and persistent allergic
rhinitis according to the duration of symptoms. Intermittent allergic rhinitis
is defined as the presence of symptoms for less than 4 days per week or for
less than 4 weeks. Persistent allergic rhinitis is defined as the presence of
symptoms for 4 days or more per week and for more than 4 weeks.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Aerius tablets were effective in
alleviating the burden of seasonal allergic rhinitis as shown by the total
score of the rhino-conjunctivitis quality of life questionnaire. The greatest
amelioration was seen in the domains of practical problems and daily activities
limited by symptoms.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Chronic idiopathic urticaria was studied
as a clinical model for urticarial conditions, since&nbsp;the underlying
pathophysiology is similar, regardless of etiology,&nbsp;and&nbsp;because
chronic patients can be more easily recruited prospectively. Since histamine
release is a causal factor in all urticarial diseases, desloratadine is
expected to be effective in providing symptomatic relief for other urticarial
conditions, in addition to chronic idiopathic urticaria, as advised in clinical
guidelines.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>In two placebo-controlled six week trials
in patients with chronic idiopathic urticaria, Aerius was effective in
relieving pruritus and decreasing the size and number of hives by the end of
the first dosing interval. In each trial, the effects were sustained over the
24&nbsp;hour dosing interval. As with other antihistamine trials in chronic
idiopathic urticaria, the minority of patients who were identified as
non-responsive to antihistamines was excluded. An improvement in pruritus of
more than 50&nbsp;% was observed in 55&nbsp;% of patients treated with
desloratadine compared with 19&nbsp;% of patients treated with placebo.
Treatment with Aerius also significantly reduced interference with sleep and
daytime function, as measured by a four-point scale used to assess these
variables.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.2&nbsp;&nbsp;&nbsp;&nbsp; Pharmacokinetic
properties</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Absorption</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine
plasma concentrations can be detected within 30&nbsp;minutes of desloratadine
administration in adults and adolescents. Desloratadine is well absorbed with
maximum concentration achieved after approximately 3&nbsp;hours; the terminal
phase half-life is approximately 27&nbsp;hours. The degree of accumulation of
desloratadine was consistent with its half-life (approximately 27&nbsp;hours)
and a once daily dosing frequency. The bioavailability of desloratadine was
dose proportional over the range of 5&nbsp;mg to 20&nbsp;mg. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>In a series of pharmacokinetic and clinical
trials, 6&nbsp;% of the subjects reached a higher concentration of
desloratadine. The prevalence of this poor metaboliser phenotype was comparable
for adult (6&nbsp;%) and paediatric subjects 2- to 11-year old (6&nbsp;%), and
greater among Blacks (18&nbsp;% adult, 16&nbsp;% paediatric) than Caucasians
(2&nbsp;% adult, 3&nbsp;% paediatric) in both populations.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt;layout-grid-mode:
line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>In a multiple-dose pharmacokinetic study
conducted with the tablet formulation in healthy adult subjects, four subjects
were found to be poor metabolisers of desloratadine. These subjects had a C</span><sub><span
lang=EN-GB>max</span></sub><span lang=EN-GB style='layout-grid-mode:line'>
concentration about 3-fold higher at approximately 7&nbsp;hours with a terminal
phase half-life of approximately 89&nbsp;hours.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>Similar pharmacokinetic parameters were observed
in a multiple-dose pharmacokinetic study conducted with the syrup formulation
in paediatric poor metaboliser subjects 2- to 11-year old diagnosed with
allergic rhinitis. The exposure (AUC) to desloratadine was about 6-fold higher
and the C</span><sub><span lang=EN-GB>max</span></sub><span lang=EN-GB
style='layout-grid-mode:line'> was about 3 to 4&nbsp;fold higher at
3-6&nbsp;hours with a terminal half-life of approximately 120&nbsp;hours. Exposure
was the same in adult and paediatric poor metabolisers when treated with
age-appropriate doses. The overall safety profile of these subjects was not
different from that of the general population. The effects of desloratadine in
poor metabolizers &lt;&nbsp;2 years of age have not been studied.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>In separate single dose studies, at the
recommended doses, paediatric patients had comparable AUC and C<sub>max</sub>
values of desloratadine to those in adults who received a 5&nbsp;mg dose of
desloratadine syrup.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Distribution</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>Desloratadine is moderately bound
(83&nbsp;% - 87&nbsp;%) to plasma proteins. There is no evidence of clinically
relevant active substance accumulation following once daily adult and
adolescent dosing of desloratadine (5&nbsp;mg to 20&nbsp;mg) for 14&nbsp;days. </span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>In a single dose, crossover study of
desloratadine, the tablet and the syrup formulations were found to be
bioequivalent. As Aerius oral solution contains the same concentration of
desloratadine, no bioequivalence study was required and it is expected to be
equivalent to the syrup and tablet.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Biotransformation</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>The enzyme responsible for the metabolism
of desloratadine has not been identified yet, and therefore, some interactions
with other medicinal products cannot be fully excluded. Desloratadine does not
inhibit CYP3A4 <i>in vivo,</i> and <i>in vitro</i> studies have shown that the
medicinal product does not inhibit CYP2D6 and is neither a substrate nor an
inhibitor of P-glycoprotein.</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Elimination</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In a single dose
trial using a 7.5&nbsp;mg dose of desloratadine, there was no effect of food
(high-fat, high caloric breakfast) on the disposition of desloratadine.<span
style='layout-grid-mode:line'> In another study, grapefruit juice had no effect
on the disposition of desloratadine.</span></span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal'><span
lang=EN-GB style='font-weight:normal'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Renally impaired patients</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The
pharmacokinetics of desloratadine in patients with chronic renal insufficiency
(CRI) was compared with that of healthy subjects in one single&#8209;dose study
and one multiple dose study. In the single&#8209;dose study, the exposure to
desloratadine was approximately 2 and 2.5&#8209;fold greater in subjects with
mild to moderate and severe CRI, respectively, than in healthy subjects. In the
multiple&#8209;dose study, steady state was reached after Day&nbsp;11, and
compared to healthy subjects the exposure to desloratadine was ~1.5&#8209;fold
greater in subjects with mild to moderate CRI and ~2.5&#8209;fold greater in
subjects with severe CRI. In both studies, changes in exposure (AUC and C<sub>max</sub>)
of desloratadine and 3&#8209;hydroxydesloratadine were not clinically relevant.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>5.3&nbsp;&nbsp;&nbsp;&nbsp; Preclinical
safety data</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Desloratadine is
the primary active metabolite of loratadine. Non-clinical studies conducted
with desloratadine and loratadine demonstrated that there are no qualitative or
quantitative differences in the toxicity profile of desloratadine and
loratadine at comparable levels of exposure to desloratadine. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Non-clinical
data reveal no special hazard for humans based on conventional studies of
safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic
potential, toxicity to reproduction and development. The lack of carcinogenic
potential was demonstrated in studies conducted with desloratadine and
loratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.1&nbsp;&nbsp;&nbsp;&nbsp; List
of excipients</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoEndnoteText style='page-break-after:avoid'><span lang=EN-GB
style='font-size:11.0pt;layout-grid-mode:line'>sorbitol,</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt;layout-grid-mode:
line'>propylene glycol,</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>sucralose E 955,</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>hypromellose 2910,</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>sodium citrate dihydrate,</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>natural and artificial flavour (bubblegum),</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>citric acid anhydrous,</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>disodium edetate,</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>purified water</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.2&nbsp;&nbsp;&nbsp;&nbsp; Incompatibilities</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Not applicable.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.3&nbsp;&nbsp;&nbsp;&nbsp; Shelf
life</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>2 years</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.4&nbsp;&nbsp;&nbsp;&nbsp; Special
precautions for storage</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not freeze.
Store in the original package.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.5&nbsp;&nbsp;&nbsp;&nbsp; Nature
and contents of container</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius oral
solution, is supplied in <span style='layout-grid-mode:line'>30, 50, 60, 100,
120, 150, 225 and 300&nbsp;ml</span> size Type III amber glass bottles closed
with a plastic child resistant (C/R) screw closure having a multi-ply
polyethylene-faced liner. All packages except the 150 ml package are supplied
with a measuring spoon marked for doses of 2.5&nbsp;ml and 5&nbsp;ml. For the
150&nbsp;ml package, a measuring spoon or an oral measuring syringe is
provided, marked for doses of 2.5&nbsp;ml and 5&nbsp;ml.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Not all pack sizes
may be marketed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.6&nbsp;&nbsp;&nbsp;&nbsp; Special
precautions for disposal</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>No special
requirements.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION HOLDER</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Merck Sharp
&amp; Dohme B.V.</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>Waarderweg 39</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>2031 BN Haarlem</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>The Netherlands</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBERS </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EU/1/00/160/061-069</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DATE
OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt'>Date of first authorisation: </span><span
lang=EN-GB>15 January 2001</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt'>Date of latest renewal: 15 January 2006</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>10.&nbsp;&nbsp;&nbsp;&nbsp; DATE
OF REVISION OF THE TEXT</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Detailed information
on this medicinal product is available on the website of the European Medicines
Agency http://www.ema.europa.eu.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:70.8pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<h3 align=center style='margin:0in;text-align:center;line-height:normal;
page-break-after:auto'><span lang=EN-GB style='font-size:11.0pt'>ANNEX II</span></h3>

<p class=MsoNormal style='margin-top:0in;margin-right:70.9pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.9pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>A.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB>MANUFACTURERS RESPONSIBLE FOR BATCH
RELEASE</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.9pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.9pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>B.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB>CONDITIONS OR RESTRICTIONS REGARDING
SUPPLY AND USE</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.9pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoHeading9 style='margin-right:70.9pt;line-height:normal;page-break-after:
auto'><span lang=EN-GB>C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER CONDITIONS AND
REQUIREMENTS OF THE MARKETING AUTHORISATION</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.9pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.9pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <span
style='text-transform:uppercase'>conditions or restrictions with regard to the
safe and effective use of the medicinal product</span></span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.9pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=TitleB style='line-height:normal'><span lang=EN-GB>A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MANUFACTURERS
RESPONSIBLE FOR BATCH RELEASE</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Name and
address of the manufacturer responsible for batch release for film-coated
tablets</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>SP Labo N.V. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Industriepark 30</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>2220
Heist-op-den-Berg</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Belgium</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Name and
address of the manufacturer responsible for batch release for orodispersible
tablet</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>SP Labo N.V. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Industriepark 30</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>2220
Heist-op-den-Berg</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Belgium</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'>Name and
address of the manufacturer responsible for batch release for oral solution</span></u></p>

<p class=MsoBodyTextIndent align=left style='text-align:left;line-height:normal;
page-break-after:avoid'><u><span lang=EN-GB style='font-weight:normal'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>SP Labo N.V. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Industriepark 30</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>2220
Heist-op-den-Berg</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Belgium</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=TitleB style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CONDITIONS OR RESTRICTIONS
REGARDING SUPPLY AND USE</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Medicinal
product subject to medical prescription.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=TitleB style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER CONDITIONS AND REQUIREMENTS
OF THE MARKETING AUTHORISATION</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:.5in;text-indent:-.5in;line-height:normal;
page-break-after:avoid'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB>Periodic Safety Update Reports</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The marketing
authorisation holder shall submit periodic safety update reports for this
product in accordance with the requirements set out in the list of Union
reference dates (EURD list) provided for under Article 107c(7) of Directive
2001/83</span><span lang=EN-GB>/EC</span><span lang=EN-GB> and published on the
European medicines web&#8209;portal.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=TitleB style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CONDITIONS OR RESTRICTIONS WITH
REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT </span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:.5in;text-indent:-.5in;line-height:normal;
page-break-after:avoid'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB>Risk Management Plan (RMP)</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The MAH shall
perform the required pharmacovigilance activities and interventions detailed in
the agreed RMP presented in Module 1.8.2 of the Marketing Authorisation and any
agreed subsequent updates of the RMP.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>An updated RMP should be submitted:</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>At the request of the European Medicines Agency;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>&middot;<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Whenever the risk management system is modified,
especially as the result of new information being received that may lead to a significant
change to the benefit/risk profile or as the result of an important
(pharmacovigilance or risk minimisation) milestone being reached.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If the dates for
submission of a PSUR and the update of a RMP coincide, they can be submitted at
the same time.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>ANNEX III</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>LABELLING AND PACKAGE LEAFLET</span></b></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=TitleA><span lang=EN-GB>A. LABELLING</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB>PARTICULARS TO APPEAR ON
THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB>BOX OF 1, 2, 3, 5, 7, 10,
14, 15, 20, 21, 30, 50, 90, 100 TABLETS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius 5&nbsp;mg
film-coated tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>desloratadine</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE(S)</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Each tablet
contains 5&nbsp;mg desloratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Contains lactose.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>See leaflet for
further information.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>1&nbsp;film-coated
tablet </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>2 film-coated tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>3 film-coated tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>5 film-coated tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>7 film-coated tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>10 film-coated tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>14 film-coated tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>15 film-coated tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>20 film-coated tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>21 film-coated tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>30 film-coated tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>50 film-coated tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>90 film-coated tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>100 film-coated tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Swallow the
tablet whole with water.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Oral use</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Read the package
leaflet before use.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Keep out of the sight
and reach of children.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not store
above 30&deg;C. Store in the original package.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Merck Sharp
&amp; Dohme B.V.</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>Waarderweg 39</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>2031 BN Haarlem</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>The Netherlands</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER(S)</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EU/1/00/160/001<span
style='color:black;background:#BFBFBF'>&nbsp; 1 tablet</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/002&nbsp; 2 tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/003&nbsp; 3 tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/004&nbsp; 5 tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/005&nbsp; 7 tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/006&nbsp; 10 tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/007&nbsp; 14 tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/008&nbsp; 15 tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/009&nbsp; 20 tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/010&nbsp; 21 tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/011&nbsp; 30 tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/012&nbsp; 50 tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/036&nbsp; 90 tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/013&nbsp; 100 tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION
IN BRAILLE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:lightgrey'>2D barcode carrying the unique identifier
included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC:</span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB>MINIMUM PARTICULARS TO
APPEAR ON BLISTERS OR STRIPS</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB>BOX OF 1, 2, 3, 5, 7, 10,
14, 15, 20, 21, 30, 50, 90, 100 TABLETS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius&nbsp;5&nbsp;mg
tablet</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>desloratadine</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EXP</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Lot</span></p>

<p class=Uberschrift2 style='margin:0in;page-break-after:auto'><span
lang=EN-GB style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=Uberschrift2 style='margin:0in;page-break-after:auto'><span
lang=EN-GB style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER</span></b></p>

</div>

<p class=Uberschrift2 style='margin:0in'><span lang=EN-GB style='font-family:
"Times New Roman",serif'>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>PARTICULARS TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>BOX OF 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90, 100 ORODISPERSIBLE
TABLETS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius
2.5&nbsp;mg orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>desloratadine</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE(S)</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Each dose of
orodispersible tablet contains 2.5&nbsp;mg desloratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Contains
mannitol and aspartame.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>See leaflet for
further information.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>5 orodispersible
tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>6 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>10 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>12 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>15 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>18 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>20 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>30 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>50 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>60 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>90 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>100 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Oral use</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Read the package
leaflet before use.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Keep out of the sight
and reach of children.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Store in the
original package. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Merck Sharp
&amp; Dohme B.V.</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>Waarderweg 39</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>2031 BN Haarlem</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>The Netherlands</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER(S)</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EU/1/00/160/037&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <span
style='color:black;background:#BFBFBF'>5 orodispersible tablets</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/038&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/039&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/040&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/041&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/042&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/043&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/044&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/045&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/046&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 60
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/047&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 90
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/048&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 100
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION
IN BRAILLE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius
2.5&nbsp;mg orodispersible tablet</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:lightgrey'>2D barcode carrying the unique identifier
included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC:</span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Aerius
2.5&nbsp;mg orodispersible tablets</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>desloratadine</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Lot</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>PARTICULARS TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>BOX OF 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90, 100 ORODISPERSIBLE
TABLETS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius 5&nbsp;mg
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>desloratadine</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE(S)</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Each dose of
orodispersible tablet contains 5&nbsp;mg desloratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Contains
mannitol and aspartame.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>See leaflet for
further information.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>5 orodispersible
tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>6 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>10 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>12 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>15 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>18 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>20 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>30 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>50 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>60 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>90 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>100 orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Oral use</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Read the package
leaflet before use.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Keep out of the sight
and reach of children.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Store in the
original package. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Merck Sharp
&amp; Dohme B.V.</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>Waarderweg 39</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>2031 BN Haarlem</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>The Netherlands</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER(S)</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EU/1/00/160/049&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <span
style='color:black;background:#BFBFBF'>5 orodispersible tablets</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/050&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/051&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/052&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/053&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/054&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/055&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/056&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/057&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/058&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 60
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/059&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 90
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/060&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 100
orodispersible tablets</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION
IN BRAILLE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>Aerius 5&nbsp;mg orodispersible tablet</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:lightgrey'>2D barcode carrying the unique identifier
included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC:</span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB>MINIMUM PARTICULARS TO
APPEAR ON BLISTERS OR STRIPS</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Aerius
5&nbsp;mg orodispersible tablets</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>desloratadine</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Lot</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=Uberschrift2 style='margin:0in;page-break-after:auto'><span
lang=EN-GB style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>PARTICULARS TO APPEAR ON THE OUTER PACKAGING </span></b></p>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>BOTTLE OF 30&nbsp;ML, 50 ML, 60 ML, 100 ML, 120 ML, 150 ML, 225 ML,
300 ML</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius
0.5&nbsp;mg/ml oral solution</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>desloratadine</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; STATEMENT
OF ACTIVE SUBSTANCE(S)</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Each ml of oral solution
contains 0.5&nbsp;mg desloratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Contains propylene
glycol and sorbitol.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>See leaflet for
further information.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>oral solution</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>30 ml with 1
spoon</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>50&nbsp;ml with 1 spoon</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>60 ml with 1 spoon</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>100 ml with 1 spoon</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>120 ml with 1 spoon</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>150 ml with 1 spoon</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>150 ml with 1 oral syringe</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>225 ml with 1 spoon</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>300 ml with 1 spoon</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
AND ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Oral use</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Read the package
leaflet before use.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Keep out of the
sight and reach of children.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not freeze.
Store in the original package.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>10.&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>11.&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Merck Sharp
&amp; Dohme B.V.</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>Waarderweg 39</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>2031 BN Haarlem</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>The Netherlands</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>12.&nbsp;&nbsp;&nbsp;&nbsp; MARKETING
AUTHORISATION NUMBER(S)</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EU/1/00/160/061<span
style='color:black;background:#BFBFBF'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30
ml with 1 spoon</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/062&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50
ml with 1 spoon</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/063&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 60
ml with 1 spoon</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/064&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 100
ml with 1 spoon</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/065&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 120
ml with 1 spoon</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/066&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 150
ml with 1 spoon</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/069&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 150
ml with 1 oral syringe</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/067&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 225
ml with 1 spoon</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>EU/1/00/160/068&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 300
ml with 1 spoon</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>13.&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>14.&nbsp;&nbsp;&nbsp;&nbsp; GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>15.&nbsp;&nbsp;&nbsp;&nbsp; INSTRUCTIONS
ON USE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>16.&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION
IN BRAILLE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>Aerius</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER &#8211; 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:lightgrey'>2D barcode carrying the unique identifier
included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.&nbsp;&nbsp;&nbsp;&nbsp; UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC:</span></p>

<p class=MsoNormal><span lang=EN-GB>SN: </span></p>

<p class=MsoNormal><span lang=EN-GB>NN: </span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS</span></b></p>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>BOTTLE OF 30&nbsp;ML, 50 ML, 60 ML, 100 ML, 120 ML, 150 ML, 225 ML,
300 ML</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius
0.5&nbsp;mg/ml oral solution</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>desloratadine</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; METHOD
OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Oral use</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EXPIRY
DATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EXP </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BATCH
NUMBER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CONTENTS
BY WEIGHT, BY VOLUME OR BY UNIT</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>30&nbsp;ml</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>50 ml</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>60 ml</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>100 ml</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>120 ml</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>150 ml</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>225 ml</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#BFBFBF'>300 ml</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Contains propylene
glycol and sorbitol.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>See leaflet for
further information.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NAME
AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB
style='color:black;background:#BFBFBF'>Merck Sharp &amp; Dohme B.V.</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE
style='color:black;background:#BFBFBF'>Waarderweg 39</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE
style='color:black;background:#BFBFBF'>2031 BN Haarlem</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE style='color:black;
background:#BFBFBF'>The Netherlands</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Keep out of the sight
and reach of children.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not freeze.
Store in the original package.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=TitleA><span lang=EN-GB>B. PACKAGE LEAFLET</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>Package leaflet: Information for the patient</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoHeading8 style='line-height:normal;page-break-after:auto'><span
lang=EN-GB>Aerius 5&nbsp;mg film-coated tablets</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>desloratadine</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Read all of
this leaflet carefully before you start taking this medicine because it
contains important information for you.</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it
again.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor, pharmacist or nurse.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness
are the same as yours.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;text-autospace:none'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If
you get any side effects, talk to your doctor, pharmacist or nurse. This
includes any possible side effects not listed in this leaflet.</span><span
lang=EN-GB> <b>See section 4.</b></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What is in this leaflet</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Aerius is
and what it is used for</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need
to know before you take Aerius</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to take
Aerius</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side
effects</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store
Aerius</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the
pack and other information</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Aerius is and what it is
used for</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What Aerius is</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Aerius contains
desloratadine which is an antihistamine.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>How Aerius works</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Aerius is an
antiallergy medicine that does not make you drowsy. It helps control your
allergic reaction and its symptoms.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>When Aerius should be used</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius relieves
symptoms associated with allergic rhinitis (inflammation of the nasal passages
caused by an allergy, for example, hay fever or allergy to dust mites) in
adults and adolescents 12&nbsp;years of age and older. These symptoms include
sneezing, runny or itchy nose, itchy palate, and itchy, red or watery eyes. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius is also
used to relieve the symptoms associated with urticaria (a skin condition caused
by an allergy). These symptoms include itching and hives.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Relief of these
symptoms lasts a full day and helps you to resume your normal daily activities
and sleep.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you take Aerius</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Do not take Aerius</span></b></p>

<p class=MsoBodyTextIndent3 style='line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if
you are allergic to desloratadine, or any of the other ingredients of this
medicine (listed in section&nbsp;6) or to loratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Warnings and precautions</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Talk to your doctor, pharmacist or nurse before taking Aerius:</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you have poor kidney function.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you have medical or familial history of seizures.</span></p>

<p class=QRDBullet style='margin-left:0in;text-indent:0in'><span lang=EN-GB
style='color:windowtext'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Use in children and adolescents</span></b></p>

<p class=QRDBullet style='margin-left:0in;text-indent:0in'><span lang=EN-GB
style='color:windowtext'>Do not give this medicine to children less than 12&nbsp;years
of age. </span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Other medicines and Aerius</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>There are no
known interactions of Aerius with other medicines.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tell your doctor
or pharmacist if you are taking, have recently taken or might take any other
medicines.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Aerius with food, drink and alcohol</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius may be
taken with or without a meal. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Use caution when
taking Aerius with alcohol.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Pregnancy, breast-feeding and fertility</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If you are
pregnant or breast-feeding, think you may be pregnant or are planning to have a
baby, ask your doctor or pharmacist for advice before taking this medicine. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Taking Aerius is
not recommended if you are pregnant or nursing a baby. </span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Fertility</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>There is no data
available on male/female fertility.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Driving and using machines</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>At the
recommended dose, this medicine is not expected to affect your ability to drive
or use machines. Although most people do not experience drowsiness, it is
recommended not to engage in activities requiring mental alertness, such as
driving a car or operating machinery until you have established your own
response to the medicinal product. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Aerius contains lactose</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius tablets
contain lactose. If you have been told by your doctor that you have an
intolerance to some sugars, contact your doctor before taking this medicinal
product.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to take Aerius</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Always take this
medicine exactly as your doctor or pharmacist has told you. Check with your doctor
or pharmacist if you are not sure.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Adults and adolescents 12&nbsp;years of age and over</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The recommended
dose is one tablet once a day with water, with or without food.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This medicine is
for oral use.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Swallow the
tablet whole.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Regarding the
duration of treatment, your physician will determine the type of allergic
rhinitis you are suffering from and will determine for how long you should take
Aerius.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>If your allergic rhinitis is intermittent (presence of symptoms for
less than 4&nbsp;days per week or for less than 4&nbsp;weeks), your physician
will recommend you a treatment schedule that will depend on the evaluation of
the history of your disease.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>If your allergic rhinitis is persistent (presence of symptoms for
4&nbsp;days or more per week and for more than 4&nbsp;weeks), your physician
may recommend you a longer term treatment.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>For urticaria,
the duration of treatment may be variable from patient to patient and therefore
you should follow the instructions of your physician.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>If you take more Aerius than you should</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Take Aerius only
as it is prescribed for you. No serious problems are expected with accidental
overdose. However, if you take more Aerius than you were told to, tell your doctor,
pharmacist or nurse immediately.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>If you forget to take Aerius</span></b></p>

<p class=MsoBodyText3 style='margin-right:0in'><span lang=EN-GB
style='letter-spacing:0pt'>If you forget to take your dose on time, take it as soon
as possible and then go back to your regular dosing schedule. Do not take a
double dose to make up for a forgotten dose.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>If you stop taking Aerius</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If you have any
further questions on the use of this medicine, ask your doctor, pharmacist </span><span
lang=EN-GB>or nurse.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side effects</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Like all
medicines, this medicine can cause side effects, although not everybody gets
them. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>During the marketing of
Aerius, cases of severe allergic reactions (difficulty in breathing, wheezing,
itching, hives and swelling) have been reported very rarely. If you notice any
of these serious side effects, stop taking the medicine and seek urgent medical
advice straight away.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>In clinical studies in adults, side effects were
about the same as with a dummy tablet. However, fatigue, dry mouth and headache
were reported more often than with a dummy tablet.</span><span lang=EN-GB> In
adolescents, headache was the most commonly reported side effect.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='layout-grid-mode:line'>In clinical studies with Aerius, the
following side effects were reported as:</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='layout-grid-mode:line'>Common: the following may affect up to
1 in 10 people</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; fatigue</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; dry
mouth</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; headache</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid;text-autospace:
none'><u><span lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Adults</span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>During the
marketing of Aerius, the following side effects were reported as:</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Very rare: the
following may affect up to 1 in 10,000 people</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; severe allergic
reactions&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679; rash&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
pounding or irregular heartbeat</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; fast heartbeat&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
stomach ache&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
feeling sick (nausea)</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; vomiting&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
upset stomach&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
diarrhoea</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; dizziness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
drowsiness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
inability to sleep</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; muscle pain&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
hallucinations&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
seizures</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; restlessness with
increased&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
liver inflammation&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679; abnormal
liver function tests</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;&nbsp; body movement</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known:
frequency cannot be estimated from the available data</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679; unusual
weakness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
yellowing of the skin and/or eyes</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; increased
sensitivity of the skin to the sun,</span><span lang=EN-GB> even in case of
hazy sun, and to UV light, for instance to UV lights of a solarium</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; changes in the way
the heart beats</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679; a</span>bnormal
behaviour</p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679; a</span>ggression</p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679; weight
increased, increased appetite</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Children</span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known:
frequency cannot be estimated from the available data</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679;</span><span
lang=EN-GB> slow heartbeat&nbsp;&nbsp; </span><span lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;</span><span
lang=EN-GB> change in the way the heart beats</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679;</span><span
lang=EN-GB> abnormal behaviour&nbsp;&nbsp;&nbsp;&nbsp; </span><span lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
a</span>ggression</p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Reporting of side effects</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If you get any
side effects, talk to your doctor, pharmacist or nurse.</span><span lang=EN-GB>
This includes any possible side effects not listed in this leaflet. You can
also report side effects directly via <span style='color:black;background:#BFBFBF'>the
national reporting system listed in </span></span><span lang=EN-GB><a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span
style='background:#BFBFBF'>Appendix V</span></a></span><span lang=EN-GB>. By
reporting side effects you can help provide more information on the safety of
this medicine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store Aerius</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText3 style='margin-right:0in'><span lang=EN-GB
style='letter-spacing:0pt'>Keep this medicine out of the sight and reach of
children.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not use this
medicine after the expiry date which is stated on the carton and blister after
EXP. The expiry date refers to the last day of that month.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not store
above 30&deg;C. Store in the original package.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not use this
medicine if you notice any change in the appearance of the tablets.</span></p>

<p class=Uberschrift2 style='margin:0in;page-break-after:auto'><span
lang=EN-GB style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=Uberschrift2 style='margin:0in;page-break-after:auto'><span
lang=EN-GB style='font-family:"Times New Roman",serif;font-weight:normal'>Do
not throw away any medicines via wastewater or household waste. Ask your
pharmacist how to throw away medicines you no longer use. These measures will
help to protect the environment.</span><span lang=EN-GB style='font-family:
"Times New Roman",serif;font-weight:normal'> </span></p>

<p class=Uberschrift2 style='margin:0in;page-break-after:auto'><span
lang=EN-GB style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=Uberschrift2 style='margin:0in;page-break-after:auto'><span
lang=EN-GB style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What Aerius contains</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is desloratadine 5&nbsp;mg</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The other ingredients of the tablet are calcium
hydrogen phosphate dihydrate, microcrystalline cellulose, maize starch, talc.
Tablet coating contains film coat (containing lactose monohydrate,
hypromellose, titanium dioxide, macrogol&nbsp;400, indigotin (E132)), clear
coat (containing hypromellose, macrogol&nbsp;400), carnauba wax, white wax.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What Aerius looks like and contents of the pack</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Aerius
5&nbsp;mg film-coated tablets are packed in blisters in packs of 1, 2, 3, 5, 7,
10, 14, 15, 20, 21, 30, 50, 90 or 100&nbsp;tablets.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Not all pack
sizes may be marketed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Marketing Authorisation Holder and Manufacturer</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Marketing
Authorisation Holder: </span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Merck Sharp
&amp; Dohme B.V.</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>Waarderweg 39</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>2031 BN Haarlem</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>The Netherlands</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Manufacturer: SP
Labo N.V., Industriepark 30, B-2220 Heist-op-den-Berg, Belgium.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>For any
information about this medicinal product, please contact the local
representative of the Marketing Authorisation Holder:</span></p>

<p class=MsoNormal style='line-height:normal'><a name="OLE_LINK1"><span
lang=EN-GB>&nbsp;</span></a></p>

<div align=center>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse'>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Belgi&euml;/Belgique/Belgien</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD Belgium BVBA/SPRL</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>T&eacute;l/Tel:
  +32(0)27766211</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>dpoc_belux@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Lietuva</span></b></p>
  <p class=MsoBodyText style='line-height:normal'><span lang=EN-GB>UAB Merck
  Sharp &amp; Dohme</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel. + 370 5
  278 02 47</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msd_lietuva@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=RU>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=RU>&#1052;&#1077;&#1088;&#1082;
  &#1064;&#1072;&#1088;&#1087; &#1080; &#1044;&#1086;&#1091;&#1084;
  &#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;
  &#1045;&#1054;&#1054;&#1044;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#1058;&#1077;&#1083;.:
  +359 2 819 3737</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>info-msdbg@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Luxembourg/Luxemburg</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD Belgium
  BVBA/SPRL</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>T&eacute;l/Tel:
  +32(0)27766211</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>dpoc_belux@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&#268;esk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme s.r.o. </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +420 233 010 111 </span></p>
  <p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>dpoc_czechslovak@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Magyarorsz&aacute;g</span></b></p>
  <p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
  lang=EN-GB>MSD Pharma Hungary Kft.</span></p>
  <p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
  lang=EN-GB>Tel.: +36 1 888 5300</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>hungary_msd@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Danmark</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Organon Denmark ApS </span></p>
  <p class=MsoNormal><span lang=EN-GB>Tlf: + 45 4484 6800</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>info.denmark@organon.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Malta</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme Cyprus Limited</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: 8007 4433 (+356 99917558)</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>malta<b>_</b>info@merck<b>.</b>com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Deutschland</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>MSD SHARP &amp; DOHME GMBH</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: 0800 673 673 673 </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>(+49 (0) 89 4561 2612)</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>e-mail@msd.de</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Nederland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme B.V.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: </span><span
  lang=EN-GB>0800 9999000 (+31 23 5153153)</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>medicalinfo.nl@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Eesti</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme O&Uuml;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: + 372
  6144 200</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>msdeesti@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Norge</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>MSD (Norge) AS</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tlf: +47 32 20 73 00</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>msdnorge@msd.no</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&#917;&#955;&#955;&#940;&#948;&#945;</span></b></p>
  <p style='margin:0in'><span lang=EN-GB style='font-size:11.0pt;font-family:
  "Times New Roman",serif'>MSD </span><span lang=EN-GB style='font-size:11.0pt;
  font-family:"Times New Roman",serif'>&#913;.&#934;.&#914;.&#917;.&#917;.</span></p>
  <p style='margin:0in'><span lang=EN-GB style='font-size:11.0pt;font-family:
  "Times New Roman",serif'>&#932;&#951;&#955;</span><span lang=EN-GB
  style='font-size:11.0pt;font-family:"Times New Roman",serif'>: +30 210 98 97
  300</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>dpoc_greece@merck.com</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&Ouml;sterreich</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme Ges.m.b.H. </span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +43 (0) 1
  26 044</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msd-medizin@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Espa&ntilde;a</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Organon Salud,
  S.L.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +34 91
  591 12 79</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Polska</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD Polska Sp.
  z o.o.</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +48 22 549 51 00</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msdpolska@merck.com
  </span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>France</span></b></p>
  <p class=MsoNormal style='text-align:justify;line-height:normal'><span
  lang=EN-GB>Organon France</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:normal'><span
  lang=EN-GB>T&eacute;l: + 33 (0) 1 57 77 32 00</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Portugal</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme, Lda</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +351 21 </span><span
  lang=EN-GB>4465700</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>inform_pt@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Hrvatska</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme d.o.o.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: + 385 1
  6611 333</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>croatia_info@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Rom&acirc;nia</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme Romania S.R.L.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: + 40 21
  529 29 00</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msdromania@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Ireland</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +353 (0)1 2998700</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>medinfo_ireland@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Slovenija</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme, inovativna zdravila d.o.o.</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +386 1 5204 201</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>msd.slovenia@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&Iacute;sland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='layout-grid-mode:line'>Vistor hf.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>S&iacute;mi: +
  354 535 70 00</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Slovensk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme, s. r. o.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel:
  +421&nbsp;2&nbsp;58282010</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>dpoc_czechslovak@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=FI>Italia</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=FI>MSD Italia S.r.l. </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +39 06 361911</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>medicalinformation.it@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Suomi/Finland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD Finland Oy</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Puh/Tel: + 358
  (0)9 804 650</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>info@msd.fi</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&#922;&#973;&#960;&#961;&#959;&#962;</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme Cyprus Limited</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>&#932;&#951;&#955;.:  800 00 673</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (+357
  22866700) </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>cyprus_info@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Sverige</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme (Sweden) AB</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +46 77
  5700488</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>medicinskinfo@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Latvija</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>SIA Merck
  Sharp &amp; Dohme Latvija</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: + 371
  67364224</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msd_lv@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>United
  Kingdom</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme Limited</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +44 (0)
  1992 467272</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>medicalinformationuk@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
</table>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>This leaflet was last revised in</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Detailed
information on this medicine is available on the European Medicines Agency website
http://www.ema.europa.eu.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoHeading8 style='line-height:normal;page-break-after:auto'><span
lang=EN-GB>Package leaflet: Information for the patient</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>Aerius 2.5&nbsp;mg orodispersible tablets</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>desloratadine</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Read all of
this leaflet carefully before you start taking this medicine because it
contains important information for you.</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it
again.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor, pharmacist or nurse.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness
are the same as yours.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you get any side effects, talk to your
doctor, pharmacist or nurse. This includes any possible side effects not listed
in this leaflet. <b>See section 4.</b></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What is in this leaflet</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What
Aerius orodispersible tablet is and what it is used for</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What
you need to know before you take Aerius orodispersible tablet</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How
to take Aerius orodispersible tablet</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible
side effects</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How
to store Aerius orodispersible tablet</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents
of the pack and other information</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Aerius orodispersible
tablet is and what it is used for</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What Aerius is</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Aerius
contains desloratadine which is an antihistamine.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>How Aerius works</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Aerius
orodispersible tablet is an antiallergy medicine that does not make you drowsy.
It helps control your allergic reaction and its symptoms.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>When Aerius should be used</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius
orodispersible tablet relieves symptoms associated with allergic rhinitis
(inflammation of the nasal passages caused by an allergy, for example, hay
fever or allergy to dust mites) in adults, adolescents and children 6&nbsp;years
of age and older. These symptoms include sneezing, runny or itchy nose, itchy
palate, and itchy, red or watery eyes. </span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius
orodispersible tablet is also used to relieve the symptoms associated with
urticaria (a skin condition caused by an allergy). These symptoms include
itching and hives.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Relief of these
symptoms lasts a full day and helps you to resume your normal daily activities
and sleep.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you take Aerius orodispersible tablet</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Do not take Aerius orodispersible tablet</span></b></p>

<p class=MsoBodyTextIndent3 style='line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if
you are allergic to desloratadine, or any of the other ingredients of this
medicine (listed in section&nbsp;6) or to loratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Warnings and precautions</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Talk to your doctor, pharmacist or nurse before taking Aerius:</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you have poor kidney function.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you have medical or familial history of
seizures.</span></p>

<p class=QRDBullet style='margin-left:0in;text-indent:0in'><span lang=EN-GB
style='color:windowtext'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Use in children and adolescents</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not give this
medicine to children less than 6&nbsp;years of age. </span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Other medicines and Aerius</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>There are no
known interactions of Aerius with other medicines.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tell your doctor
or pharmacist if you are taking, have recently taken or might take any other
medicines.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Aerius orodispersible tablet with food, drink and alcohol</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Aerius orodispersible tablet does not need to be taken with water or
liquid. Additionally, Aerius orodispersible tablet may be taken with or without
a meal. Use caution when taking Aerius with alcohol.</span></p>

<p class=MsoEndnoteText><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Pregnancy, breast-feeding and fertility</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If you are
pregnant or breast-feeding, think you may be pregnant or are planning to have a
baby, ask your doctor or pharmacist for advice before taking this medicine. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Taking Aerius is
not recommended if you are pregnant or nursing a baby.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Fertility</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>There is no data
available on male/female fertility.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Driving and using machines</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>At the
recommended dose, this medicine is not expected to affect your ability to drive
or use machines. Although most people do not experience drowsiness, it is
recommended not to engage in activities requiring mental alertness, such as
driving a car or operating machinery until you have established your own
response to the medicinal product.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Aerius orodispersible tablet contains aspartame</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This product
contains aspartame. Aspartame is a source of phenylalanine, which may be
harmful for people with phenylketonuria.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to take Aerius
orodispersible tablet</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Always take this
medicine exactly as your doctor or pharmacist has told you. Check with your doctor
or pharmacist if you are not sure.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Adults and adolescents 12&nbsp;years of age and over</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The recommended
dose is two tablets once a day with or without food.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This medicine is
for oral use.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>Before using, carefully peel open the blister and
remove the dose of </span><span lang=EN-GB>orodispersible tablet<span
style='layout-grid-mode:line'> without crushing it. Place it in your mouth and
it will disperse immediately. Water or other liquid is not needed to swallow
the dose. </span>Take the dose immediately after removal from the blister.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Children from 6&nbsp;to 11&nbsp;years of age</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>The
recommended dose is one </span><span lang=EN-GB style='font-size:11.0pt'>tablet
once a day with or without food.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Regarding the
duration of treatment, your physician will determine the type of allergic
rhinitis you are</span><span lang=EN-GB> suffering from and will determine for
how long you should take Aerius orodispersible tablets.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>If your allergic rhinitis is intermittent (presence of symptoms for
less than 4&nbsp;days per week or for less than 4&nbsp;weeks), your physician
will recommend you a treatment schedule that will depend on the evaluation of
the history of your disease.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>If your allergic rhinitis is persistent (presence of symptoms for
4&nbsp;days or more per week and for more than 4 weeks), your physician may
recommend you a longer term treatment.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>For urticaria, the
duration of treatment may be variable from patient to patient and therefore you
should follow the instructions of your physician.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>If you take more Aerius orodispersible tablet than you should</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Take Aerius
orodispersible tablet only as prescribed for you. No serious problems are
expected with accidental overdose. However, if you take more Aerius
orodispersible tablet than you were told to, tell your doctor, pharmacist or
nurse immediately.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>If you forget to take Aerius orodispersible tablet</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If you forget to
take your dose on time, take it as soon as possible and then go back to your
regular dosing schedule. Do not take a double dose to make up for forgotten
individual doses.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>If you stop taking Aerius orodispersible tablet</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If you have any
further questions on the use of this medicine, ask your doctor, pharmacist </span><span
lang=EN-GB>or nurse.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side effects</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Like all
medicines, this medicine can cause side effects although not everybody gets
them.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>During the marketing of
Aerius, cases of severe allergic reactions (difficulty in breathing, wheezing,
itching, hives and swelling) have been reported very rarely. If you notice any
of these serious side effects, stop taking the medicine and seek urgent medical
advice straight away.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In clinical
studies in adults, side effects were about the same as with a dummy tablet.
However, fatigue, dry mouth and headache were reported more often than with a
dummy tablet.</span><span lang=EN-GB> In adolescents, headache was the most
commonly reported side effect.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>In clinical studies with Aerius, the following side effects were
reported as:</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Common: the following may affect up to 1 in 10 people</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; fatigue</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; dry
mouth</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; headache</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Adults</span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>During the marketing of Aerius, the following side effects were
reported as: </span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Very rare: the following may affect up to 1 in 10,000 people</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; severe allergic
reactions&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679; rash&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
pounding or irregular heartbeat</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; fast heartbeat&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
stomach ache&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
feeling sick (nausea)</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; vomiting&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
upset stomach&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
diarrhoea</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; dizziness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
drowsiness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
inability to sleep</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; muscle pain&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
hallucinations&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
seizures</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; restlessness with
increased &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
liver inflammation&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679; abnormal
liver function tests</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;&nbsp; body movement</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Not known: frequency cannot be estimated from the available data</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679; unusual
weakness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
yellowing of the skin and/or eyes</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; increased
sensitivity of the skin to the sun</span><span lang=EN-GB>, even in case of
hazy sun, and to UV light, for instance to UV lights of a solarium</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; changes in the way
the heart beats</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679; a</span>bnormal
behaviour</p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679; a</span>ggression</p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679; weight
increased, increased appetite</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Children</span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known:
frequency cannot be estimated from the available data</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679;</span><span
lang=EN-GB> slow heartbeat&nbsp;&nbsp; </span><span lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;</span><span
lang=EN-GB> change in the way the heart beats</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679;</span><span
lang=EN-GB> abnormal behaviour&nbsp;&nbsp;&nbsp;&nbsp; </span><span lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
a</span>ggression</p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Reporting of side effects</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If you get any
side effects, talk to your doctor, pharmacist or nurse.</span><span lang=EN-GB>
This includes any possible side effects not listed in this leaflet. You can
also report side effects directly via<span style='color:black;background:#BFBFBF'>
the national reporting system listed in </span></span><span lang=EN-GB><a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span
style='background:#BFBFBF'>Appendix V</span></a></span><span lang=EN-GB>. By
reporting side effects you can help provide more information on the safety of
this medicine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store Aerius
orodispersible tablet</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Keep this
medicine out of the sight and reach of children.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not use this
medicine after the expiry date which is stated on the carton and blister after
EXP. The expiry date refers to the last day of that month.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Store in the
original package.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not use this
medicine if you notice any change in the appearance of Aerius orodispersible
tablet.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=Uberschrift2 style='margin:0in;page-break-after:auto'><span
lang=EN-GB style='font-family:"Times New Roman",serif;font-weight:normal'>Do
not throw away any medicines via wastewater or household waste. Ask your
pharmacist how to throw away medicines you no longer use. These measures will
help to protect the environment.</span><span lang=EN-GB style='font-family:
"Times New Roman",serif;font-weight:normal'> </span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What Aerius orodispersible tablet contains</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is desloratadine
2.5&nbsp;mg</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other
ingredients are microcrystalline cellulose, pregelatinized starch, sodium
starch glycolate, magnesium stearate, butylated methacrylate copolymer,
crospovidone, sodium hydrogen carbonate, citric acid, colloidal silicon
dioxide, ferric oxide, mannitol, aspartame (E951) and flavour Tutti-Frutti.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What Aerius orodispersible tablet looks like and contents of the
pack</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=Uberschrift2 style='margin:0in;page-break-after:auto'><span
lang=EN-GB style='font-family:"Times New Roman",serif;font-weight:normal'>Aerius
2.5&nbsp;mg orodispersible tablet is light red, speckled, and round with
&#8220;K&#8221; branded on one side. Aerius orodispersible tablet is packed in
unit dose blisters in packs of
5,&nbsp;6,&nbsp;10,&nbsp;12,&nbsp;15,&nbsp;18,&nbsp;20,&nbsp;30,&nbsp;50,&nbsp;60,&nbsp;90
and 100&nbsp;doses of orodispersible tablet. Not all pack sizes may be
marketed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Marketing Authorisation Holder and Manufacturer</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Marketing
Authorisation Holder: </span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Merck Sharp
&amp; Dohme B.V.</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>Waarderweg 39</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>2031 BN Haarlem</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>The Netherlands</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Manufacturer: SP
Labo N.V., Industriepark 30, B-2220 Heist-op-den-Berg, Belgium.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>For any
information about this medicinal product, please contact the local
representative of the Marketing Authorisation Holder:</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div align=center>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse'>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Belgi&euml;/Belgique/Belgien</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD Belgium
  BVBA/SPRL</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>T&eacute;l/Tel:
  +32(0)27766211</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>dpoc_belux@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Lietuva</span></b></p>
  <p class=MsoBodyText style='line-height:normal'><span lang=EN-GB>UAB Merck
  Sharp &amp; Dohme</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel. + 370 5
  278 02 47</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msd_lietuva@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=RU>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=RU>&#1052;&#1077;&#1088;&#1082;
  &#1064;&#1072;&#1088;&#1087; &#1080; &#1044;&#1086;&#1091;&#1084;
  &#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;
  &#1045;&#1054;&#1054;&#1044;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#1058;&#1077;&#1083;.:
  +359 2 819 3737</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>info-msdbg@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Luxembourg/Luxemburg</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD Belgium
  BVBA/SPRL</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>T&eacute;l/Tel:
  +32(0)27766211</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>dpoc_belux@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&#268;esk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme s.r.o. </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +420 233 010 111 </span></p>
  <p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>dpoc_czechslovak@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Magyarorsz&aacute;g</span></b></p>
  <p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
  lang=EN-GB>MSD Pharma Hungary Kft.</span></p>
  <p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
  lang=EN-GB>Tel.: +36 1 888 5300</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>hungary_msd@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Danmark</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Organon Denmark ApS </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tlf: + 45 4484 6800</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>info.denmark@organon.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Malta</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme Cyprus Limited</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: 8007 4433 (+356 99917558)</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>malta<b>_</b>info@merck<b>.</b>com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Deutschland</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>MSD SHARP &amp; DOHME GMBH</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: 0800 673 673 673 </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>(+49 (0) 89 4561 2612)</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>e-mail@msd.de</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Nederland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme B.V.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: </span><span
  lang=EN-GB>0800 9999000 (+31 23 5153153)</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>medicalinfo.nl@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Eesti</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme O&Uuml;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: + 372
  6144 200</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>msdeesti@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Norge</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>MSD (Norge) AS</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tlf: +47 32 20 73 00</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>msdnorge@msd.no</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&#917;&#955;&#955;&#940;&#948;&#945;</span></b></p>
  <p style='margin:0in'><span lang=EN-GB style='font-size:11.0pt;font-family:
  "Times New Roman",serif'>MSD </span><span lang=EN-GB style='font-size:11.0pt;
  font-family:"Times New Roman",serif'>&#913;.&#934;.&#914;.&#917;.&#917;.</span></p>
  <p style='margin:0in'><span lang=EN-GB style='font-size:11.0pt;font-family:
  "Times New Roman",serif'>&#932;&#951;&#955;</span><span lang=EN-GB
  style='font-size:11.0pt;font-family:"Times New Roman",serif'>: +30 210 98 97
  300</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>dpoc_greece@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&Ouml;sterreich</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme Ges.m.b.H. </span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +43 (0) 1
  26 044</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msd-medizin@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Espa&ntilde;a</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Organon Salud,
  S.L.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +34 91
  591 12 79</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Polska</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD Polska Sp.
  z o.o.</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +48 22 549 51 00</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msdpolska@merck.com
  </span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>France</span></b></p>
  <p class=MsoNormal style='text-align:justify;line-height:normal'><span
  lang=EN-GB>Organon France</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:normal'><span
  lang=EN-GB>T&eacute;l: + 33 (0) 1 57 77 32 00</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Portugal</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme, Lda</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +351 21 </span><span
  lang=EN-GB>4465700</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>inform_pt@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Hrvatska</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme d.o.o.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: + 385 1
  6611 333</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>croatia_info@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Rom&acirc;nia</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme Romania S.R.L.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: + 40 21
  529 2900</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msdromania@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Ireland</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +353 (0)1 2998700</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>medinfo_ireland@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Slovenija</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme, inovativna zdravila d.o.o.</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +386 1 5204 201</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>msd.slovenia@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&Iacute;sland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='layout-grid-mode:line'>Vistor hf.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>S&iacute;mi: +
  354 535 70 00</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Slovensk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme, s. r. o.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel:
  +421&nbsp;2&nbsp;58282010</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>dpoc_czechslovak@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=FI>Italia</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=FI>MSD Italia S.r.l. </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +39 06 361911</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>medicalinformation.it@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Suomi/Finland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD Finland Oy</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Puh/Tel: + 358
  (0)9 804 650</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>info@msd.fi</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&#922;&#973;&#960;&#961;&#959;&#962;</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme Cyprus Limited</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>&#932;&#951;&#955;.:  800 00 673</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (+357
  22866700) </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>cyprus_info@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Sverige</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme (Sweden) AB</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +46 77
  5700488</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>medicinskinfo@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Latvija</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>SIA Merck
  Sharp &amp; Dohme Latvija</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: + 371
  67364224</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msd_lv@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>United
  Kingdom</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme Limited</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +44 (0)
  1992 467272</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>medicalinformationuk@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
</table>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>This leaflet was last revised in</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Detailed
information on this medicine is available on the European Medicines Agency website
http://www.ema.europa.eu.</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoHeading8 style='line-height:normal;page-break-after:auto'><span
lang=EN-GB>Package leaflet: Information for the patient</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>Aerius 5&nbsp;mg orodispersible tablets</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>desloratadine</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Read all of
this leaflet carefully before you start taking this medicine because it
contains important information for you.</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it
again.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor, pharmacist or nurse.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness
are the same as yours.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you get any side effects, talk to your
doctor, pharmacist or nurse. This includes any possible side effects not listed
in this leaflet. <b>See section 4.</b></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What is in this leaflet</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What
Aerius orodispersible tablet is and what it is used for</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What
you need to know before you take Aerius orodispersible tablet</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How
to take Aerius orodispersible tablet</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible
side effects</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How
to store Aerius orodispersible tablet</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the
pack and other information</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Aerius orodispersible
tablet is and what it is used for</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What Aerius is</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Aerius
contains desloratadine which is an antihistamine.</span></p>

<p class=MsoEndnoteText><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>How Aerius works</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Aerius
orodispersible tablet is an antiallergy medicine that does not make you drowsy.
It helps control your allergic reaction and its symptoms.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>When Aerius should be used</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius
orodispersible tablet relieves symptoms associated with allergic rhinitis
(inflammation of the nasal passages caused by an allergy, for example, hay
fever or allergy to dust mites) in adults and adolescents 12&nbsp;years of age
and older. These symptoms include sneezing, runny or itchy nose, itchy palate,
and itchy, red or watery eyes. </span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius
orodispersible tablet is also used to relieve the symptoms associated with
urticaria (a skin condition caused by an allergy). These symptoms include
itching and hives.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Relief of these
symptoms lasts a full day and helps you to resume your normal daily activities
and sleep.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you take Aerius orodispersible tablet</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Do not take Aerius orodispersible tablet</span></b></p>

<p class=MsoBodyTextIndent3 style='line-height:normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if
you are allergic to desloratadine, or any of the other ingredients of this
medicine (listed in section&nbsp;6) or to loratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Warnings and precautions</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Talk to your doctor, pharmacist or nurse before taking Aerius:</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you have poor kidney function.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you have medical or familial history of
seizures.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Use in children and adolescents</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not give this
medicine to children less than 12</span><span lang=EN-GB>&nbsp;years of age.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Other medicines and Aerius</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>There are no
known interactions of Aerius with other medicines.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tell your doctor
or pharmacist if you are taking, have recently taken or might take any other
medicines.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Aerius orodispersible tablet with food, drink and alcohol</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Aerius orodispersible tablet does not need to be taken with water or
liquid. Additionally, Aerius orodispersible tablet may be taken with or without
a meal. Use caution when taking Aerius with alcohol.</span></p>

<p class=MsoEndnoteText><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Pregnancy, breast-feeding and fertility</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If you are
pregnant or breast-feeding, think you may be pregnant or are planning to have a
baby, ask your doctor or pharmacist for advice before taking this medicine. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Taking Aerius is
not recommended if you are pregnant or nursing a baby.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Fertility</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>There is no data
available on male/female fertility.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Driving and using machines</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>At the recommended
dose, this medicine is not expected to affect your ability to drive or use
machines. Although most people do not experience drowsiness, it is recommended
not to engage in activities requiring mental alertness, such as driving a car
or operating machinery until you have established your own response to the
medicinal product.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Aerius orodispersible tablet contains aspartame</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This product
contains aspartame. Aspartame is a source of phenylalanine, which may be
harmful for people with phenylketonuria.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to take Aerius
orodispersible tablet</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Always take this
medicine exactly as your doctor or pharmacist has told you. Check with your
doctor or pharmacist if you are not sure. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Adults and adolescents 12&nbsp;years of age and over</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The recommended
dose is one tablet once a day with or without food.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This medicine is
for oral use.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>Before using, carefully peel open the blister and
remove the dose of </span><span lang=EN-GB>orodispersible tablet<span
style='layout-grid-mode:line'> without crushing it. Place it in your mouth and
it will disperse immediately. Water or other liquid is not needed to swallow
the dose. Take the dose immediately after removal from the blister.</span></span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Regarding the
duration of treatment, your physician will determine the type of allergic
rhinitis you are suffering from and will determine for how long you should take
Aerius orodispersible tablets.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>If your allergic rhinitis is intermittent (presence of symptoms for
less than 4&nbsp;days per week or for less than 4&nbsp;weeks), your physician
will recommend you a treatment schedule that will depend on the evaluation of
the history of your disease.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>If your allergic rhinitis is persistent (presence of symptoms for
4&nbsp;days or more per week and for more than 4 weeks), your physician may
recommend you a longer term treatment.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>For urticaria,
the duration of treatment may be variable from patient to patient and therefore
you should follow the instructions of your physician.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>If you take more Aerius orodispersible tablet than you should</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Take Aerius
orodispersible tablet only as prescribed for you. No serious problems are
expected with accidental overdose. However, if you take more Aerius
orodispersible tablet than you were told to, tell your doctor, pharmacist or
nurse immediately.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>If you forget to take Aerius orodispersible tablet</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If you forget to
take your dose on time, take it as soon as possible and then go back to your
regular dosing schedule. Do not take a double dose to make up for forgotten
individual doses.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>If you stop taking Aerius orodispersible tablet</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If you have any
further questions on the use of this medicine, ask your doctor, pharmacist </span><span
lang=EN-GB>or nurse.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side effects</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Like all
medicines, this medicine can cause side effects although not everybody gets
them.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>During the marketing of
Aerius, cases of severe allergic reactions (difficulty in breathing, wheezing,
itching, hives and swelling) have been reported very rarely. If you notice any
of these serious side effects, stop taking the medicine and seek urgent medical
advice straight away.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In clinical
studies in adults, side effects were about the same as with a dummy tablet.
However, fatigue, dry mouth and headache were reported more often than with a
dummy tablet.</span><span lang=EN-GB> In adolescents, headache was the most
commonly reported side effect.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In clinical studies
with Aerius, the following side effects were reported as:</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Common: the following may affect up to 1 in 10 people</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; fatigue</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; dry
mouth</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; headache</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Adults</span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>During the marketing of Aerius, the following side effects were
reported as:</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Very rare: the following may affect up to 1 in 10,000 people</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; severe allergic
reactions&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679; rash&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
pounding or irregular heartbeat</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; fast heartbeat&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
stomach ache&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
feeling sick (nausea)</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; vomiting&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
upset stomach&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
diarrhoea</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; dizziness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
drowsiness &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
inability to sleep</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; muscle pain&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
hallucinations&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
seizures</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; restlessness with
increased &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
liver inflammation&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679; abnormal
liver function tests</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;&nbsp; body movement</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Not known: frequency cannot be estimated from the available data</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679; unusual
weakness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
yellowing of the skin and/or eyes</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; increased
sensitivity of the skin to the sun,</span><span lang=EN-GB> even in case of
hazy sun, and to UV light, for instance to UV lights of a solarium</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; changes in the way
the heart beats</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679; a</span>bnormal
behaviour</p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679; a</span>ggression</p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679; weight increased,
increased appetite</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Children</span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known:
frequency cannot be estimated from the available data</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679;</span><span
lang=EN-GB> slow heartbeat&nbsp;&nbsp; </span><span lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;</span><span
lang=EN-GB> change in the way the heart beats</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679;</span><span
lang=EN-GB> abnormal behaviour&nbsp;&nbsp;&nbsp;&nbsp; </span><span lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
a</span>ggression</p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Reporting of side effects</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If you get any
side effects, talk to your doctor, pharmacist or nurse.</span><span lang=EN-GB>
This includes any possible side effects not listed in this leaflet. You can
also report side effects directly via<span style='color:black;background:#BFBFBF'>
the national reporting system listed in </span></span><span lang=EN-GB><a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span
style='background:#BFBFBF'>Appendix V</span></a></span><span lang=EN-GB>. By
reporting side effects you can help provide more information on the safety of
this medicine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store Aerius
orodispersible tablet</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Keep this
medicine out of the sight and reach of children.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not use this
medicine after the expiry date which is stated on the carton and blister after
EXP. The expiry date refers to the last day of that month.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Store in the
original package.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not use this
medicine if you notice any change in the appearance of Aerius orodispersible
tablet.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=Uberschrift2 style='margin:0in;page-break-after:auto'><span
lang=EN-GB style='font-family:"Times New Roman",serif;font-weight:normal'>Do
not throw away any medicines via wastewater or household waste. Ask your
pharmacist how to throw away medicines you no longer use. These measures will help
to protect the environment.</span><span lang=EN-GB style='font-family:"Times New Roman",serif;
font-weight:normal'> </span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What Aerius orodispersible tablet contains</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is desloratadine 5&nbsp;mg</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other
ingredients are microcrystalline cellulose, pregelatinized starch, sodium
starch glycolate, magnesium stearate, butylated methacrylate copolymer,
crospovidone, sodium hydrogen carbonate, citric acid, colloidal silicon
dioxide, ferric oxide, mannitol, aspartame (E951) and flavour Tutti-Frutti. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What Aerius orodispersible tablet looks like and contents of the
pack</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Aerius
5&nbsp;mg orodispersible tablet is light red, speckled, and round with
&#8220;A&#8221; branded on one side</span><span lang=EN-GB style='font-size:
11.0pt'>. </span><span lang=EN-GB style='font-size:11.0pt'>Aerius
orodispersible tablet</span><span lang=EN-GB style='font-size:11.0pt'> </span><span
lang=EN-GB style='font-size:11.0pt'>is packed in unit dose blisters in packs of
5,&nbsp;6,&nbsp;10,&nbsp;12,&nbsp;15,&nbsp;18,&nbsp;20,&nbsp;30,&nbsp;50,&nbsp;60,&nbsp;90
and 100&nbsp;doses of orodispersible tablet.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Not all pack
sizes may be marketed.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Marketing Authorisation Holder and Manufacturer</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Marketing
Authorisation Holder: </span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Merck Sharp
&amp; Dohme B.V.</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>Waarderweg 39</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>2031 BN Haarlem</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>The Netherlands</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Manufacturer: SP
Labo N.V., Industriepark 30, B-2220 Heist-op-den-Berg, Belgium.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>For any
information about this medicinal product, please contact the local
representative of the Marketing Authorisation Holder:</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div align=center>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse'>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Belgi&euml;/Belgique/Belgien</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD Belgium
  BVBA/SPRL</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>T&eacute;l/Tel:
  +32(0)27766211</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>dpoc_belux@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Lietuva</span></b></p>
  <p class=MsoBodyText style='line-height:normal'><span lang=EN-GB>UAB Merck
  Sharp &amp; Dohme</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel. + 370 5
  278 02 47</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msd_lietuva@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=RU>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=RU>&#1052;&#1077;&#1088;&#1082;
  &#1064;&#1072;&#1088;&#1087; &#1080; &#1044;&#1086;&#1091;&#1084;
  &#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;
  &#1045;&#1054;&#1054;&#1044;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#1058;&#1077;&#1083;.:
  +359 2 819 3737</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>info-msdbg@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Luxembourg/Luxemburg</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD Belgium
  BVBA/SPRL</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>T&eacute;l/Tel:
  +32(0)27766211</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>dpoc_belux@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&#268;esk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme s.r.o. </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +420 233 010 111 </span></p>
  <p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>dpoc_czechslovak@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Magyarorsz&aacute;g</span></b></p>
  <p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
  lang=EN-GB>MSD Pharma Hungary Kft.</span></p>
  <p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
  lang=EN-GB>Tel.: +36 1 888 5300</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>hungary_msd@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Danmark</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Organon Denmark ApS</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tlf: + 45 4484 6800</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>info.denmark@organon.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Malta</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme Cyprus Limited</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: 8007 4433 (+356 99917558)</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>malta<b>_</b>info@merck<b>.</b>com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Deutschland</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>MSD SHARP &amp; DOHME GMBH</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: 0800 673 673 673 </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>(+49 (0) 89 4561 2612)</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>e-mail@msd.de</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Nederland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme B.V.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: </span><span
  lang=EN-GB>0800 9999000 (+31 23 5153153)</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>medicalinfo.nl@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Eesti</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme O&Uuml;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: + 372
  6144 200</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>msdeesti@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Norge</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>MSD (Norge) AS</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tlf: +47 32 20 73 00</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>msdnorge@msd.no</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&#917;&#955;&#955;&#940;&#948;&#945;</span></b></p>
  <p style='margin:0in'><span lang=EN-GB style='font-size:11.0pt;font-family:
  "Times New Roman",serif'>MSD </span><span lang=EN-GB style='font-size:11.0pt;
  font-family:"Times New Roman",serif'>&#913;.&#934;.&#914;.&#917;.&#917;.</span></p>
  <p style='margin:0in'><span lang=EN-GB style='font-size:11.0pt;font-family:
  "Times New Roman",serif'>&#932;&#951;&#955;</span><span lang=EN-GB
  style='font-size:11.0pt;font-family:"Times New Roman",serif'>: +30 210 98 97
  300</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>dpoc_greece@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&Ouml;sterreich</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme Ges.m.b.H. </span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +43 (0) 1
  26 044</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msd-medizin@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Espa&ntilde;a</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Organon Salud,
  S.L.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +34 91
  591 12 79</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:normal'><span
  lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Polska</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD Polska Sp.
  z o.o.</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +48 22 549 51 00</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msdpolska@merck.com
  </span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>France</span></b></p>
  <p class=MsoNormal style='text-align:justify;line-height:normal'><span
  lang=EN-GB>Organon France</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:normal'><span
  lang=EN-GB>T&eacute;l: + 33 (0) 1 57 77 32 00</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Portugal</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme, Lda</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +351 21 </span><span
  lang=EN-GB>4465700</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>inform_pt@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Hrvatska</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme d.o.o.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: + 385 1
  6611 333</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>croatia_info@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Rom&acirc;nia</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme Romania S.R.L.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: + 40 21
  529 29 00</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msdromania@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Ireland</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +353 (0)1 2998700</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>medinfo_ireland@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Slovenija</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme, inovativna zdravila d.o.o.</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +386 1 5204 201</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>msd.slovenia@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&Iacute;sland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='layout-grid-mode:line'>Vistor hf.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>S&iacute;mi: +
  354 535 7000</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Slovensk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme, s. r. o.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel:
  +421&nbsp;2&nbsp;58282010</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>dpoc_czechslovak@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=FI>Italia</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=FI>MSD Italia S.r.l. </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +39 06 361911</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>medicalinformation.it@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Suomi/Finland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD Finland Oy</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Puh/Tel: + 358
  (0)9 804 650</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>info@msd.fi</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&#922;&#973;&#960;&#961;&#959;&#962;</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme Cyprus Limited</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>&#932;&#951;&#955;.:  800 00 673</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (+357
  22866700) </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>cyprus_info@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Sverige</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme (Sweden) AB</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +46 77
  5700488</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>medicinskinfo@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Latvija</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>SIA Merck
  Sharp &amp; Dohme Latvija</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: + 371
  67364224</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msd_lv@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>United
  Kingdom</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme Limited</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +44 (0)
  1992 467272</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>medicalinformationuk@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
</table>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoCaption style='page-break-after:avoid'><span lang=EN-GB>This
leaflet was last revised in</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Detailed
information on this medicine is available on the European Medicines Agency website
http://www.ema.europa.eu.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>Package leaflet: Information for the patient</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoHeading8 style='line-height:normal;page-break-after:auto'><span
lang=EN-GB>Aerius 0.5&nbsp;mg/ml oral solution</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>desloratadine</span></p>

<p class=MsoNormal style='line-height:normal'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Read all of
this leaflet carefully before you start taking this medicine because it
contains important information for you.</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it
again.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor, pharmacist or nurse.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if their signs of illness
are the same as yours.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you get any side effects, talk to your
doctor, pharmacist or nurse. This includes any possible side effects not listed
in this leaflet. <b>See section 4.</b></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What is in this leaflet</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Aerius oral
solution is and what it is used for</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need
to know before you take Aerius oral solution</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to take
Aerius oral solution</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side
effects</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store
Aerius oral solution</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the
pack and other information</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Aerius oral solution is
and what it is used for</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What Aerius is</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Aerius contains
desloratadine which is an antihistamine.</span></p>

<p class=MsoEndnoteText><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>How Aerius works</span></b></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Aerius oral
solution is an antiallergy medicine that does not make you drowsy. It helps
control your allergic reaction and its symptoms.</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>When Aerius should be used</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius oral
solution relieves symptoms associated with allergic rhinitis (inflammation of
the nasal passages caused by an allergy, for example, hay fever or allergy to
dust mites) in adults, adolescents and children 1&nbsp;year of age and older. These
symptoms include sneezing, runny or itchy nose, itchy palate, and itchy, red or
watery eyes. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius oral
solution is also used to relieve the symptoms associated with urticaria (a skin
condition caused by an allergy). These symptoms include itching and hives.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Relief of these symptoms
lasts a full day and helps you to resume your normal daily activities and
sleep.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What you need to know before
you take Aerius oral solution</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Do not take Aerius oral solution</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are
allergic to desloratadine, or to any of the other ingredients of this medicine
(listed in section&nbsp;6) or to loratadine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Warnings and precautions</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Talk to your doctor, pharmacist or nurse before taking Aerius:</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you have poor kidney function.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you have medical or familial history of
seizures.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Use in children and adolescents</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not give this
medicine to children less than 1</span><span lang=EN-GB>&nbsp;year of age.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Other medicines and Aerius</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>There are no
known interactions of Aerius with other medicines.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tell your doctor
or pharmacist if you are taking, have recently taken or might take any other
medicines.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Aerius oral solution with food, drink and alcohol</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Aerius may be taken with or without a meal. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Use caution when
taking Aerius with alcohol.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Pregnancy, breast-feeding and fertility</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If you are
pregnant or breast-feeding, think you may be pregnant or are planning to have a
baby, ask your doctor or pharmacist for advice before taking this medicine. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Taking Aerius
oral solution is not recommended if you are pregnant or nursing a baby.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Fertility</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>There is no data
available on male/female fertility.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Driving and using machines</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>At the
recommended dose, this medicine is not expected to affect your ability to drive
or use machines. Although most people do not experience drowsiness, it is
recommended not to engage in activities requiring mental alertness, such as driving
a car or operating machinery until you have established your own response to
the medicinal product.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Aerius oral solution contains sorbitol</span></b></p>

<p class=MsoBodyText align=left style='text-align:left;line-height:normal'><span
lang=EN-GB>Aerius oral solution contains sorbitol. If you have been told by
your doctor that you have an intolerance to some sugars, contact your doctor
before taking this medicinal product.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to take Aerius oral
solution</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Always take this
medicine exactly as your doctor or pharmacist has told you. Check with your
doctor or pharmacist if you are not sure.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Children</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Children
1&nbsp;through&nbsp;5&nbsp;years of age: </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The recommended
dose is 2.5&nbsp;ml (&frac12; of a 5&nbsp;ml spoonful) of oral solution once a
day.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Children
6&nbsp;through&nbsp;11&nbsp;years of age: </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The recommended
dose is 5&nbsp;ml (one 5&nbsp;ml spoonful) of oral solution once a day.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Adults and adolescents 12&nbsp;years of age and over</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The recommended
dose is 10&nbsp;ml (two 5&nbsp;ml spoonfuls) of oral solution once a day.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In case an oral
measuring syringe is provided with the bottle of oral solution, you can
alternatively use it to take the appropriate amount of oral solution.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This medicine is
for oral use.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Swallow the dose
of oral solution and then drink some water. You can take this medicine with or
without food.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Regarding the
duration of treatment, your physician will determine the type of allergic
rhinitis you are suffering from and will determine for how long you should take
Aerius oral solution.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>If your allergic rhinitis is intermittent (presence of symptoms for
less than 4&nbsp;days per week or for less than 4&nbsp;weeks), your physician
will recommend you a treatment schedule that will depend on the evaluation of
the history of your disease.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>If your allergic rhinitis is persistent (presence of symptoms for
4&nbsp;days or more per week and for more than 4 weeks), your physician may
recommend you a longer term treatment.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>For urticaria,
the duration of treatment may be variable from patient to patient and therefore
you should follow the instructions of your physician.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>If you take more Aerius oral solution than you should</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Take Aerius oral
solution only as it is prescribed for you. No serious problems are expected
with accidental overdose. However, if you take more Aerius oral solution than
you were told to, tell your doctor, pharmacist or nurse immediately.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>If you forget to take Aerius oral solution</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If you forget to
take your dose on time, take it as soon as possible and then go back to your
regular dosing schedule. Do not take a double dose to make up for a forgotten
dose.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>If you stop taking Aerius oral solution</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If you have any
further questions on the use of this medicine, ask your doctor, pharmacist </span><span
lang=EN-GB>or nurse.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a name="OLE_LINK3">Possible
side effects</a></span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>Like all medicines, this medicine can cause side
effects, although not everybody gets them. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>During the marketing of
Aerius, cases of severe allergic reactions (difficulty in breathing, wheezing,
itching, hives and swelling) have been reported very rarely. If you notice any
of these serious side effects, stop taking the medicine and seek urgent medical
advice straight away.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='layout-grid-mode:line'>In clinical studies in most children and adults,
side effects with Aerius were about the same as with a dummy solution or
tablet. However, common side effects in children less than 2&nbsp;years of age
were diarrhoea, fever and insomnia while in adults, fatigue, dry mouth and
headache were reported more often than with a dummy tablet.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>In clinical studies with Aerius, the following side effects were
reported as:</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Children</span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Common in children less than 2&nbsp;years of age: the following may
affect up to 1 in 10 children</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; diarrhoea</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; fever </span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; insomnia</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid;text-autospace:
none'><u><span lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Adults</span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Common: the
following may affect up to 1 in 10 people</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; fatigue</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; dry
mouth</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; headache</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>During the
marketing of Aerius, </span><span lang=EN-GB>the following side effects were
reported as:</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid;text-autospace:
none'><u><span lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Adults</span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Very rare: the following may aff<span style='letter-spacing:-.15pt;
layout-grid-mode:line'>ect up to 1 in 10,000 people</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; severe allergic
reactions&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679; rash&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
pounding or irregular heartbeat</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; fast heartbeat&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
stomach ache&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
feeling sick (nausea)</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; vomiting&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
upset stomach&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
diarrhoea</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; dizziness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
drowsiness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
inability to sleep</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; muscle pain&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
hallucinations&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
seizures</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; restlessness with
increased &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
liver inflammation&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679; abnormal
liver function tests</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;&nbsp;&nbsp;body
movement</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not </span><span
lang=EN-GB>known: frequency</span><span lang=EN-GB> </span><span lang=EN-GB>cannot
be estimated from the available data</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679; unusual
weakness&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
yellowing of the skin and/or eyes</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; increased
sensitivity of the skin to the sun,</span><span lang=EN-GB> even in case of
hazy sun, and to UV light, for instance to UV lights of a solarium</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='letter-spacing:-.15pt;layout-grid-mode:line'>&#9679; changes in the way
the heart beats</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679; a</span>bnormal
behaviour</p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679; a</span>ggression</p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679; weight
increased, increased appetite</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Children</span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB style='letter-spacing:-.15pt;layout-grid-mode:line'>Not known:
frequency cannot be estimated from the available data</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679;</span><span
lang=EN-GB> slow heartbeat&nbsp;&nbsp; </span><span lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;</span><span
lang=EN-GB> change in the way the heart beats</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#9679;</span><span
lang=EN-GB> abnormal behaviour&nbsp;&nbsp;&nbsp;&nbsp; </span><span lang=EN-GB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9679;
a</span>ggression</p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Reporting of side effects</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If you get any
side effects, talk to your doctor, pharmacist or nurse.</span><span lang=EN-GB>
This includes any possible side effects not listed in this leaflet. You can
also report side effects directly via<span style='color:black;background:#BFBFBF'>
the national reporting system listed in </span></span><span lang=EN-GB><a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span
style='background:#BFBFBF'>Appendix V</span></a></span><span lang=EN-GB>. By
reporting side effects you can help provide more information on the safety of
this medicine.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store Aerius oral
solution</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Keep this
medicine out of the sight and reach of children.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not use this
medicine after the expiry date which is stated on the bottle after EXP. The
expiry date refers to the last day of that month.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not freeze.
Store in the original package.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not use this
medicine if you notice any change in the appearance of the oral solution.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=Uberschrift2 style='margin:0in;page-break-after:auto'><span
lang=EN-GB style='font-family:"Times New Roman",serif;font-weight:normal'>Do
not throw away any medicines via wastewater or household waste. Ask your
pharmacist how to throw away medicines you no longer use. These measures will
help to protect the environment.</span><span lang=EN-GB style='font-family:
"Times New Roman",serif;font-weight:normal'> </span></p>

<p class=Uberschrift2 style='margin:0in;page-break-after:auto'><span
lang=EN-GB style='font-family:"Times New Roman",serif;font-weight:normal'>&nbsp;</span></p>

<p class=Uberschrift2 style='margin:0in;page-break-after:auto'><span
lang=EN-GB style='font-family:"Times New Roman",serif;font-weight:normal'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contents of the pack and
other information</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What Aerius oral solution contains</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The active substance is desloratadine
0.5&nbsp;mg/ml</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The other ingredients of the oral solution are <span
style='layout-grid-mode:line'>sorbitol, propylene glycol, sucralose E 955,
hypromellose 2910, sodium citrate dihydrate, natural and artificial flavour
(bubblegum), citric acid anhydrous, disodium edetate and purified water.</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>What Aerius oral solution looks like and contents of the pack</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Aerius oral
solution is available in bottles of <span style='layout-grid-mode:line'>30, 50,
60, 100, 120, 150, 225 and 300&nbsp;</span>ml, with a childproof cap. For all
packages except the 150 ml bottle, a measuring spoon is provided, marked for
doses of 2.5&nbsp;ml and 5&nbsp;ml. For the 150&nbsp;ml package, a measuring
spoon or an oral measuring syringe is provided, marked for doses of 2.5&nbsp;ml
and 5&nbsp;ml. </span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>Not all pack
sizes may be marketed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>Marketing Authorisation Holder and Manufacturer</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Marketing
Authorisation Holder: </span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>Merck Sharp
&amp; Dohme B.V.</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>Waarderweg 39</span></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=DE>2031 BN Haarlem</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE>The Netherlands</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Manufacturer: SP
Labo N.V., Industriepark 30, B-2220 Heist-op-den-Berg, Belgium.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>For any
information about this medicinal product, please contact the local
representative of the Marketing Authorisation Holder:</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div align=center>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse'>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Belgi&euml;/Belgique/Belgien</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD Belgium
  BVBA/SPRL</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>T&eacute;l/Tel:
  +32(0)27766211</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>dpoc_belux@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Lietuva</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>UAB Merck
  Sharp &amp; Dohme</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel. + 370 5
  278 02 47</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msd_lietuva@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=RU>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=RU>&#1052;&#1077;&#1088;&#1082;
  &#1064;&#1072;&#1088;&#1087; &#1080; &#1044;&#1086;&#1091;&#1084;
  &#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;
  &#1045;&#1054;&#1054;&#1044;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&#1058;&#1077;&#1083;.:
  +359 2 819 3737</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>info-msdbg@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Luxembourg/Luxemburg</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD Belgium
  BVBA/SPRL</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>T&eacute;l/Tel:
  +32(0)27766211</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>dpoc_belux@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&#268;esk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme s.r.o. </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +420 233 010 111 </span></p>
  <p class=MsoEndnoteText><span lang=EN-GB style='font-size:11.0pt'>dpoc_czechslovak@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Magyarorsz&aacute;g</span></b></p>
  <p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
  lang=EN-GB>MSD Pharma Hungary Kft.</span></p>
  <p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
  lang=EN-GB>Tel.: +36 1 888 5300</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>hungary_msd@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Danmark</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Organon Denmark ApS </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tlf: + 45 4484 6800</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>info.denmark@organon.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Malta</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme Cyprus Limited</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: 8007 4433 (+356 99917558)</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>malta<b>_</b>info@merck<b>.</b>com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Deutschland</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>MSD SHARP &amp; DOHME GMBH</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: 0800 673 673 673 </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>(+49 (0) 89 4561 2612)</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>e-mail@msd.de</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Nederland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme B.V.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: </span><span
  lang=EN-GB>0800 9999000 (+31 23 5153153)</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>medicalinfo.nl@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Eesti</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme O&Uuml;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +372 6144
  200</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>msdeesti@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Norge</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>MSD (Norge) AS</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tlf: +47 32 20 73 00</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>msdnorge@msd.no</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&#917;&#955;&#955;&#940;&#948;&#945;</span></b></p>
  <p style='margin:0in'><span lang=EN-GB style='font-size:11.0pt;font-family:
  "Times New Roman",serif'>MSD </span><span lang=EN-GB style='font-size:11.0pt;
  font-family:"Times New Roman",serif'>&#913;.&#934;.&#914;.&#917;.&#917;.</span></p>
  <p style='margin:0in'><span lang=EN-GB style='font-size:11.0pt;font-family:
  "Times New Roman",serif'>&#932;&#951;&#955;</span><span lang=EN-GB
  style='font-size:11.0pt;font-family:"Times New Roman",serif'>: +30 210 98 97
  300</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>dpoc_greece@merck.com</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&Ouml;sterreich</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme Ges.m.b.H. </span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +43 (0) 1
  26 044</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msd-medizin@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Espa&ntilde;a</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Organon Salud,
  S.L.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +34 91
  591 12 79</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Polska</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD Polska Sp.
  z o.o.</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +48 22 549 51 00</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msdpolska@merck.com
  </span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>France</span></b></p>
  <p class=MsoNormal style='text-align:justify;line-height:normal'><span
  lang=EN-GB>Organon France</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:normal'><span
  lang=EN-GB>T&eacute;l: + 33 (0) 1 57 77 32 00</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Portugal</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme, Lda</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +351 21 </span><span
  lang=EN-GB>4465700</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>inform_pt@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Hrvatska</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme d.o.o.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: + 385 1
  6611 333</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>croatia_info@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Rom&acirc;nia</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme Romania S.R.L.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: + 40 21
  529 29 00</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msdromania@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Ireland</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +353 (0)1 2998700</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>medinfo_ireland@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Slovenija</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme, inovativna zdravila d.o.o.</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +386 1 5204 201</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>msd.slovenia@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&Iacute;sland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB
  style='layout-grid-mode:line'>Vistor hf.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>S&iacute;mi: +
  354 535 7000</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Slovensk&aacute;
  republika</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme, s. r. o.</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel:
  +421&nbsp;2&nbsp;58282010</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>dpoc_czechslovak@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=FI>Italia</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=FI>MSD Italia S.r.l. </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Tel: +39 06 361911</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>medicalinformation.it@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Suomi/Finland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MSD Finland Oy</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Puh/Tel: + 358
  (0)9 804 650</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>info@msd.fi</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&#922;&#973;&#960;&#961;&#959;&#962;</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>Merck Sharp &amp; Dohme Cyprus Limited</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>&#932;&#951;&#955;.:  800 00 673</span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>(+357 22866700) </span></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=EN-GB>cyprus_info@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Sverige</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme (Sweden) AB</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +46 77
  5700488</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>medicinskinfo@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='page-break-inside:avoid'>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Latvija</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>SIA Merck
  Sharp &amp; Dohme Latvija</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: + 371
  67364224</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>msd_lv@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="50%" valign=top style='width:50.0%;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>United
  Kingdom</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Merck Sharp
  &amp; Dohme Limited</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +44 (0)
  1992 467272</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>medicalinformationuk@merck.com</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
</table>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>This leaflet was last revised in</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Detailed
information on this medicine is available on the European Medicines Agency website
http://www.ema.europa.eu.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

</div>

</body>

</html>
